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Abstract
Large conductance calcium- and voltage-activated potassium (BK) channels are
important determinants of endocrine, vascular and neuronal cell excitability, displaying
diverse regulation through several mechanisms including reversible protein
phosphorylation. Although transcribed from only one gene (KCNMA1), native BK
channels achieve functional and regulatory diversity through alternative splicing of pre-
mRNA. This is exemplified by the different response of two major BK channel splice
variants to protein kinase A (PKA). Channels expressing a unique, 58 residue, cysteine-
rich insert (STREX) located within the intracellular C-terminal domain of the channel
are inhibited by PKA, whereas channels lacking this insert (ZERO) are activated. This
suggests that splicing of the BK channel gene is critical to the regulation of BK channels
by reversible phosphorylation. However, whether the BK channel a-subunit is
phosphorylated directly by PKA or if the kinase associates as part of a signalling
complex with the mammalian channel protein is undetermined. Thus, this thesis aimed
to investigate the molecular nature of the regulation and interaction of PKA with BK
channel variants.
Two experimental strategies were pursued: i.) generation of recombinant fusion proteins
of the BK channel a-subunit C-terminal domain to identify putative PKA consensus
phosphorylation sites and domains critical to the assembly of a PKA-BK channel
complex, and ii.) generation and expression of epitope-tagged full-length channels in a
heterologous expression system to enable the investigation of channel phosphorylation
and complex assembly in vivo.
v
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In conjunction with site-directed mutagenesis, biochemical phosphorylation analyses
and the development of phospho-specific antibodies revealed a conserved PKA
phosphorylation site at serine residue, S869, that is also a potential target for CaMKII
but not PKC. In addition, a STREX insert serine residue, STREX S4, was identified as a
PKA-mediated phosphorylation target, possibly functioning as a PKC but not CaMKII
phosphorylation target residue.
The catalytic subunit of PKA co-immunoprecipitated with both the STREX and ZERO
BK channel splice variants in vivo and complex assembly was dependent upon a
conserved leucine zipper motif, LZ1, within the C-terminal domain of the BK channel
a-subunit. PKA interaction was mediated via a -130 amino acid region encompassing
LZ1 and required intermediary adapter protein(s).
These data suggest that the different response of the STREX and ZERO channels to
PKA is likely to result from the differential phosphorylation of specific PKA consensus
motifs within the splice variants and not as a result of differential association of the
kinase.
Finally, co-immunoprecipitation assays suggested heteromultimerisation between the
STREX and ZERO a-subunit variants in vivo. Such interactions may contribute further
to the regulatory diversity of BK channels.
vi









BK channel large conductance calcium- and voltage-activated potassium
channel
bp base pair
bRIA mammalian cell IP buffer
bRIA-T bRIA + 1 % Triton X-100
BSA bovine serum albumin
CaM calmodulin
CaMK calmodulin kinase
cAMP adenosine-3',5'-cyclic monophosphate (cyclic AMP)
cfu colony forming units







DMEM Dulbecco's Modified Eagle Medium
DNA deoxyribonucleic acid
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EDRF endothelium-derived relaxing factor
EDTA ethylenediaminetetraacetic acid
EGFP enhanced green fluorescent protein
EGTA ethyleneglycol-bis(P-aminoethylether)-N,N,N',N'-tetraacetic acid
FCS foetal calf serum
FITC fluorescein isothiocyanate isomer
FSG fish skin gelatin
GC guanylate cyclase




HEK293 human embryonic kidney cell line 293
HEPES N-[2-hydroxyethyl]piperazine-N'-[2-ethanesulphonic acid]
HPA stress axis hypothalmic-pituitary-adreno-cortical stress axis









KLH keyhole limpet hemocyanin
LB Luria Berani — broth/agar
LDS-LB lithium dodecyl sulphate - loading buffer
MALDI-TOF matrix-assisted laser desorption/ionisation - time of flight mass
spectroscopy
MBG Membrane Biology Group
MCS multiple cloning site
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MOPS 3-[N-morpholino] propane sulphonic acid
MthK Methanobacterium thermoautotrophicum potassium channel









PBS phosphate buffered saline
PBS-T PBS + 0.05 % Tween 20
PCR polymerase chain reaction
PGS protein-G-sepharose; protein from group C streptococci that binds
Fc portion of IgG bound to sepharose
PHAS-I phosphorylated heat-and acid-stable protein regulated by insulin
PI protease inhibitors
PK protein kinase
PKA protein kinase A. Also known as cAMP-dependent protein kinase
(cAPK) & A-kinase
PKAc PKA catalytic subunit
PKAr PKA regulatory subunits
PKC protein kinase C
PKG protein kinase G
P„ mean channel open probability
PP protein phosphatase
PP1 protein phosphatase 1
PP2A protein phosphatase 2A
Ptac promoter - IPTG regulated
PTZ pentylenetetrazole
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PVDF polyvinylidene fluoride
RNA ribonucleic acid
SDM site directed mutagenesis
SDS sodium dodecylsulphate (sodium lauryl sulphate)
SDS-LB SDS-loading buffer
SDS-PAGE SDS-polyacrylamide gel electrophoresis
STET sucrose, Tris, EDTA, Triton X-100 Buffer (See Section 2.1.2)
STREX stress regulated, or stress axis related exon
STREX channel BK channel splice variant that expresses the STREX insert
TBE Tris, boric acid, EDTA buffer (See Section 2.1.1)




2TM/P 2 transmembrane-pore domain (See Section 1.3.2.1)
TRITC tetramethylrhodamine isothiocyanate
TTB Towbin transfer buffer
TTP thymidine 5'-triphosphate
V5-H6 V5-polyhistidine
v/v volume per volume
w/v weight per volume
ZERO channel BK channel splice variant lacking splice inserts
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Chapter One:
An Introduction to BK Channels
1.1 Introduction: BK channels in the potassium channel super-family
The large super-family of the potassium channels encompasses a wide range of
structurally and functionally diverse transmembrane ion channels responsible for
conducting the physiologically critical cation, potassium (Figure 1.1; [1-3]). Within this
family, the calcium-activated potassium (Kca) channels are distinct due to their
activation by elevations in intracellular calcium with the subsequent potassium ion
efflux contributing to cellular hyperpolarisation [3, 4], These channels were sub-divided
according to the relative potassium conductance into three sub-families (Scheme 1.1).
Scheme 1.1: Relative conductances of the three Kca channel families [1, 3, 4]
Kca channel sub-family Abbreviation
Conductance range in
symmetrical K+ (pS)
Small conductance SK 4-14
Intermediate conductance IK 20-80
Large conductance BK 150-350
Voltage-activated potassium channels 8-27
2
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Figure 1.1
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Figure 1.1: Schematic representation of the potassium channel
super-family family tree. Potassium ion (K+) conducting channels are
divided into three groups according to the predicted membrane
topology; the number of transmembrane domains. Each group is
divided into families according to sequence homology (not gene
families) and can be further divided into subfamilies (Based on Coetzee
etal, 2001 [3]).
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The large conductance calcium- and voltage-activated potassium channels (BK
channels, also known as maxi-K or Slo channels) possess an unusually large potassium
conductance approximately ten-fold greater than that of other potassium channels [4-6]
(See Scheme 1.1). In addition, BK channels couple the calcium-responsiveness that is
characteristic of the Kca channel family with a voltage-sensitivity that echoes the
intrinsic property of voltage-gated potassium channels (Kv) [4-7], This unique dual
activation provides a critical and fundamental link between the electrical and metabolic
state of a cell [8] and is just one of several distinct features that cause these intrinsic ion
channels to be distinct among the potassium channel super-family.
Since their discovery in mammalian sarcoplasmic reticulum in 1980 [9], BK channels
have been a focus of interest due to their proposed roles in several disease mechanisms
and their numerous, unique structural, molecular and functional properties. The
elucidation of many of these novel features has been investigated by several individual
studies and has been facilitated greatly by the initial cloning of the BK channel gene of
Drosophila melanogaster, the Slowpoke (Slo I) gene, by Atkinson and by Adelman [10,
1 I]. Slowpoke gene homologs from numerous species have been identified by sequence
homology, leading to the elucidation of an ion channel with near ubiquitous expression
and conservation throughout the cells and tissues of the majority of multicellular
organisms [12-17] (Reviewed: [4-7]). This is indicative of an ion channel under great
evolutionary pressure and thus, of great physiological importance [4-6],
4
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Such physiological importance is illustrated by the ubiquity and requirement of BK
channels in several physiological processes ranging from action potential frequency
modulation to endocrine secretion and cochlea hair cell electrical tuning (Section 1.2).
Remarkably, such functional diversity results from proteins encoded by just one gene
with alternative pre-mRNA splicing producing distinct BK channel proteins (Section
1.3). Additionally, the channels respond to several, distinct, integrating signal
transduction pathways (Section 1.4) with some of the effecting proteins suggested to
complex directly with the core BK channel protein (Section 1.5). Thus, BK channels are
of great interest physiologically, biochemically, and molecularly, with their unique
features, ubiquity, variability, and functional importance, all contributing to the
individuality and fascination of BK channels.
1.2 The physiological roles of BK channels
Similarly to the majority of Kv channels, the sensitivity of BK channels to membrane
depolarisation enables their integral role in the shaping of action potential repolarisation
[1, 2]. Consequently, BK channels influence neuronal plasticity, resting membrane
potential, the control of neuronal firing frequency and spike inhibition during sustained
depolarisation [18-23]. Additionally, BK channels are observed presynaptically in
peripheral and central nervous tissues where they facilitate synaptic transmission and
neurotransmitter release [19, 20, 24], Such BK channels exhibit an electrophysiology,
functionality and pharmacology distinct from their axonal and cell body counterparts
that are involved in spike potentiation [19, 20, 23, 24]. This demonstrates ion channel
5
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specialisation relative to sub-cellular location [20, 23, 24] and is conspicuous
particularly in dedicated sensory cells such as cochlea hair cells where BK channels are
integral to the precision electrical tuning of the basolateral membrane tonotopic axis
(Section 1.3.1.2) [25-30],
Uniquely, as BK channel activity is enhanced by increasing intracellular calcium, the
incumbent hyperpolarisation is crucial to the negative feedback of calcium signalling,
terminating calcium entry by closing voltage-gated calcium channels [8]. Through such
dual electrical/metabolic regulation. BK channels are critical to several cellular secretion
processes ranging from sweating to neurotransmitter release. The BK channels of
epithelial cells including glandular tissues [31, 32] are suggested to be integral to
calcium-mediated transepithelial fluid secretion such as that of equine sweat glands [31].
In endocrine tissues such as glomus and chromaffin cells, BK channels are implicated in
the control and feedback of catecholamine secretion [33, 34]. Thus, BK channels are
implicated in numerous, wide-ranging physiological processes including pancreatic
hormone secretion [35], kidney filtration [20, 36, 37], the fight or flight response
(Reviewed: [38]) and even emotional reactions [39],
Although present in skeletal muscle, BK channels are prevalent in smooth muscle where
they are implicated in the control and regulation of contractile tone and activity rate [40-
42], Thus, they influence multiple muscular functions including arterial relaxation and
the maintenance of blood pressure [43-46], motility in the gastrointestinal tract [41],
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urinary bladder voiding [47], bronchiole gas exchange [48, 49] and contribute to
changes in uterine contractability during pregnancy [50-54].
BK channels are implicated in protective responses to several pathological conditions
and physiological disorders including incontinence [55], stroke and ischaemia [7] and in
conditions where neuronal spikes are prohibitively small or absent [56], Additionally,
BK channels are present within algal tonoplast membranes and are the only non-ATP-
dependent potassium channels detected in the inner mitochondrial membrane suggestive
of a putative calcium-buffering role in these organelles [57-59],
Thus, the ubiquity of these novel channels implicates them in several physiological and
pathophysiological processes and they are demonstrated to be integral to several of these
functions. BK channels achieve such diversity and specialisation, yet are encoded by
only one gene.
1.3 The BK channel q-subunit
The BK channel a-subunit is encoded by one gene, Slol, the mammalian orthologue
recently renamed KCNMA1, and is responsible for forming the potassrum-conducting
pore of the functional BK channel tetramer [3],
7
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1.3.1 Slol / KCNMA1 gene
The Drosophila me/anugaster Slowpoke mutant has a distinct behavioural phenotype
characterised by semi-flightlessness and "sticky feet"; an inappropriate immobilization
of the insects on a surface following over-stimulation by bright light or a heat pulse [60,
61]. The basis of this phenotype was found to result from defective calcium-activated
potassium currents in nerve and muscle tissue derived from mutation of the Slowpoke
(Slol) gene [61-63], Subsequently, the gene was cloned [10, 11] and found to display
sufficient homology to Shaker potassium channel genes to indicate that the translated
protein was a member of the voltage-gated potassium channel super-family (Figure 1.1)
[64, 65]. Following this crucial discovery, Slol homologues have been identified and
described in numerous species ranging from frogs (Kukuljan, M., Hofmann, A.D.,
Chouimard, H.A., Rojas, C. and Ribera, A.B., 2000 (unpublished): ncbi accession no.
#AF274053) to mice ([12]: #NM_010610) and from chickens ([66]: #U23823) to cows
([67]: #U60105) with the human gene mapped to chromosome 10 at position 10q22.2-
10q.23.1 and renamed KCNMA1 ([68]: #NM_002247) [3, 6],
KCNMA1 is highly conserved with greater than 97 % identity observed at the amino acid
level among mammalian homologues [5]. Such identity is astonishing, especially when
the gene is encoded nearly ubiquitously throughout the cells and tissues of organisms [5,
6]1 where numerous distinct and divergent physiological processes rely upon its
expression of the BK channel a-subunit protein (Section 1.2). Electrophysiological
1 Cardiac myocytes do not express the KCNMAI gene product and are the only
mammalian cell type observed not to encode the gene (Review: [5]).
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investigations of BK channels from different cellular sources have uncovered variation
in the single channel characteristics with divergent kinetics, calcium sensitivities and
responses to various modulators among the contrasting properties observed [5, 13, 69],
Although the unique metabolism and intracellular environment account for some of this
variation (Section 1.4) [5], such diversity usually results from multi-gene ion channel
families for example, the Shaker family (Kv channels: See Figure 1.1) [1, 2, 69],
However, as the BK channel a-subunit is encoded by only one gene, variation results
from multiple promoters [61, 70] and extensive pre-mRNA splicing [5, 6, 12, 13],
Slo2 & Slo3
Two genes encoding channels displaying structural homology to Slol have been
described recently and adjoined to the Slo family by virtue of their dual activation by
voltage sensitivity and intracellular signalling [6]. The SLO-2 paralogue, also called
Slack ("sequence like a calcium-activated potassium channel") is expressed abundantly
in Caenorhahdiitis elegans brain and skeletal muscle and is sensitive to voltage and,
synergistically, to calcium and chloride [71] whilst the murine SLO-3 channel links the
cellular membrane potential to intracellular pH in spermatotocytes [72], However, they
appear distinct from BK channels in amino acid sequence and physiological function [7].
1.3.1.1 Tissue-specific transcriptional promoters
Expression of the Drusophila Slol gene is suggested to result from at least five distinct,
tissue-specific transcriptional promoters transcribing BK channels with dissimilar N-
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terminii that prime the channels for tissue-specific functions to confer the appropriate
phenotypic behaviour [61, 70, 73-75],
1.3.1.2 Splicing of the BK channel a-subunit gene
Alternative pre-RNA splicing is a dynamic mechanism that enables the generation of
multiple proteins with divergent functional and regulatory properties from a single gene
by the processing of the nuclear pre-mRNA into several discrete isoforms with distinct
exon combinations (Figure 1.2) [76-78], Small variations in the mRNA sequence can
induce profound functional influence to enhance the specialisation and functional
diversity of a particular protein [76-78], Thus, splicing is employed commonly and has
been described for assorted proteins including transcription factors, hormone receptors
and ion channels such as the N-type calcium channel and, crucial to this study, the BK
channel [3, 77-79],
Alternative pre-mRNA splicing enables the generation of BK channel variants with
distinct properties ranging from differences in calcium- and voltage-dependence, ion
conductance and the kinetics of activation and inactivation, to regulatory differences
such as the specific regulatory influence of individual signal transduction pathways [4.
5, 69, 77, 80-82], Several splice sites have been identified within the mammalian BK
channel a-subunit-encoding gene [13, 80] with additional sites suggested in avian
homologues [27], Two splice sites have been identified in the mammalian N-terminal
and five in the cytoplasmic C-terminal domain-encoding region (Figures 1.2, 1.3 & 1.4,
10
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Figure 1.2
Alternative R1NA splicing
Nuclear pre-mRNA - transcribed from KCNMA1 gene
Splice site: 1 2 3 4 5
1 1 11
^Alternative RNA splicing
Final mRNA - to be translated into protein
Splice variants:
ZERO
A y\ /\ /\
IYF
- h /\ /\
STREX
ZN 11 /\ /\ A\
Figure 1.2: Simplified schematic diagram of the mechanism by
which alternative RNA splicing generates distinct isoforms of
proteins such as the BK channel a-subunit. Transcribed nuclear pre-
mRNA contains introns, sequences removed prior to translation, and
exons, retained sequences that are translated into protein. Alternative
RNA splicing produces various exon combinations yielding multiple
mRNA isoforms. In the example illustrated, a simplified and non-scaled
representation of the BK channel a-subunit gene, KCNMA1, five major
splice sites are shown (See Figure 1.3) and result in several distinct BK
channel proteins. For example, splicing at site 2 may generate three
individual BK channel isoforms; ZERO from mRNA encoding none of
the splice sites, STREX with a 174 base exon, and IYF subunits
resulting from an alternative 9 base pair exon.
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Section 1.3.2.2.2) [3], Several distinct exons are recognized at each site exemplified by
the human gene for which in excess of twenty-nine distinct exons are suggested [4-6, 82,
83]. With the potential complexity of BK channel alternative pre-mRNA splicing, over
500 unique transcripts could result [77] potentially expressing the same number of
distinct BK channel isoforms. However, nowhere near this number is described
currently. Such variability has profound implications for physiological specialisation as
it produces the capacity to express the specific BK channel splice variant or combination
of variants to cater perfectly for the dynamic and unique spatial and temporal
requirements of the cell or sub-cellular location [77, 82],
Reverse transcription polymerase chain reaction (RT-PCR) in combination with patch
clamping has enabled investigation of the differential expression patterns of splice
variants in vivo and has uncovered distinct splice variant expression implicating precise
physiological specialisation of BK channels through RNA splicing [26, 27, 29, 69, 77,
84], Perhaps the most elegant example of this is the tonotopic gradient of avian and
reptilian cochleae [26, 27]. Hair cells along the cochlea are mapped tonotopically, each
tuned precisely to a specific frequency partly instigated by the intrinsic electrical
properties of the specific BK channel splice variants expressed by the individual cell
[26-30], The precise allocation of BK channel splice variants depends upon the resonant
frequency of the individual cell and vice versa, illustrating perfectly organ manipulation
of the differential properties of BK channel splice variants to engender precise and
effective specialisation [26, 27, 29, 84, 85]. Such specialisation has been suggested on a
neuronal level with different brain regions expressing specific ratios of BK channel
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splice variants to enable precise tuning of neuronal electrical excitability [82], Even on
a subcellular level, nerve terminals and cell bodies may express distinct splice variants
to cater perfectly to the physiological function of the location [19, 20, 24],
Far from remaining static, BK channel splice variant expression is influenced by
dynamic factors such as during development [86, 87] and hormonal signalling [50, 84],
This enables cells and organs to alter electrical excitability, adapting to respond
appropriately and effectively to a particular stimulation. Splicing of the STREX exon
illustrates distinctly such regulation of splicing and the functional consequences of the
dynamic process.
1.3.1.2.1 The STREX insert
Adrenal chromaffin cells express at least three discrete BK channel splice variants, two
of which possess distinct functional properties when analysed in heterologous
expression systems [69]. Channels encoding a cysteine-rich 58 amino acid insert
(STREX) at splice site 2 have increased calcium sensitivity, slower deactivation and
faster activation that occurs at more negative potentials than ZERO channels that do not
express the insert [69, 84]. Thus, these channels open more easily and minimise the
duration of the action potential [84]. Quantitative RT-PCR investigation of the ratio of
ZERO channel to STREX insert-containing channel expression found that
hypophysectomy (pituitary removal) in rats, a process that abolishes stress axis function,
reduced the proportion of STREX insert-containing mRNA in the adrenal medulla
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without altering total channel transcription [84], Indeed, an altered whole cell
excitability of adrenal chromaffin cells from hypophysectomised rats demonstrates a
change in splice variant expression [88]. Subcutaneous injection of adrenocorticotropic
hormone (ACTH) reactivated glucocorticoid release and restored the splice variant ratio
[84], Thus, stress hormones including glucocorticoids and adrenal androgens are
suggested to induce complex alternative splicing of BK channel mRNA to fine-tune the
chromaffin cell excitability and secretory response [84, 88, 89, 90] leading to the naming
of the insert, STREX, for stress-regulated, or stress axis-related-exon [84]. Increasing
the proportion of STREX channel expression enables increased repetitive firing to
sustain rapid adrenaline secretion during the stress response [38, 88, 89], Thus, a
correlation between the state of the hypothalamic-pituitary-adrenal axis of an animal and
the STREX:ZERO channel expression ratio is observed [38, 89],
Similarly, the STREXiZERO channel expression ratio alters in the murine myometrium
during gestation [50]. Although levels of STREX channel mRNA and the resultant
protein remain constitutively expressed throughout pregnancy, expression of the ZERO
channel is only detected midterm leading to an increase in total BK channel expression
[50]. Due to the lower sensitivity of ZERO channels to calcium and voltage compared
to that of STREX channels, the intrinsic excitability of the myometrium alters during
gestation [50], This may be beneficial in regulating pre-term uterine contraction and is
suggested to result from the fluctuations in oestrogen and/or progesterone that occur
during pregnancy altering splicing of the BK channel gene [50].
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Conversely, depolarisation of GH3 pituitary cells has been shown to inhibit alternative
splicing of the STREX exon via the calmodulin kinase (CaMK) IV signalling pathway
[91]. CaMKlV decreases the expression of STREX-encoding mRNA by interacting
with a CaMKIV-responsive RNA element (CaRRE) to lower the expression of STREX
channels and thus decrease the calcium sensitivity and opening probability of the GH3
cell BK channels [91]. Consequently, long-term adaptation of the firing properties of
pituitary cells is achieved [91],
1.3.2 Channel topology & structural features
1.3.2.1 Structural features conserved with other Kv channels
Members of the Kv channel multi-gene family respond to membrane depolarisation by
enabling potassium ion permeation through a central pore formed by the association of
four independent, associated subunits (See Figure 1.7) [1-3, 92], These crucial ion
channels share a common structural topology through the core, channel-forming subunit
that exhibits a modular structure with distinct, intrinsic domains responsible for distinct,
intrinsic properties, namely gating, voltage sensitivity and ion selectivity [3, 92, 93].
The BK channel a-subunit shares the conserved, core structural characteristics of Kv
channels with the six transmembrane helices, S1-S6 (Figures 1.3 & 1.4) [93]. The
potassium channel super-family "trademark", 2TM/P (2 transmembrane-pore) domain,
is observed comprising helices S5 and S6 with the linking P-loop that is structurally
analogous to the prokaryotic KcsA channel whose tertiary structure was resolved by X-
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ray crystallography [94] (Reviewed by Sansom et al, 1998 [92]). The P-loops line the
functional pore and constitute the ion conduction pathway surface including the
conserved glycine-tyrosine-glycine (G-Y-G) motif that, in part, forms the selectivity
filter via stereochemical oxygen atom checkpoints [1, 95-97], The oxygens surrogate
for the potassium ion hydration shell to maintain hydrogen bonding and lower the
interaction energy whilst inhibiting, both physically and energetically, the entry of larger
and smaller ions [97-101] (Reviewed: [92, 96]). This enables the conserved, selective,
high cation permeation with the characteristic potassium-conducting channel selectivity
sequence of K+ > Rb+ > Cs+ > Na+ > Li+ [92, 96, 98, 102-104] Reviewed: [1, 93, 105],
The pore region shares sequence homology with other potassium channels and is
inhibited by wide-spectrum potassium channel blockers such as tetraethylammonium
(TEA+) and charybdotoxin (ChTx), inhibitors that interact specifically with pore
residues to occlude ion flux [12, 96, 106-111], This demonstrates that BK channels
share common, conserved residues with other Kv channel pores [12, 96, 106-11 1],
The membrane depolarisation-induced activation of Kv channels, including BK
channels, occurs via the conserved voltage sensor comprised of positively charged
residues within the S4 transmembrane helix (Figure 1.4) [112] (Reviewed in Choe,
2002 [93]). Although the precise molecular mechanism of this response is not
understood fully, point mutation studies and the use of spectroscopic probes affixed to
the helix [112], have determined that conserved, charged residues are sensitive to
changes in membrane potential [113, 114], Depolarisation alters the membrane electric
field inducing a conformational sliding movement of the S4 helix via the responsive
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Figure 1.3
The murine BK channel protein sequence
Figure 1.3: The amino acid sequence of the murine BK channel
STREX splice variant illustrating important features. The murine
STREX channel sequence (NCBI accession number: AAD49225)
differs from the ZERO channel (NCBI accession number: NP 034740)
by the insertion of the 58 residue STREX insert (red text) at splice site
2 (pink arrow, number 2) which contains a putative PKA
phosphorylation consensus motif (red box in STREX sequence).
Standard one letter amino acid code used. Features that are shared
between the two splice variants include the following:
• transmembrane helices, S0-S6 ( )
• putative cytoplasmic helices, S7-S10 (dark blue text)
• the pore domain (light blue box; GYG motif underlined)
• conserved voltage sensor arginines ( )
• an N-terminal EF hand motif (green box )
• the major RCK domain - responsible for tetramerisation (purple text)
• the calcium bowl (yellow box)
• two putative leucine zipper (LZ) motifs (Neon blue box; integral
residues underlined )
• several putative phosphorylation target residues (red boxes:
individual protein kinases are indicated above serine or tyrosine
residues)
• serine protease-like domain (orange arrow -►)
Also indicated are:
• five sites of splice variation (pink arrows T)
• the start and end points of the fusion proteins used in this study (gray
arrows -► ; See Chapter 3; Table 3.1)
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Figure 1.3
The murine BK channel protein sequence
r> SO
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S2 S3
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S6
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r> LZ1 S7
451 hpkiriitqm ijqyhnkahll nipswnwkeg ddaiclaelk lgfiaqscla
S8
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551 fttvcelcfvk lkllmiaiey ksanresril inpgnhlkbq egtlgffias
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Figure 1.4
BK channel topology
Figure 1.4: Schematic representation of the BK channel a-subunit
predicted membrane topology. The BK channel a-subunit is
proposed to resemble Kv channel topology through transmembrane
(TM) helices, S1-S6, with the charged S4 voltage sensor, P-loop and
K+-selective filter. It differs by an additional N-terminal, TM-helix,
SO, integral to [l-subunit interaction, and an extended, cytoplasmic C-
terminal domain responsible for many modulatory interactions. This
domain comprises four putative a-helices, S7-S10, the putative
tetramerisation domain, RCK, the calcium bowl (yellow), and five
established sites of splice variation (ssl-5) including ss2 where STREX
inserts (red). The (3-subunit (purple) comprises two TM-helices,
intracellular termini and extracellular glycosylation. Not to scale.
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charged residues [114] (Reviewed: Choe, 2002 [93]). The movement propagates
through transducing elements to open the potassium ion conduction pathway, providing
the structural basis of Kv and BK channel voltage sensitivity [112, 114, 115] (specific to
BK channels: [113] Reviewed: Choe, 2002 [93]).
1.3.2.2 Structural features distinct to BK channels
Although the "core" region of the BK channel a-subunit protein shares certain structural
and topological characteristics with other potassium-conducting channels, the ion
channel protein maintains its individuality through several, unique properties.
1.3.2.2.1 BK channel pore
Even within the "core" region there are notable differences, the most distinct due to the
high ion flux (See Scheme 1.1) [3, 103]. The BK channel pore is suggested to exhibit
distinct electrostatic and conformational pore properties resulting from unique aromatic
and associated residues that provide proximal cation binding sites to maximise the ionic
repulsion between fluxing potassium ions and unique negative vestibule charges to
increase local potassium ion concentrations for faster reactivity [103]. Indeed, the
distinct peptidyl toxin-pharmacology of BK channels compared to Kv channels, suggests
distinct outer vestibule structures. Each peptidyl toxin possesses a distinct structure that
enables or precludes its interaction with a potassium channel pore. Thus, a-KTx 2.x and
a-KTx 3.x toxin subfamilies block Kv channels yet have no influence on BK channels
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[106], Concomitantly, the asymmetric charge of the scorpion venom, lberiotoxin (IbTX
ora-KTx 1.3), makes it a high-affinity, BK channel-specific blocker [12, 106, 116-120],
1.3.2.2.2 Carboxvl-Terminal Domain
The carboxyl-terminal domain of the BK channel a-subunit protein is unique among the
potassium channel super-family [10]. Comprising -80 kDa, it constitutes -70 % of the
total protein mass (-126 kDa), producing a protein of more than 1100 residues in length
compared to around 550 amino acids for the average Kv channel [4, 5],
Although the precise topology of this domain is undetermined currently, the region is
suggested to be soluble, cytoplasmic, and include four putative a-helices, S7-S10
(Figure 1.4) [113, 121, 122], In vitro expression of a truncated S9-S10 peptide in
Xenopus oocytes indicated such solubility and demonstrated that removal of the C-
terminal tail inhibits native channel activity which can be reconstituted by co-expression
of the S9-S10 peptide or longer, truncated regions of the C-terminal tail, thus
highlighting the integrity of the region to BK channel function [123], Indeed, several
accessory proteins and other modulatory factors directly or indirectly associate with, or
exert influence through, this domain (Sections 1.4 & 1.5) and the hyper-conservation of
certain C-terminal regions is demonstrative of crucial influence [124], One such region
is the "calcium bowl".
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The Calcium Bowl
Located in the hyper-conserved region between helices S9 and S10 (Figures 1.3 & 1.4),
the "calcium bowl" is involved in the modulation of the BK channel by the ubiquitous
second messenger, calcium [8, 123, 124], The 28-residue, negatively charged, aspartate-
rich motif was identified by mutagenesis [123-125] and exhibits homology with
calcium-binding proteases [67] and plasma membrane calcium pumps [124], Unlike the
calcium-sensitive regions of SK and IK channels, the calcium bowl is suggested to bind
the cation directly and not via intermediary proteins such as calmodulin [4, 102], Other
additional regions such as the RCK (regulator of potassium conductance) domain
(Figures 1.3 & 1.4) are implicated in calcium sensing by their analogy to homologous
regions in other calcium-gated channels [8, 109, 124, 126] (Crystal structure of
Methanobacterium thermoautotrophicum potassium channel (MthK) RCK domain:
[127]). It should be noted that a recent study has suggested that the BK channel can be
regulated by calcium in the absence of the calcium bowl and RCK domain suggesting
that another domain of the channel protein may be involved in calcium-regulation of BK
channels [128], BK channels can function as purely voltage-gated in the absence of
calcium, but this requires high-voltage depolarisation of ~ 100 mV [121, 129-133], In
the presence of physiological calcium levels, the ion shifts the voltage range of
activation to more negative potentials with calcium concentrations above 100 nM acting
synergistically with depolarisation to induce channel activation and increase the open
probability (Pu) [18, 121, 126, 134], Such synergistic activation is unique; Kv channels
are sensitive to voltage but not calcium [135] and the other Kca channels, IK and SK
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channels, are activated by calcium and not depolarisation (Reviewed Vergara et til, 1998
[4]).
As each a-subunit of the BK channel tetramer has a calcium bowl [102] and, as multiple
binding sites per subunit are possible, the calcium-binding permutations and the
subsequent influence upon the channel kinetics is complex [8, 134], In addition to the
influence of voltage, additional factors such as phosphorylation state, associated,
auxiliary proteins, and the particular BK channel splice variant are likely to affect
calcium-mediated gating. Thus, gating is not just novel, rapid and allosteric [102], but
convoluted and thus too complex to describe within the limits of this thesis. Studies
investigating the phenomenon are described in the following references: [130-140] and
reviewed in Magleby, 2001 [141],
However, the synergistic regulation of BK channels by calcium and voltage provide a
crucial, unique, molecular link between the cellular metabolism and the electrical state
of the cellular membrane [134, 142].
Splicing
In contrast to the hyper-conservation of the calcium bowl, the C-terminal tail region of
the BK channel a-subunit is also the region of the greatest diversity among BK channel
isoforms due to the presence of several sites of alternative splicing throughout the
domain (Figures 1.2 & 1.3; See Section 1.3.1.2) [10, 13], As the C-terminal tail is the
target of many accessory regulatory factors (Sections 1.4 & 1.5) including calcium, the
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modulatory and functional differences observed between individual splice variants may
be attributable to splicing in this region [50, 82, 125] (See above & Section 1.3.1.2),
1.3.2.2.3 Tetramerisation domain
The crystal structure of the Shaker potassium channel tetramerisation domain was
determined as a [3-strand structure at the cytoplasmic N-terminal domain of the channel
subunit protein [143]. This T1 domain induces specific Shaker-Shaker subunit assembly
and homologous regions in other potassium channels are suggested to function similarly
[143, 144], However, BK channels do not include T1 due to the additional N-terminal
SO transmembrane helix and the extracellular N-terminal (See Figure 1.4). However,
gating studies determined at least four calcium ion-binding sites per BK channel
suggestive of BK channel a-subunit tetramerisation [102], Thus, BK channels exhibit a
distinct tetramerisation domain, BK-T1 or RCK, characterised as a Rossman fold and
present as hydrophobic patches at the S6 transmembrane helix S6 - C-terminal domain
interface (Figures 1.3 & 1.4) [145, 146]. The RCK domain is analogous to the
Methanococcus jannaschii Ktr potassium import system KTN domain, a region
responsible for NADH/NAD+(nicotinamide adenine dinucleotide)-binding and
tetramerisation and, although it does not bind NADH, it displays sufficient analogy to
enable tetramerisation [145, 147], Analysis of the MthK channel RCK domain crystal
structure, suggested to be integral to calcium binding (See Section 1.3.2.2.2), reveals the
formation of a "gating ring" structure at the intracellular pore vestibule formed from the
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association of eight RCK domains [145], Analogous associations of BK channel a-
subunit RCK domains may indeed, prove to be integral to channel tetramerisation.
Homomultimerisation v. Heteromultimerisation
The stoichiometry of individual splice variants in a BK channel tetramer is yet to be
determined but, as regions of splice variation are distinct from the RCK domain,
theoretically, phenotypically distinct BK channel a-subunit splice variants could
associate to form functional channels. Channels could result from one, two, three, or
four different splice variants with perhaps subtle differences and a range of intermediary
gating, regulatory, pharmacological and functional differences contributing to the wide
physiological variation and tissue-specific specialisation of BK channels. Although
homotetrameric assembly is uncovered commonly [3, 148, 149], such heteromultimeric
assembly is observed in several Kv channel families ([150-154] Reviewed: [2,3,155]).
The presence of different BK channel splice variants in single hair cells from the chick
cochlea [26] and in rat adrenal chromaffin cells [156] suggests that this may apply to BK
channels too [26, 34, 149, 156]. Indeed, heterologous expression of the BK channel a-
subunit with subunits from the low conductance potassium channel Slack (SLO-2) is
suggested to form functional, intermediate-conductance channels by co-association,
providing indirect yet evocative evidence of the ability of different BK channel splice
variants to form heteromultimers [157],
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1.3.2.2.4 Amino-Terminal Domain
As noted above, BK channels possess a conserved, additional transmembrane helix, SO,
absent from other potassium-conducting channels (Figure 1.4) [4, 5]. The region is
conserved and vital to effective ion channel function and has been implicated in
influencing several key channel features including channel open time, ion conductance
and voltage-dependence [158], The generation of chimeras suggests that the region is
crucial to a-subunit interaction with modulatory p-subunits [159],
The (3-suhunits
Many ion channels associate with accessory p-subunits that modulate their activation
and BK channels are no exception [160-162], Bi-functional cross linking [163],
biochemical purification [164] and co-immunoprecipitation [165] of the BK channel
complex have identified four individual P-subunits that confer distinct regulatory
influences upon BK channel activity. The P-subunits do not form ion channels when
expressed in the absence of a-subunits, but alter intrinsic properties of the BK channel,
namely calcium sensitivity, gating kinetics, toxin sensitivity and response to modulators
such as protein kinases [29, 160, 161, 164, 166-171], This expands the physiological
range and specialisation of BK channels, "exaggerating" kinetic variation between BK
channels comprised of different a-subunit splice variants [29, 170], For example,
investigation of the kinetics of four individual BK channel splice variants noted eight
functionally distinct channels following heterologous co-expression with and without a
P-subunit [170]. Indeed, the distinct influences of the different P-subunits upon BK
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channel activity suggests that co-expression of the individual P-subunits with the
channels could result in several functionally distinct channels in native cells.
All four P-subunits share a common topology of two transmembrane helices with
intracellular termini, N-linked glycosylation and molecular weights between 25-31 kDa
(Figure 1.4) [6, 163, 172], The first thirty-one residues of the N-terminal region of the
pore-forming, a-subunit are suggested to associate with p-subunits via non-covalent
interactions in a 1:1 stoichiometry [159, 164, 165] enabling four, individual p-subunits
to encircle a functional BK channel pore tetramer. However, RT-PCR [69, 170, 173], in
situ hybridisation [29, 161], immunohistochemistry [161] and electrophysiology [69,
161, 163] have demonstrated that a-subunits may not be saturated by p-subunit in all
native tissues [29], Indeed, P is not obligatory and, in contrast to the ubiquitous a-
subunit, is absent from certain tissues [69, 169] including rat skeletal tissue [169],
murine corticotropes [80] and certain mammalian brain neurons [161, 163], Conversely,
high expression of particular p-subunits is observed in hippocampal and cochlea cells
[173], and in various smooth muscle tissues [163, 164, 174] including tracheal and aortic
[158, 161, 171],
Despite the common topology, sequence identity between different human P-subunits is
low with between 43 to 21 % identity observed with hp 1 and hp2, and hp 1 and hp4
respectively [175]. Even within a P-subunit sub-group less conservation is observed
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than with the a-subunit with 82-85% identity observed between different mammalian pi
species compared to greater than 95% for the pore forming subunit [161].
PI
The pi subunit (KCNMB1) was the first to be characterised [165, 176] and is the best
described of the four distinct proteins. It is enriched in peripheral tissues especially
smooth, but not skeletal, muscle and exhibits limited expression in the brain [69, 160,
166-168, 175, 177, 178], implicating pi in the facilitation of the role of BK channels in
setting arterial muscle tone and fine-tuning low frequency cochlea hair cells [29],
The subunit increases BK channel calcium sensitivity whilst slowing activation in a
calcium-dependent manner without altering channel expression, single channel
conductance or ionic selectivity [136, 160, 166-168, 175, 177, 178], The mechanism of
this modulation is uncharacterised, however, the pi protein is suggested to regulate the
rates of transition between open and closed states to increase the duration of activity
bursts thus increasing the PQ [169], The subunit is suggested to modulate the protein
kinase regulation and pharmacological properties of BK channels too [166, 167],
decreasing sensitivity to ChTX [171] and rendering the channel sensitive to
dehydrosoyasaponin-1 (DHS-1) activation [160]. Intriguingly, two-hybrid assays and
electrophysiological investigation upon heterologous co-expression of pi and the
chloride-conducting channel, CLCA1, indicated a physical association and modulation
of the chloride current amplitude suggesting that the BK channel p-subunits may interact
with other ion channels in vivo [179],
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The P2 subunit (KCNMB2, referred to as p3 by Xia et al, 1999 [180]) induces rapid
inactivation and thus, rapid single channel openings upon BK channels [6, 172, 181] in
several tissues including adrenal chromaffin cells, various neurons [6, 172, 182, 183]
and pancreatic P-cells where they are observed to modulate neurosecretion patterns
[180, 184], The distinct, cytosolic N-termina! protein has been characterised by nuclear
magnetic resonance (NMR) and found to exhibit a "ball and chain" inactivation structure
similar to that of Kv channels [181] (Review of Kv channel inactivation: [93]). Removal
of this region produces a protein with high sequence and functional similarity to the pi
subunit [175],
/33 & [34
The P3 subunit (KCNMB3) is enriched in testes and has slight influence only, increasing
BK channel activation [185], In contrast, the novel P4 subunit (KCNMB4) exhibits low
expression outwith the nervous system and is enriched in brain tissue where it slows BK
channel gating kinetics, reduces channel sensitivity to IbTX and ChTX, and modulates
calcium sensitivity in a calcium dependent manner; inhibiting openings at low calcium
concentrations whilst increasing openings in high calcium conditions [172, 185, 186],
1.4 BK Channel Modulation
As described in Section 1.2, BK channels perform a wide range of physiological
functions that exhibit and require specialisation by channels manifesting a wide kinetic,
regulatory and sensitivity range. Much of this specialisation is attributable to splice
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variation and the (3-subunit, but some results from the intrinsic and dynamic intracellular
properties of the cell or subcellular location. Many cellular factors influence BK
channel activity including the lipid, pH and redox environment, and accessory factors
such as protein kinases, protein phosphatases and hormones illustrating the
responsiveness of the channels to several, distinct signal transduction mechanisms. This
enables BK channels to react to and facilitate many physiological processes, acting as a
linchpin to multi-sourced modulation allowing diverse, rapid and extensive ion channel
responses. Some of these regulatory mechanisms are described below.
1.4.1 Phosphorylation
The effectiveness, efficiency and plasticity of reversible protein phosphorylation make it
one of the most common mechanisms of protein modulation. Numerous signal
transduction pathways mediate their appropriate physiological responses through
manipulation of specific protein kinases and protein phosphatases controlling the
reversible phosphorylation and subsequent functional regulation of particular target
proteins ranging from transcription factors to ion channels [187-188], Activated protein
kinases induce the hydrolysis and transfer of the terminal phosphate of adenosine 5'-
triphosphate (ATP) onto the hydroxyl group of serine, threonine or tyrosine residues of
specific, targeted consensus sequences whereas catalytically active protein phosphatases
act in opposition, mediating the dephosphorylation of such residues. The application of
ATP with no exogenous protein kinase to reconstituted, cloned, and native BK channels
from several, distinct sources alters channel activity and calcium sensitivity [190-198],
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Some studies have reported a direct ATP-mediated influence upon BK channel activity
in the absence of protein kinase activation through a mechanism that is undetermined
currently [142, 189], However, generally, the use of non-hydrolysable ATP analogues
such as AMP-PNP have no influence upon channel activity [190-192], This suggests
ATP hydrolysis, implicating BK channels or closely associated proteins as targets of in
vivo phosphorylation by native, proximal protein kinases [190], The reversibility of this
modulation implicates the activity of protein phosphatases and thus demonstrates the
dynamic, critical use of reversible protein phosphorylation in the regulation of BK
channels [190-198], Although the role of protein phosphatases has not been investigated
as fully as that of protein kinases and thus, is not discussed as much in this text, their
role in reversing phosphorylation to maintain the dynamic plasticity of this mode of
regulation should not be overlooked (Review of protein phosphatase influences on ion
channels: [199]).
1.4.1.1 Signal transduction pathways
Several, distinct protein kinases are implicated as regulators of BK channel activity
including serine-threonine phosphorylating kinases such as protein kinase A (PKA)
[166, 190, 191, 194, 200-206], protein kinase C (PKC) [193, 201, 207, 208] and protein
kinase G (PKG) [37, 196, 209-212] and tyrosine-phosphorylating protein kinases such as
Src tyrosine kinase [204, 213], Equally, protein phosphatases (PP) such as PP1 and
PP2A are implicated as BK channel modulators [190, 191, 194-196], Individual protein
kinases and phosphatases are activated by distinct signal transduction pathways
demonstrating convergent, multi-origin regulation of these ubiquitous ion channels [5,
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214], For example, the ubiquitous serine-threonine protein kinase, PKA, is regulated by
changes in the intracellular cyclic adenosine monophosphate (cAMP) concentration
influenced by indirect hormonal modulation of membranous adenylate cyclase by
several physiological processes and responses [215-217]. The inactive protein kinase
exists as a tetrameric holoenzyme composed of two regulatory (PKAr) and two catalytic
subunits (PKAc) (See Appendix A) [214, 217, 218]. Elevation of intracellular cAMP
activates the holoenzyme inducing release of catalytically active PKAc subunits able to
phosphorylate target proteins [214, 218] (Representative PKA-phosphorylation targets
illustrated: [219-223]). In contrast, the equally ubiquitous PKC is stimulated by
phospholipids and calcium generated and released through inositol phospholipid
hydrolysis via activation of phospholipase C (PLC) [206] (Review: [214, 218, 224]).
Other protein kinases that are suggested as BK channel regulators include protein kinase
G (PKG), stimulated by elevation of intracellular cyclic guanylate monophosphate
(cGMP) following activation of guanylate cyclase (GC) isoforms by nitric oxide (NO)
(See Section 1.4.2.2) or by peptides including atrial naturetic peptide (ANP) [196, 209-
211]; and certain calcium and calmodul in-activated protein kinases including
calmodulin-activated protein kinases 11 and IV (CaMKlI & CaMKlV) [138, 225] and
Src tyrosine kinase [213]. Responsiveness to such diverse signal transduction pathways
illustrates the convergent use of these integral ion channels through the common
mechanism of reversible phosphorylation providing an important demonstration to the
ability of the channels to remain critical to so many diverse physiological processes.
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1.4.1.2 Protein kinase consensus motifs & phosphorylation targets
Although the physical mechanism of phosphorylation is maintained consistently by all
protein kinases, the targeting of phosphorylation is distinct to each type of protein kinase
with specific consensus motifs required (Table 1.1) [226-228], Thus, different protein
kinases are likely to phosphorylate at different target residues, implicating distinct
modes of channel regulation, either directly via phosphorylation of the BK channel a-
subunit. or indirectly through intermediary protein modulation.
Direct phosphorylation ofBK channelprotein
The 32P from y-32P-labelled ATP, incorporated into a 125 kDa protein corresponding to
the human BK channel following addition of exogenous PKG, or the constitutively
active analogue, PKG-la [211], The effect was not observed with inactivated kinase,
implying that a direct, catalytic phosphorylation is responsible [211], Indeed, sequence
analysis in combination with site directed mutagenesis has identified several putative
phosphorylation target sequences within the a-subunit, particularly in the C-terminal
domain (Figure 1.5) [5, 21 1],
Serine-942 of the Drosophila BK channel was identified as a putative site of direct
phosphorylation by PKA following the inhibition of the PKA-mediated response [190,
205], Mutation of the residue to non-phosphorylatable alanine also precluded channel
activation by PKA in detached patches, further implicating direct phosphorylation [190,
205], Although the mammalian equivalent of this motif is less specific for PKA than the
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Table 1.1:
Protein kinase consensus motifs









Table 1.1: Optimal protein kinase consensus motifs. The accepted optimal
consensus motifs of protein kinases A (PKA), C (PKC), G (PKG), calmodulin kinase
II (CaMKII) and Src tyrosine kinase are illustrated together with other suitable,
common consensus motifs [226-228], Other motifs that are not shown may function
as consensus motifs for these protein kinases also. Phosphorylatable residues are
highlighted in red. Standard one letter amino acid code used.
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Drosophila sequence, comprising R-Q-P-S869 in comparison to the insect R-R-G-S942
(See Table 1.1), mutation of the serine also inhibits PKA-mediated regulation of the
mammalian BK channel [205, 229]. Similarly, mutagenesis of the canine smooth
muscle BK channel serine-1072 to alanine inhibited PKG-mediated activation of the
channel suggestive of direct PKG-phosphorylation at the site [209],
In other situations regulation of BK channel activity by various protein kinases can be
influenced by integrating signal transduction pathways via direct phosphorylation of the
a-subunit protein [195], Priming of the SI 151-S1 154 tandem PKC consensus motif of
certain bovine aortic smooth muscle BK channel splice variants makes channels
responsive to PKG, but not PKA [195]. Inhibition of PKC-phosphorylation, or assay of
splice variants lacking the S1151 -S1154 motif, switches channel responsiveness from
PKG to PKA thus implicating a complex, integrative regulation of the ion channels via
direct protein phosphorylation [195], The responsiveness of a particular BK channel to
a specific protein kinase in a particular system or cell type is, therefore, likely to be
influenced by several factors including the associated proteins, the sequence of signal
transduction pathway stimulation and the BK channel splice variant expression [195,
210]. For example, rat small arterial BK channels are suggested to respond to PKA, but
not PKG [230], rat hippocampal neuronal and rabbit distal colon epithelial BK channels
are responsive to PKA, and not PKC [191, 200] and dopamine-induced vascular
relaxation of porcine coronary arteries results from PKG and not PKA [210],
Additionally, in rat anterior pituitary tumour cells conditional phosphorylation between
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PKA and PKC is suggested at distinct sites that can be reversed by distinct protein
phosphatases [192], Although the molecular mechanisms of these effects are
uncharacterised, they may explain, at least in part, why BK channels exhibit a range of
responses to protein kinases and phosphatases in different locations and under different
physiological conditions [195, 210] and even why some BK channels are reported as
being unresponsive to protein kinase activity [142],
Indirect phosphorylation influencing BK channel activity
Alternatively, certain protein kinases may exert their influence on BK channel activity
indirectly through phosphorylation and subsequent activation/inactivation of auxiliary or
intermediary proteins [161]. Conserved protein kinase consensus motifs in the (34-
subunit implicate this as a possible pathway of regulation, influencing the functional
coupling of the auxiliary protein to the channel [161, 186]. Similarly, PKG in bovine
tracheal smooth muscle cells is suggested to influence the activity of BK channels by
stimulating protein phosphatase action on the phosphorylated BK channel protein [231],
Additionally, association of the novel protein, Slob, with Drosophila BK channels is
dependent on its phosphorylation by CaMKlI (See Section 1.5.2).
1.4.1.3 Splicing influences BK channel regulation by reversible phosphorylation
As suggested by the integrative PKA-PKG-regulation observed with bovine aortic
smooth muscle BK channels (See above, [195]), the effect of a particular protein kinase
on channel activity can be influenced by splicing of the channel a-subunit mRNA,
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providing another facet of the specialisation and functional diversity exhibited by BK
channels (See Section 1.3.1.2). The STREX insert provides a perfect illustration of this.
Channels expressing the cysteine-rich insert not only possess distinct kinetics and
calcium/voltage-sensitivities in comparison to their insert-less, ZERO, counterparts (See
Section 1.3.1.2.1), but also display variation in the PKA-mediated response [69, 80,
229], Activation of endogenous PKA induces heterologously expressed ZERO channel
activation, whereas STREX channels are inhibited [80, 229], Such distinctive
divergence may be critical to the role of the splice variants in various physiological
processes including the hypothalmic-pituitary-adreno-cortical (HPA) stress axis where
the STREX:ZERO channel ratio is crucial to the dynamic effectiveness and
responsiveness of the stress response (Section 1.3.1.2.1) [80, 84, 89, 229]. The
molecular mechanism that underlies this distinct variation in PKA-mediated response is
uncharacterised currently. However, several putative phosphorylation target sites are
identified within the 58 residue STREX insert sequence including one motif of notable
homology to the optimal PKA consensus motif (Serine 4, Figure 1.6) [229], Such sites
may co-phosphorylate or compete with and override other phosphorylatable residues in
the channel sequence inducing the inhibition of channel activity. Equally, the presence
of the insert in the regulatory-critical C-terminal domain (Section 1.3.2.2.2) may alter
the domain structure conformationally, particularly probable due to the presence of the
multiple STREX cysteine residues, amino acids that are often critical in forming protein
secondary structures [69], This may create or obstruct phosphorylation target sites or
influence the association of regulatory proteins that are crucial to the PKA-mediated
response, perhaps even the kinase itself, lntriguingly, the presence of the STREX insert
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in the channel sequence is required for BK channel sensitivity to glucocorticoids [229,
232], Glucocorticoids, including synthetic dexamethasone, are suggested to induce the
synthesis of proteins that stimulate protein phosphatases or a phosphatase-like protein to
influence the effects of PKA upon splice variant activity [194, 233].
1.4.2 Other modes of regulation
In addition to reversible phosphorylation, many other factors influence BK channel
activity, providing further evidence for the intrinsic nature of these vital channels to
many, diverse physiological processes. The wide variation and number of these putative
regulatory factors is outlined within the following section (Figure 1.7). This overview is
not definitive but serves to illustrate how diverse regulatory pathways may converge to
regulate BK channel function and activity.
1.4.2.1 Hormones
Oestradiol
Steroid hormones such as oestrogen and progesterone initiate physiological effects via
nuclear receptors, stimulating genomic effects namely the transcription and translation
of proteins [214, 218], However, recent evidence suggests that oestrogens may instigate
rapid cellular responses by non-genomic action upon the BK channel complex [234-
236], Oestradiol and analogues such as the chemotherapeutic xenoestrogen, tamoxifen
([Z]-l-[/?-dimethylaminoethoxyphenyl]-l,2-di-phenyl-l-butene), are suggested, at
physiological/therapeutic concentrations, to interact with the BK channel [31, and
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possibly {33 and (34, subunits via an extracellular binding site or auxiliary protein [185,
234-236]. This activates BK channels influencing the kinetics and activation potentials
affecting physiological functions such as vascular smooth muscle tone [234-236], The
effect is not observed in [31 subunit knock out mice and the rapidity, reversibility and
observance of the effect in cell-free patches highlights the non-genomic nature of the
response [235]. Addition of non-membrane-permeable tags such as bovine serum
albumin (BSA) or ethylbromide to oestradiol compounds does not inhibit the effect of
the hormone, indicating that the influence occurs at an extracellular binding site [234,
236]. Thus, other hormones and signalling agents could interact extracellularly with the
BK channel complex in addition to intracellular signalling. Steroidal bile acids have
been implicated [237].
1.4.2.2 Nitrocompounds
Activation of cellular nitric oxide synthase (NOS) generates production of endothelium-
derived relaxing factor (EDRF), nitric oxide (NO) [1%, 238], This diffusible gas
activates soluble guanylate cyclase (GC) inducing cGMP production and subsequent
activation of PKG, which, as noted above (Section 1.4.1), regulates BK channels by
phosphorylation [196, 239], However, GC inhibition or removal of ATP or GTP in
combination with NOS stimulation or exogenous NO application still results in BK
channel stimulation is some systems indicating a PKG-independent pathway [36, 239,
240], NO has been reported to remove the calcium requirement for BK channel
activation enabling activation at nanomolar calcium concentrations, well below those
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required under basal conditions [36]. Conversely, inhibition of NOS reduces the BK
channel Po in rat smooth muscle cells [241], Thus, NO and various, related
nitrocompounds or their by-products are suggested to modulate BK channels via direct
chemical modification of the channel protein or associated proteins [36, 239]. This
indicates that drugs that stimulate NO synthesis, such as the barbiturate, thiopentone
[242], and l-ethyl-2-benzimidazolinone (1-EBIO) [44], may induce their effects, at least
in part, through this mechanism [44, 242], Such nitrocompound stimulation of BK
-stimulation and the subsequent decrease in membrane
excitability that underlines reduced posterior pituitary hormone secretion [36], the
pathophysiology of cirrhosis [243], and the influence of the peptide vasodilator,
bradykinin [244],
1.4.2.3 Redox Reagents / pH
The redox potential of the sub-cellular, cytoplasmic environment surrounding the BK
channel influences channel activity [245], Chemical reducing agents such as
dithiothreitol activate cloned human BK channels, whereas oxidising agents such as
hydrogen peroxide inhibit [245]. This implies that native, intracellular redox reagents,
including NADH and glutathione, may modulate the channels in vivo, perhaps regulating
the oxidative stress response [246-250], However, the Drosophila BK channel is not
responsive to redox reagents suggesting that the effect is not universal and may not be an
important method ofmodulation [245]. The effect may result from reagents altering the
ionisation state of integral BK channel residues that affect the response to other
regulatory factors such as the pi subunit [245, 246], In heterologously expressed rat BK
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channels, the presence of the cysteine-rich STREX insert makes the channels ten-fold
more sensitive to inhibition by oxidation than ZERO channels that do not express the
insert demonstrating that sequence differences due to splice variation can be influential
to such regulation [251], Indeed, alteration of the ionisation state of residues may be the
basis of the pH response of BK channels, where activation follows a decrease in the test
solution proton concentration (pH 7.0 - 7.8) and inhibition follows an increase [252,
253],
1.4.2.4 Lipids
Recognition of bacterial lipid endotoxins during mammalian cell infection induces NOS
expression that stimulates BK channels through PKG and NO (See Sections 1.4.1 &
1.4.2.2) contributing to the pathophysiology of septic shock and bacterial meningitis
[254, 255]. Following exogenous application of the E.coli endotoxin,
lipopolysaccharide, to murine arterial smooth muscle, BK channels are activated rapidly
and reversibly, an effect observed with NOS inhibitor, A^-nitro-L-arginine, treatment
and in NOS-knock-out mice cells [256]. This suggests that the lipid induces PKG- and
NO-independent channel activation either directly, or by intermediate proteins [256],
Even in non-stress situations, lipids may influence BK channel activity. The common
fatty acid, arachidonic acid (AA), is synthesised and travels in the circulation for uptake
by the central nervous system and metabolism into ion channel-influencing active
factors [257, 258]. Intact, non-metabolised AA is suggested to activate certain rat G1T3
cell BK channel splice variants, increasing calcium-sensitivity through a putative,
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cytosolic AA-binding site or via interacting proteins [212, 259]. AA is proposed not to
influence the membrane properties to affect its influence [259] although the membrane
lipid content is influential to BK channel activity [260, 261]. The conductance of bovine
smooth muscle BK channels reconstituted into charged lipid bilayers is higher than in
neutral membranes [260], and the differential properties of cell body and presynaptic
channels (See Section 1.3.1.2) is partially attributed to the distinct proteolipid
environments of the subcellular locations [20], Indeed, ethanol, which induces analgesia
and parethesia, is suggested to disturb membrane lipids non-specifically, increasing BK
channel Po [262-264]. Thus, the plasma membrane lipids could be influential to BK
channel specialisation.
1.4.2.5 Pharmacological activators & inhibitors
As mentioned in the introduction to this section (Section 1.4), several factors may
influence the activity of BK channels, far too many to explain in detail in this thesis.
Therefore, only a few of these are described below.
Activators
The benzimidazolones, compounds including NS004, NS1608, NS1619, niflumic acid
and 1-EBIO, are suggested to activate BK channels directly [43, 44, 119, 136, 138, 265-
270], Other putative BK channel activators include cromakalim [271], the alkylating
agent, N-ethyl-maieimide (NEM) [36], the indicator azo dye, Evans Blue [43, 272, 273],
and the anilide carbinol, ZD6169 at high concentrations, 50 pM, although lower
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concentrations activate ATP-activated potassium channels [274]. Additionally, the
saponin, DHS-I, is observed to activate BK channels in the presence of [3-subunits, but
not in the absence of the auxiliary protein (See Section 1.3.2.2.4; [160])
Inhibitors
Indole diterpene alkaloids including verruculogen, penetrem A, aflatrem and the fungal
mycotoxin, paxilline, are among the most potent BK channel blockers, acting at a site
distinct from the ChTX binding site (See Section 1.3.2.1) [119, 184, 275] (Reviewed
Kaczorowski et al, 1996 & 1999 [65, 276]). A serine-proteinase-like domain (See
Figure 1.3) is proposed in the BK channel a-subunit C-terminus that enables the
interaction of inhibitory serine protease inhibitors, namely bovine pancreatic trypsin
inhibitor and chicken ovoinhibitor [67]. Other putative inhibitors include gadolinium
[47], verapamil [277], tetrandrine, an alkaloid that may act via cAMP signalling [43,
273], and the convulsant, pentylenetetrazole (PTZ) [241],
1.4.3 Overview of BK Channel Modulation
Thus, the modulation of BK channels is influenced by several, distinct signal
transduction pathways, through multiple mechanisms including reversible
phosphorylation of the channel and auxiliary proteins, hormone regulation, and changes
in pH and the redox state surrounding the channel. The intrinsic cellular and subcellular
environments are influential to channel activity through characteristic features including
the lipid environment. Pathological conditions such as bacterial infection and ischemia
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affect BK channel regulation and various drugs are determined as influential to channel
activity also. All of these factors are in addition to the intrinsic voltage and calcium
regulation that are characteristic of BK channels. Some of the influences are illustrated
in Figure 1.7 and it is probable that several other factors will be uncovered with the
elucidation of the molecular mechanisms underlying the overall, complex modulation of
the BK channel. Thus, BK channels integrate many cellular and extracellular,
homeostatic and pathological signalling pathways enabling the diverse, rapid and
extensive responses that facilitate the significance of BK channel to numerous, varied
physiological processes (Section 1.2).
1.5 The BK Channel Complex
As illustrated in Sections 1.3 and 1.4, BK channel activity is influenced by several,
diverse, independent signalling pathways (Figure 1.7), some of which exert their
influence directly upon the BK channel a-subunit protein through signalling proteins
including the P-subunits, protein kinases and protein phosphatases. Indeed, co-
immunoprecipitation and yeast two-hybrid strategies have identified novel as well as
well-documented proteins that may assemble with BK channels, in addition to the
accessory p-subunits (discussed in Section 1.3.2.2.4). The ability of BK channels to
respond rapidly to many protein signals led to the suggestion of the channel tetramer
functioning as a scaffold, forming a channel complex that encompasses several
signalling proteins bound either directly or indirectly through intermediary, scaffolding
proteins [6, 125, 204], Such proteins are proposed to associate intimately with the
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channel protein in sufficient proximity to facilitate rapid and thus effective ion channel
responses, removing the need for the prohibitive, time-limiting translocation of
signalling molecules to the channel tetramer [125, 278], Such complexes are described
for other ion channels [125], including Kv channels [279, 280], calcium channels [281]
and N-methyl-D-aspartate (NMDA)-receptors [282, 283], The body of evidence
supporting such a model for BK channels is increasing.
1.5.1 Protein kinases & protein phosphatases
In the absence of exogenous protein kinase or phosphatase, reconstituted BK channels
and those investigated in excised membrane patches, still exhibit the regulatory effects
of reversible phosphorylation [190, 196, 200, 202, 204], This implicates close
associations between the channel tetramer and endogenous protein kinases and/or
phosphatases and suggests that that the channel may be part of a multi-protein regulatory
complex [204, 284]. For example, rat brain BK channels have been suggested to
associate with a PKC-like protein kinase [284], a PP1 -like protein phosphatase [284] and
PKA [200], The Drosophila BK channel from native and heterologous expression
sources co-immunoprecipitates simultaneously with the independently regulated Src
kinase and the catalytic subunit of PKA (PKAc) [204], Co-immunoprecipitation
suggests a physical interaction and this was shown to be independent of the
phosphorylation state of the channel with the C-terminal domain characterised as the
location of PKAc association [204], However, although PKAc is suggested to bind
directly to the BK channel protein, Src may associate indirectly through an auxiliary,
bridging protein(s) [204], In mammalian systems, even the occurrence and the nature of
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a PKAc-BK channel interaction is undetermined although other mammalian channels
are noted to bind protein kinases directly [285-287], Mammalian cells often express
AKAPs (A-kinase anchoring proteins), accessory proteins that bind to the regulatory
subunits of PKA with nanomolar affinity via hydrophobic interactions, anchoring the
protein kinase to directly bind to the channel, proximal to target proteins to facilitate
efficient phosphorylation (Figure 1.7) [202, 278, 288], AKAPs have been found to
mediate the targeting of PKA to several, distinct ion channels including calcium
channels [278, 289] and AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole
propionate)/kainite receptors [288], Thus, mammalian BK channels may interact with
protein kinases via AKAPs or similar anchoring proteins. The AKAP inhibitor, Ht31, is
reported to block ATP-dependent regulation of BK channels in equine smooth muscle
cells [290], Further investigations of the interactions may uncover the molecular
mechanism that may underlie such associations.
Other protein kinases and phosphatases may associate functionally with the BK channel
[194, 231]. However, it should be noted that a protein kinase or phosphatase may be
associated functionally and thus be able to promote phosphorylation/dephosphorylation,
but may not interact physically as to co-immunoprecipitate with the channel. For
example, CaMKll phosphorylates human and Drosophila BK channels in vivo and in
vitro, but co-immunoprecipitates with the human form only [204], Equally, protein-
protein interactions may be influenced by BK channel splice variation and by the
metabolic state of the signal transduction pathways of the cell.
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Figure 1.7: Modulation of the BK channel. BK channels (blue) are
modulated by several, distinct signal transduction pathways. Intrinsic
modulation by membrane depolarisation (red), and by intracellular
calcium through the calcium bowl (yellow) occurs. Intracellular
calcium concentrations are influenced by release from intracellular
stores and activation of Ca^, channels (light green). Other modulatory
factors include (3-subunits (purple), hormones, nitrocompounds such as
nitric oxide (NO), redox reagents, pi I, lipids and various
pharmacological agents. Reversible phosphorylation of the BK channel
protein and/or accessory proteins by various protein kinases and protein
phosphatases is also implicated. Some factors may associate as part of
a channel complex, perhaps via bridging proteins like AKAPs, and
divergent influences are observed depending upon factors including
channel splicing and cellular protein expression.
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1.5.2 Accessory proteins
In addition to the (3-subunits (Section 1.3.2.2.4) and protein kinases and phosphatases
(Section 1.5.1), other proteins have been identified as associating with the BK channel
complex. Yeast two-hybrid screens with a Drosophila BK channel identified a novel
protein that associated with the ion channel, the Slowpoke-binding protein (Slob) [291,
292], The CaMKIl-phosphorylated Slob protein bound the 14-3-3 adapter protein C,
isoform in native Drosophila tissues and in heterologous systems, bridging 14-3-3^ and
the BK channel [292], As 14-3-3 proteins are suggested to act as scaffolds for
regulatory proteins including protein kinases, this association may be crucial to the
formation and maintenance of the BK channel complex, and may be influential to BK
channel regulation, perhaps especially in processes such as cell cycle control and
apoptosis in which 14-3-3 proteins are implicated [292].
1.5.3 Overview of the BK channel complex
Increasing evidence is accumulating suggesting that the BK channel exists as a complex
of several auxiliary and regulatory proteins bound around the central pore. Described in
the above section are some putative associating proteins that may directly or indirectly
associate with the BK channel tetramer. However, these proteins may not associate in
all species, cell type, sub-cellular location and with particular splice variants and may be
dependent dynamically upon the metabolic state of the cell. The possible protein
associations are numerous and are likely to vary depending upon such factors. The
complex may be large, composed of several additive factors. Not all regulatory proteins
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may be associated at all times, if at all. Indeed, PKG is not observed to associate with
the channel, although it is implicated in direct phosphorylation of the BK channel a-
subunit [195], However, the benefits in forming a channel complex both in efficiency
and effectiveness support the idea that BK channels exist as a dynamic complex.
1.6 Overview & aims of this thesis
In conclusion, BK channels represent a unique yet integral subset of potassium channels
that manifest many distinct properties that allow them to participate in, and be critical to,
a wide range of important physiological functions through multi-sourced regulation,
responsive to several signal transduction pathways, both homeostatic and pathological.
Therefore, these channels are of great interest physiologically, in their functional roles;
biochemically, in their complex modulation; and biophysically, in their complex kinetics
and activation. All this resulting from only one gene, with variation in the intrinsic
channel characteristics resulting at least in part from pre-mRNA splicing.
This study aims to investigate the molecular basis of mammalian BK channel regulation
by PKA. In Chapter 3, the various fusion proteins and antibodies used in this study are
described. Chapter 4 investigates whether the a-subunit protein is a direct target of
PKA-mediated phosphorylation and addresses the influence of the STREX insert on
channel phosphorylation. In Chapter 5, the assembly of the BK channel complex is
investigated, determining ifPKA can associate with the a-subunit.
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2.1 General materials & reagents
General molecular biology reagents used throughout this study were of analytical grade
and obtained from Sigma Chemical Company, except where stated otherwise. Unless
indicated, solutions were autoclaved (100 kPa, 20 mins, B&T autoclave 225EH).
2.1.1 Molecular biology reagents
DEPC-Treated Distilled Water
0.05 % diethyl pyrocarbonate (v/v; DEPC) in distilled water (dPEO).
TBE Buffer
50x TBE Buffer: 2.2 M Tris, 2.45 M boric acid. 80 mM ethylenediaminetetraacetic acid
(EDTA) in dfEO. Diluted as required.
DNA Loading Buffer
6x stock prepared with 720 pi 50x TBE Buffer, 330 pi glycerol, and bromophenol blue,
diluted to lx with dH^O and DNA for use.
DNA Markers
1 kb markers (Gibco), diluted 1/10 for use.
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2.1.2 Biochemistry reagents
Luria Berarti (LB) Broth andAgar
10 g tryptone (BD), 5 g yeast extract (BD), and 5 g NaCl were dissolved in 1 L dH20
and the pH raised to pH 7.4 with NaOH. For LB-agar, 3.75 g of Bacto-Agar (BD) was
added to 250 ml LB broth and all solutions were autoclaved prior to use.
lsopropyl f3-D-thiogalactopyranoside (IPTG, Calhiochem)
1PTG was stored at -20 °C as a I M solution, prepared by dissolving 2.383 g in 10 ml of
dFLO. This sugar induces recombinant protein synthesis from plasmids containing the
lac operon, such as the pGEX plasmids used in this study.
STETBuffer
8 % sucrose (w/v); 10 mM Tris HC1, pH8.0; 0.5 M EDTA; 0.5 % Triton X-100 (v/v).
Phosphate buffered saline (PBS)
137 mM NaCl, 2.7 mM KCI, 4.3 mM Na2HP04, 1.47 mM KH2P04, adjusted to pH 7.1.
Phosphate buffered saline + Tween-20 (PBS-T)
0.05 % (v/v) Tween-20 added to PBS.
2.1.2.1 Antibiotic Solutions
Ampicillin (Amp)
A stock solution of 100 mg/ml in dH20 was diluted to 100 pg/ml in LB broth and agar
for selection of bacteria expressing pcDNA3, pGEX and pBAD/Thio-TOPO vectors.
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Tetracycline (TET)
Stock solutions of 5 mg/ml in ethanol were diluted to 50 pg/ml in LB broth and agar for
selection of the E.coli XLl-Blue strain.
Geneticin (G418, Calbiochem)
Stock solution of 0.8 g/ml in dLLO stored at -20 °C, used at 0.8 mg/ml final
concentration for selection of pcDNA3 plasmids in HEK293 cells.
2.1.2.2 Protein Analysis Solutions
Laemmli Buffer — SDS-PAGE Running Buffer
lOx Stock: 35 mM sodium dodecylsulphate (SDS), 0.25 M Tris and 2 M glycine in
dHaO. Dilute to lx for use as running buffer for non-radioactive protein electrophoresis.
SDS-Polyacrylamide Gel Electrophoresis Loading Buffer (SDS-LB)
2x stock of 125 mM Tris, pH 6.8, 20 % glycerol (v/v), 4.1 % SDS (w/v), in dLLO with
sufficient bromophenol blue to turn the solution blue. This stock was stored at -20 °C
and used as lx for diluting protein samples.
Protein Markers
Kaleidoscope pre-stained standards (BioRad) with a range of 200 - 6.5 kDa.
Towbin Transfer Buffer (TTB)
lOx TTB (Stock Solution): 0.25 M Tris, 35 mM SDS, and 2 M glycine in dLLO. Diluted
to lx for use in 10 % ethanol (v/v).
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Lithium dodecyl sulphate - Loading Buffer (LDS-LB)
A 2x stock solution was prepared by mixture of 320 pi dH^O, 250 pi LDS Sample
Buffer (Invitrogen), and 100 pi 0.5 M 2-mercaptoethanol for use as the NOVEX gel
(Invitrogen) loading buffer.
MOPS SDS Running Buffer
Prepared as 20x Buffer: 1 M MOPS (3-[N-morpholino] propane sulphonic acid), 1 M
Tris base, 69.3 mM SDS, 20.5 mM EDTA, pH 7.7. Used as lx for running NOVEX
gels (Invitrogen).
2.2 General Molecular Biology Protocols
General molecular protocols were based upon those of Sambrook et al (1989) [293]
unless stated otherwise.
2.2.1 Transformation of plasmid DNA into bacterial ce(ls
50 - 100 pi of competent bacteria cells were incubated with -10 ng plasrpjd DNA (4 °C,
30 mins). Heat shock to induce plasmid uptake (42 °C, 45 sec) was followed by
recovery (4 °C, 2 mins) and dilution with 400 pi LB broth. Cultures were incubated
with agitation (37 °C, 45 mins), then 50-200 pi plated onto a LB agar plate with
antibiotic appropriate for plasmid selection. Plates were incubated at 37 °C for -16
hours.
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2.2.1.1 Bacterial strains
The XLl-Blue (Stratagene) and JM109 (Stratagene) strains of Escherichia coli (E.coli)
were employed in this study when amplification ofDNA was required.
The BL21-RIL E.coli strain (Stratagene) was used for recombinant protein expression.
The strain does not express the Lon and OmpT proteases, reducing recombinant protein
proteolysis compared to that of other bacterial strains. In addition, the strain expresses
greater quantities of arginine (R), isoleucine (I), and leucine (L) tRNAs than other BL21
varieties (314). The efficiency of recombinant protein expression is proposed to be
influenced by the contrasting levels of certain tRNAs in a bacterial system and that of
the organism from which the protein has been isolated [294], Comparison of the codon
usage of native E.coli and the species that the fusion partners and BK channel protein
was isolated from is illustrated in Table 2.1. As E.coli employ R, I and L codons less
than the other species, use of the BL21-RIL strain shpuld decrease this difference,
encouraging effective and efficient recombinant protein production. This may
contribute particularly to the successful expression of the leucine zipper fusion protein
that encompasses a high proportion of isoleucine and leucine residues (Section 3.2.1.2).
2.2.2 Determination of bacterial exponential growth
Determination of exponential growth ofE.coli cells was achieved by measurement of the
optical density of a culture at 600 nm (ODeoo) using a Cecil CE2040 spectrophotometer.
Values indicative of the phase are between 0.4 and 0.8.
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2.2.3 Rubidium chloride preparation of competent cells
Competent cells were prepared as described by Hanahan (1985) [296],
A single colony of E.coli competent cells from a LB-agar plate* was inoculated into 5
ml LB broth* and incubated with constant shaking (37 °C, -16 hours), then inoculated
into 250 ml LB broth* and grown at 37 °C with constant agitation until the cells reached
the exponential growth phase. Cells were centrifuged (4500 g, 4 °C, 5 mins) and the
pellet resuspended on ice in 100 ml of TFB1 (TransFormation Buffer I; 30 mM
potassium acetate, 10 mM CaCl2, 50 mM MnCL, 100 mM RbCl, 15 % glycerol (v/v)
adjusted to pH 5.8 with 1 M acetic acid and sterilised through 0.2 pm filter).
Resuspension in 10 ml of ice-cold TFB2 (TransFormation Buffer 11: 10 mM MOPS, 75
mM CaCL, 10 mM RbCl, adjusted to pH 6.5 with 1 M KOH and sterilised through 0.2
pm filter) followed a second centrifugation (5 mins, 4500 g, 4 °C). Cells were incubated
(1 hr, 4 °C), aliquoted, and snap-frozen by dry ice / isopropanol treatment prior to
storage at -70 °C.
*no antibiotic added except during XL 1-Blue competent cells preparation using 50
pg/ml TET.
2.2.3.1 Test of the transformation efficiency of competent cells
Competent cells were transformed with 1 pg, 0.1 pg and 0.01 pg of control plasmid
DNA, 100 pi plated on LB-agar plates with appropriate antibiotic and incubated (16 hrs,
37 °C). To assess background, negative control reactions were performed in the absence
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of plasmid DNA. The numbers of colonies (colony forming units, cfu) on each test plate
were used to calculate a value for the transformation efficiency of the competent cells,




Typical transformation efficiencies of 10 7 - 108 cfu / pg were obtained for prepared
competent cells. Cells displaying significantly lower efficiencies were discarded.
2.2.4 Bacterial glycerol stocks
-0.85 ml of bacteria culture incubated with agitation (37 °C, ~16 hrs) was diluted with
-0.15 ml sterile glycerol, suspended by vortexing and snap-frozen in an isopropanol /
dry ice bath prior to long-term storage at -70 °C. Cultures were recovered by
inoculation into LB broth with appropriate selecting antibiotic.
2.2.5 Determination of Protein Concentration (Bradford Assay)
Analysis ofprotein concentration was determined following the procedure ofBradford
[298],
20 pi dilutions of the protein of interest were combined with 50 pi 1 M NaOH and 1 ml
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(v/v), 95 % ethanol (v/v), and dEUO, at a ratio of 10:5:85 by vol.). Solutions were mixed
by vortexing, incubated at room temperature for 10 mins, and the absorbance at 590 nm
measured. Protein concentration was determined by comparison to a standard curve,
prepared by Bradford analysis of standard concentrations of bovine serum albumin
(BSA).
2.3 General DNA Analysis Protocols
2.3.1 Agarose gel electrophoresis
Gels composed of lx TBE buffer, 1 % agarose (w/v; Promega, U.K.) and ethidium
bromide (0.5 pg/ml) to allow visualisation of DNA under ultraviolet light. Gels were
run on the Pharmacia Gel Electrophoresis Apparatus GNA-100 in lx TBE Buffer.
2.3.2 Purification of DNA from agarose gels
DNA bands cut from agarose gels were purified using the Q1AGEN Q1AEX II
purification kit following the Q1AGEN protocol as follows; bands were dissolved in
Buffer QX1 (1:3 weight:volume, 50 °C) and incubated (10 mins, 50 °C) with 10 pi
QIAEX II slurry permitting DNA-slurry association. Washing with Buffer QX1 and
Buffer PE preceded air-drying of the pellet (10-15 mins, -16 °C) and incubation in 20 pi
DEPC dEEO (5 mins, -16 °C) to release the DNA into solution. The slurry was
removed by centrifugation (30 sec, 10 000 g; Eppendorf Centrifuge 5415C).
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2.3.3 Restriction digestion of DNA
Endonuclease digestion of DNA at particular motifs allowed the production of
complimentary ends of plasmid and insert allowing ligation and subsequent construct
formation, and to assess DNA fragments following construct formation.
~1 pg ofDNA was combined with endonuclease(s) (Promega/New England BioLabs) in
appropriate buffer (Promega/New England BioLabs) and incubated at a temperature and
for a period appropriate for optimal endonuclease activity as recommended by the
enzyme manufacturers. Samples were analysed by agarose gel electrophoresis (Section
2.3.1).
2.3.4 Alkaline Lysis: Plasmid DNA purification
Purification ofplasmid DNA was performed as described by Birnboim & Doly (1979)
[299],
2.3.4.1 Mini-preparation
The cellular pellet from ~1.5 ml of bacteria culture (incubated 37 °C, -16 hrs;
centrifuged 30 sec, 10 000 g) was resuspended in 250 pi Resuspension Solution (10 mM
Tris HC1, pH 8.0; 1 mM EDTA, pH 8.0; 8 % RNase A (v/v)) and incubated for 5 mins at
room temperature to promote suspension and RNA degradation. Addition and gentle
mixing of 250 pi Lysis Solution (0.2 M NaOH; 1 % SDS (w/v)) promoted plasma
membrane and hydrophobic protein solubilisation to lyse the bacterial cells whilst
denaturing plasmid and chromosomal DNA. Within 5 mins, 350 pi of Neutralisation
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Solution (3 M K+, 5 M acetate: 60 ml 5 M potassium acetate, 11.5 ml glacial acetic acid,
28.5 ml dFhO) was added gently and incubated (-20 °C, 5 mins). This aided the
precipitation of the insoluble dodecylsulphate potassium salt with insoluble aggregates
of chromosomal DNA and aggregated proteins that were removed by centrifugation (5
mins, 10 000 g). Interstrand rehybridisation maintained plasmid DNA in solution, and
850 pi phenol:chloroform:isoamyl alcohol (25:24:1) was added and mixed to enable
separation of the aqueous plasmid DNA from any phenol-soluble proteins and non-
plasmid DNA. 850 pi isopropanol was added to the separated aqueous phase
precipitating the double stranded plasmid DNA. Following centrifugation (30 mins, 10
000 g), the supernatant was aspirated and 70 % ethanol (v/v) added to remove residual
salt and replace the less volatile isopropanol. Plasmid DNA was resuspended in 50 pi
Resuspension Solution after centrifugation (30 sec, 10 000 g) and ethanol removal.
2.3.4.2 Midi- and maxi- preparations
Alkaline lysis purification of plasmid DNA on midi- (<200 pg) or maxi- (>200 pg)
scales were performed using the Q1AGEN HiSpeed™ Midi Plasmid Preparation and
Q1AGEN QIAfilter™ Plasmid Maxi Preparation Kits respectively, following the
manufacturer's instructions.
2.3.5 Ethanol extraction
To concentrate nucleic acid solutions, 3 M sodium acetate, pH 5.5, was mixed with
DNA solution (1:10 by volume). Addition of ice-cold, 100 % ethanol and glycogen
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(2.5:0.01:1 DNA solution by volume) aids DNA precipitation and isolation. The DNA
pellet was washed with 70 % ethanol (v/v) following centrifugation (10 000 g, 30 mins)
and resuspended in an appropriate volume of Resuspension Solution (See Section 2.3.4).
2.3.6 DNA quantification & determination of contamination
Measurement of the optical density of a DNA solution at 260 nm, OD260, determined the
nucleic acid concentration. The ratio of OD26o'OD28o was used as a measure of protein
and phenol contamination, with values less than 1.8 indicative of high contamination.
2.4 Molecular cloning & manipulation
2.4.1 Polymerase chain reaction amplification of DNA sequences
The Polymerase Chain Reaction (PCR) was used to amplify regions of mouse BK
channel splice variant cDNA allowing sub-cloning of the DNA fragments into bacterial
plasmids and also, to confirm the success of directional sub-cloning.
Primers, designed to anneal specifically to the regions of interest (Figure 2.1), were
generated by MWG Biotech Co. and are listed in Table 2.2. Primers amplifying the
STREX exon introduced restriction sites into the PCR product to facilitate cloning into
the pGEX5x-l plasmid. Primers used to produce TA-vector inserts were designed to
account for the 3' adenine overhangs of the PCR products.
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Bam HI pGEX5x-l 72.9
GGT CGT GGG ATC CCC





Sal 1 pGEX5x-l 74.0
ATC CCC GAA TTC GGC













































AGG CGG CCC AAG ATG






CAT TCT CTT GTA GAT






ATG TTA CGC CAG CCG





GAC CCC AGT TGT GAT






GCT CAA GGC GCC TCC
ACA ATG CTT GCC AAT




CCT CAT AGA GAA GGC
ATT GGC AAG CAT TGT
GGA GGC GCC TTG AGC
Primers used to amplify regions of the murine BK channel sequence (illustrated
schematically in Figure 2.1) to enable construct generation (See Table 3.1) or
mutagenesis (red text). Lettering refers to Figure 2.1.
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Typically, cloning reactions were performed with the following components: 1-10 ng
DNA, 10 pmol of forward primer and 10 pmol of reverse, 10 nmol each of dATP, dCTP,
dGTP, and dTTP (Pharmacia Biotech), 75 pmol (=2.5 mM) Mg2+ within lx Expand™
High Fidelity Buffer (Boehringer Mannheim), and 2.6 U Expand™ Taq/Pwo Enzymes
(Boehringer Mannheim), all in DEPC dH20 to a final reaction volume of 50 pi. The
enzyme was added "hot start"; following heating of the reaction mixture to 95 °C, to
inhibit non-specific primer associations. Negative controls were performed with non¬
specific DNA or DEPC dHaO replacing the DNA. PCR reactions used for rapid
screening were performed as above, but used Taq polymerase and appropriate buffers
(Promega). All reactions were performed in a Perkin-Elmer GeneAmp PCR System
2400 with cycling parameters (Table 2.3) specific to the primer pair used, relative to the
respective melting temperatures (Tm; Table 2.2). Samples were analysed by agarose gel
electrophoresis (Section 2.3.1).
2.4.2 Ligation of insert DNA into plasmids
2.4.2.1 Ligation of restricted fragments
Insert and vector digested by the appropriate restriction endonucleases (Section 2.3.3),
separated by agarose gel electrophoresis (Section 2.3.1) and purified from the agarose
(Section 2.3.2) were analysed by electrophoresis to confirm purification and enable
approximation of the relative DNA concentrations.
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Table 2.3
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95 °C- 30 sec
3Ox
95 °C - 30 sec
55 °C - 30 sec
72°C-1 min
lx






95 °C- 30 sec
3Ox
95 °C - 30 sec
49 °C- 30 sec
72 °C - 1 min
lx
72 °C~ 30 sec
4°C -oo
* Primer labels refer to Table 2.2 & Figure 2.1
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In general, three experimental 10 pi reactions of varying insert concentration were
performed in the presence of vector, 1 U T4 ligase (Promega) and 30 mM Tris HC1, pH
7.8, 10 mM MgCh, 10 mM dithiothreitol (DTT), 1 mM adenosine triphosphate (ATP),
(Promega) as recommended by the enzyme manufacturer [300], Reactions omitting the
insert and enzyme were performed in parallel as controls of vector re-annealing and
contamination. Reactions were incubated (16 °C, -16 hours) prior to transformation into
competent XLl-Blue or JM109 E.coli cells.
2.4.2.2 Ligation into TOPO vector
Fresh PCR product was incubated with TOPO vector (-20 °C, 5 mins) and transformed
into TOPI 0 E.coli cells (lnvitrogen) as recommended by the vector manufacturer [301 ].
2.4.2.3 Assessment of ligation transformants
Assessment of ligation efficiency was determined by the presence or absence of colonies
on the control plates; the presence of colonies indicated bacteria that do not contain the
insert within their plasmid and thus, experimental plates were discounted. If the
experiment demonstrated no or low background, individual colonies from experimental
plates were inoculated into 5 ml LB/amp cultures for DNA analysis via alkaline lysis
(Section 2.3.4.1) and test restriction digests (Section 2.3.3) or insert orientation-specific
PCR reactions (Section 2.4.1).
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2.4.3 Site directed mutagenesis (SDM)
Site directed mutagenesis was performed using the Stratagene Quikchange™ Site-
Directed Mutagenesis Kit following the manufacturer's instructions [302]. 5-50 ng
DNA were polymerised by 2.5 U Pfu DNA polymerase (Promega) with 125 ng of each
mutagenic primer (MWG Biotech Co.; See Figure 3.4) and 2.5 mM of dATP, dCTP,
dGTP and dTTP in lx reaction buffer (10 mM KC1, 6 mM (NH^SCh, 20 mM Tris-HCl,
pH8.0, 2 mM MgCb, 0.1 % Triton X-100 (v/v), 10 pg/ml BSA), diluted to final volume
of 50 pi with DEPC dFEO. PCR was performed in a Perkin-Elmer GeneAmp PCR
System 2400 for 16 cycles (95 °C, 30 sec; 55 °C, 1 min; 68 °C, 2 min/kb plasmid
length), and 10 U Dpnl (Promega) incubated with each reaction (37 °C, 1 hr) to digest
parental, non-mutated, DNA prior to transformation into XL 1-Blue E.coli cells. DNA
was then isolated (as Section 2.3.4) to allow confirmation of mutagenesis by sequencing
(MWG Biotech Co.).
2.5 Recombinant protein expression & purification from bacterial
expression systems
2.5.1 Recombinant protein expression
250 ml LB/amp media inoculated from a BL21-R1L E.coli colony expressing the
plasmid of interest (See Section 2.2.1) was incubated with agitation (37 °C) until
reaching exponential growth (See Section 2.2.2). Test cultures were exposed to a range
of induction temperatures, durations and inducer concentrations to determine the most
effective conditions for soluble recombinant protein production. For pGEX5x-l plasmid
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recombinant protein translation, 0.5 mM 1PTG for -16 hrs at 16 °C was most successful,
and for the pBAD/Thio-TOPO vector, 0.02 % L-arabinose (w/v) under the same
conditions.
2.5.1.1 Solubility test
A bacterial cell pellet from an induced 1 ml test culture was resuspended in 100 pi ice-
cold STET buffer, lysed with 10 pi of 50 mg/ml lysozyme, vortexed and incubated on
ice (20 mins). The insoluble fraction, pelleted by centrifugation (-30 sec, 10 000 g) and
resuspended in SDS-LB. was compared to the soluble fraction (diluted 1:1 in 2x SDS-
LB) by SDS-PAGE analysis (Section 2.7.1).
2.5.2 Purification of GST-tagged proteins
Purification ofGST-fusion proteins was performed using an optimised protocol based
on that recommended by the slurry manufacturer [303].
Cell pellets (6 000 g, 15 min) from 250 ml LB/amp GST (Glutathione-S-transferase)-
tagged protein inductions were washed in 5 ml ice cold PBS, re-pelleted (6 000 rpm, 15
min), resuspended in 4 ml ice cold STET + protease inhibitors (Boehringer Mannheim)
and lysed by lysozyme (500 pi of 50 mg/ml; stirred 30 mins, 4°C) and sonication (8x10
sec, 6 microns, Soniprep 150, Sanyo). Following centrifugation (10 000 g, 30 mins), the
supernatant was diluted with 27 ml 0. lx PBS, pH 8.5 and incubated with stirring (1 hr, 4
°C) with 5 ml 50 % GS4B (w/v; glutathione sepharose 4B; Amersham Pharmacia) pre-
equilibrated with PBS. The GS4B was washed repeatedly with PBS then exposed to an
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affinity pull-down assay (Section 2.9.2) or incubated in 2.5 ml Elution Buffer (50 mM
Tris base, 10 mM glutathione; 30 mins, 4 °C) to elute the GST-fusion proteins
competitively.
Note: GS4B was prepared, stored and regenerated following manufacturer's instructions
(Amersham Pharmacia).
2.5.3 Ni+NTA purification of His-tagged proteins
Purification of 6x Histidine (His6)-tagged proteins was performed using nickel-
nitrilotriacetic acid (Ni^TSTA) metal-affinity chromatography matrices following the
manufacturer's recommended protocol for batch purification under native conditions
[304], Cell pellets (6 000 g, 15 min) from 250 ml LB/amp His6-tagged protein
inductions were resuspended in 2 ml Lysis Buffer (50 mM NaFLPCL, 300 mM NaCl, 10
mM imidazole, pH 8.0) + EDTA-free protease inhibitors (Roche) per g cell pellet and
lysed by lysozyme-treatment (1 mg/ml; stirred 30 mins, 4°C) and sonication (8 x 10 sec,
6 microns). Following centrifugation (10 000 g, 30 mins, 4 °C), the supernatant was
incubated with stirring (1 hr, 4 °C) with 50 % Ni^TA (w/v) pre-equilibrated with Lysis
Buffer (1 ml Ni^TMTA per 4 ml lysate). The Ni+NTA was washed repeatedly with
Washing Buffer (50 mM NaFLPCL, 300 mM NaCl, 20 mM imidazole, pH 8.0) then
exposed to an affinity pull-down assay (Section 2.9.2) or the His6-tagged protein was
eluted by 4x 0.5 ml Elution Buffer (50 mM NaLLPCL, 300 mM NaCl, 250 mM
imidazole, pH 8.0).
72
Chapter Two: Materials & Methods
2.5.4 Immunoprecipitation
Bacterial cell pellets (induced where appropriate as in Section 2.5.1; centrifuged 6 000 g,
10 min, 4 °C) were resuspended in 2 ml Lysis Buffer (150 mM NaCl, 50 mM Tris, pH
8.0, 1 % Triton-X-100 (v/v)) + protease inhibitors (Roche) per g wet pellet weight as
recommended by Invitrogen [305]. Cells were lysed by lysozyme treatment (1 mg/ml;
stirred 30 mins, 4°C) and sonication (8 x 10 sec, 6 microns) and spun (10 000 g, 20
mins, 4 °C). The supernatant was pre-cleared with 50 pi of 50 % protein-G-sepharose
(PGS; w/v) in Lysis Buffer per 1 ml supernatant (agitated - 1 hour, 4 °C), then spun (10
000 g, <1 min, 4 °C) and the pre-cleared supernatant incubated with agitation (16 hrs, 4
°C) with 50 pi 50 % PGS (w/v) and the appropriate antibody (Table 2.4). The slurry
pellet (10 000 g, <1 min, 4 °C) was washed (3x 200 pi Lysis Buffer, lx 200 pi dHoO)
and suspended in 25 pi 2x SDS-LB for direct protein analysis, or exposed to in vitro
phosphorylation (Section 2.8) or affinity pull-down (Section 2.9.3).
2.6 Recombinant protein expression & purification from mammalian
expression systems
2.6.1 Mammalian cell culture
Human embryonic kidney 293 (HEK293) cells were maintained in Dulbecco's Modified
Eagle Medium (DMEM; Gibco) + 10 % foetal calf serum (v/v; FCS; Harlan) at 37 °C, 5
% COi in a CC>2-incubator (Wolf Laboratories), and passaged following standard tissue
culture procedures [306] using Trypsin-EDTA (Gibco) to release confluent cells.
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2.6.2 Transfection & creation of stable cell lines
HEK293 cells at -50 % confluency were transfected with cDNA using
L1POFECTAMINEim Reagent (Gibco) following the manufacturer's instructions. 0.5-1
pg cDNA / ml final reaction volume were used routinely with a 1:1 cDNA ratio applied
in co-transfections. Cells transfected transiently were harvested for
immunofluorescence or immunoprecipitation 24-72 hours after transfection. Stable cell
lines were created by adding a selection media with an antibiotic appropriate to the
resistance of the transfected plasmid 24 hours after transfection. The selection media
was replaced every 48 hours to remove dead cells for -2 weeks until no further cell
death was observed. Cells were then passaged and following recovery, maintained in
selection media as a stable cell line.
2.6.3 Immunoprecipitation
Immunoprecipitation of proteins from mammalian cell tines was performed using a
method based upon those ofRotman et al (1995) and Fanger et al (1999) [222, 307],
Stable cell lines were grown in 75 cm' tissue culture flasks until reaching confluency
whilst transient transfections were harvested 24-72 hrs following transfection. Flasks
were washed twice with 1 ml bRIA (50 mM Tris-HCl, pFl 7.5, 0.5 mM MgCh, 0.2 M
NaCl, 10 mM EDTA, 20 mM sodium pyrophosphate, 100 mM sodium fluoride, 1 mg/ml
BSA), then suspended in 300 pi bRIA + 1 % Triton X-100 (v/v; bRIA-T) + protease
inhibitors prior to sonication (4x10 sec, 8 mA). Insoluble material was removed by
centrifugation (10 000 g, 15 min, 4 °C) and the lysate pre-cleared by incubation with 20
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jliI of 50 % PGS in bRIA-T (w/v; agitation, 1 hr, 4 °C). The immunoprecipitating
antibody at the appropriate dilution (Table 2.4) with 40 pi 50 % PGS in bRIA-T (w/v)
was added to the pre-cleared lysate and incubated (4 hrs, 4 °C). The pellet was washed
(3x bRIA-T, lx dH20) and diluted with 20 pi 2x SDS-LB for direct analysis, or exposed
to in vitro phosphorylation (Section 2.8) or affinity pull-down (Section 2.9.3).
2.6.4 Analysis on BK channel expression in vivo in HEK293 cells
2.6.4.1 -EGFP visualisation
Transiently transfected or stable cell lines were grown on coverslips until -40-50 %
confluency was observed (typically 24-72 hrs following passage/transfection). Cells
were washed gently three times with PBS + 2 mM Ca2+ + 1 mM Mg2+ removing debris,
then fixed (4 % paraformaldehyde in PBS (v/v), pH 7.1, 20 mins, -16 °C). Fixing was
quenched (50 mM NH4CI, 10 mins, -16 °C) following washing (3x PBS), then washed
(3x PBS). Nuclear material was stained with TO-PRO-3™ (Molecular Probes) (10
mins, -16 °C), then coverslips re-washed (3x PBS), mounted with Mowiol (Calbiochem)
and stored at 4 °C prior to confocal microscopy.
2.6.4.2 Confocal microscopy
Labelled proteins fixed on coverslips prepared as described in Section 2.6.4.1 were
visualised using confocal microscopy on a Zeiss 510 LSM in conjunction with Linda
Sharp. EGFP was excited at 478 nm to produce a fluorescent emission peak with a
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maximum at 507 nm (green). T0-PR03™ (Molecular Probes) was excited at 642 nm,
with emission at 661 nm (blue).
2.6.5 Electrophysiology
Patch clamp electrophysiology was performed in conjunction with Dr Lijun Tian.
Isolated inside-out patches from HEK293 cells were depolarised to +20, +40, and +60
I 2~E
mV in physiological K gradient in the presence of 0.2 pM free Ca . Data acquisition
was controlled by an Axopatch 200B amplifier and pCLAMP6 software (Axon
Instruments Inc.). All recordings were filtered at 2 kHz and sampled at 10 kHz. Bath
solution: 140 mM KC1, 1 mM BAPTA (l,2-bis[2-aminophenoxy]ethane-
N,N,N',N',tetraacetic acid), 10 mM HEPES (N-[2-hydroxyethyl]piperazine-N'-|2-
ethanesulphonic acid), 30 mM glucose, pH 7.4 in 2 mM MgATP, with free Ca2+
buffered to 0.2 pM. Pipette solution: 140 mM NaCl, 5 mM KC1, 0.1 mM CaCb, 5 mM
MgC^, 10 mM HEPES, 20 mM glucose, pH 7.4. Patch pipettes manufactured from
Garner #7052 glass with resistance of 1.5 - 3 M£2 in physiological saline. Steady state
mean open probability was determined over at least 20 sec of recording.
2.7 Protein analysis
2.7.1 Polvacrylamide gel electrophoresis
Non-radioactive protein samples in SDS-LB were heated (42 °C, ~5 mins for full-length
channel immunoprecipitations. 100 °C, ~5 mins for all other samples) and analysed by
standard SDS-polyacrylamide gel electrophoresis (SDS-PAGE) protocols using the Mini
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Protean® 3 Cell gel electrophoresis system (BioRad) run in Laemelli Buffer (Section
2.1.2.2). Proteins with large molecular weights (>50 kDa) were analysed on gels of 7.5
% acrylamide (w/v) whilst smaller proteins (<50 kDa) were analysed on 10 %
acrylamide gels, all with 3 % acrylamide stacking gels [As 308], Gels were analysed by
Western blotting (Section 2.7.2), or stained by Coomassie (15 mins in stain: 500 ml
methanol, 100 ml acetic acid, 400 ml dH20, 1 g Coomassie R-250. Destain: 50 %
methanol, 10 % acetic acid (v/v) in dH20), Colloidal Coomassie (1 hr; GelCode® Blue
Stain Reagent, Pierce. Destain: dH20) or Silver stain (Section 2.7.1.1) to enable protein
visualisation.
2.7.1.1 Silver stain
Silver staining of acrylamide gels was performed by the method of Wray et aI (1981)
[309],
Gels were fixed in 50 % methanol, 10 % acetic acid solution (v/v, 20 mins), then soaked
in 50 % methanol (v/v, 20 mins). Following washing (dH20, 5 mins), gels were re-
soaked in methanol and washed twice more, prior to staining (0.4 g silver nitrate, 21 ml
of 0.36 % NaOH (v/v), 1.4 ml of 14.8 M NH4OH made up to 100 ml with dH20; 20
mins, ~16 °C). The gel was transferred to developer (2.5 ml of 1 % citric acid (w/v),
0.25 ml of 38 % formaldehyde (v/v) in 500 ml dH20) after washing (5 mins, dH20).
When sufficient protein visualisation was observed (typically 5-15 mins), further
development was inhibited using a 50 % methanol, 10 % acetic acid (v/v) solution. Gels
were rinsed and stored in dH20 prior to drying.
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2.1.2 Western blot analysis
Western blot analysis was performed using standard protocols for wet transfer of
proteins in acrylamide gels (Section 2.7.1) onto polyvinylidene fluoride (PVDF,
Amersham) membranes [310], Membranes, activated by methanol, and gels were
soaked in lx Towbin Transfer Buffer (TTB) and transfer was performed in lx TTB
using a Hoefer TE22 Series Transphor Electrophoresis Unit (1 hr, 400 mA). Transferred
membranes were blocked in PBS-T + 5 % Marvel (w/v; Premier Brands) for between 1
hr (at -16 °C) and 16 hrs (at 4 °C), washed, and incubated in the appropriate primary
antibody solution (Table 2.4). Secondary antibodies conjugated to horseradish
peroxidase (HRP) were applied following washing (Table 2.4), and detection was
performed by enhanced chemiluminescence (ECL) using Amersham reagents as
described in the manufacturer's protocols. ECL reactions were detected by Konica MG-
Super Rapid Medical Film developed in a Kodak SRX-101A X-ray developer. Unless
stated otherwise, illustrated Western blots are typical of three independent experiments.
Antibodies were diluted appropriately (Table 2.4) in PBS-T + 1 % Marvel (w/v), except
for the Diagnostic Scotland a-phospho- and a-non-phospho- antibodies that were
diluted in PBS-T + 1 % Marvel (w/v) + competing peptides as illustrated in Table 2.4.
Primary antibody incubations were performed at -16 °C for 2-4 hrs, or 4 °C for -16 hrs.
Secondary antibodies were incubated with the membranes for 1-2 hrs at -16 °C. Non¬
specific reactivity was assessed by test membranes and dot blot analysis (Section
2.7.2.1), exposing membranes to secondary antibodies without primary antibody
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Table 2.4
Characteristics & use of antibodies: A. Primary antibodies
a B. Secondary antibodies
Antibody Species Supplier Epitope sequence(if known)
Dilution for use
WB IP
a-V5 Mouse Invitrogen gkp1pnpllgldst 1/5000 1/1000
a-HA
(12ca5)








v94, ndtnvqfldqddd 1/1000 _
a-HA (Y11) Rabbit Santa Cruz ypydvpdya 1/333 -
a-STREX-1 Rabbit HG Knaus M659( 27)SGrvrgnvdtlert
fp
1/2000 _
a-GST Goat Pharmacia polyclonal 1/2000 -
a-GFP Mouse Clontech " 1/1000 -
a-phospho-









STREX Sheep d-s c628(-5)GCRRPKMS(p)1ykrm
1/1000
+2
a-STREX Sheep d-s c628(-5)gcrrpkms iykrm
1/1000
+'
Antibody Species Supplier WB dilution
a-mouse-HRP Sheep Diagnostics Scotland 1/1000
a-goat/sheep-HRP Donkey Diagnostics Scotland 1/15000
a-rabbit-HRP Donkey Diagnostics Scotland 1/5000
Epitope sequence numbering as murine STREX BK channel (See Figure 1.3).
Numbering within STREX insert (in brackets) as Figure 1.6. WB - Western blot, IP -
immunoprecipitation, D-S - Diagnostics Scotland. Standard one letter amino acid code
used.
1 10 pg/ml each of phospho-STREX & S869 peptides (Scheme 2.1)
2 10 pg/ml each of phospho-S869 & STREX peptides (Scheme 2.1)
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incubation, pre-incubation of antibodies with target peptides and/or exposure of
antibodies to positive and negative control proteins.
2.7.2.1 Generation of phospho-specific antibodies & dot blot analysis
Phospho-specific antibodies were generated commercially in sheep by Diagnostic
Scotland against KLH (Keyhole Limpet Hemocyanin)-conjugated peptides of the S869
and STREX S4 regions of the BK channel (Scheme 2.1). Peptides were phosphorylated
chemically to ensure phosphorylation was permanent. In the case of the S869 peptides,
an additional cysteine residue was included at the N-terminal to enable conjugation to
KLH. This was not necessary with the STREX peptides as cysteine is present in the
native sequence.
Scheme 2.1: Booster peptides for immunisation in sheep
Sequence numbering of epitopes is as murine STREX BK channel (See Figure 1.3).
Numbering within STREX insert is as in Figure 1.6 and shown in brackets. Standard
one letter amino acid code used.
Peptide Sequence





Phospho-S869 -C-V9i9HGMLRRQPS (p) ITTGV
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Preliminary investigation of the specificity and cross-reactivity of these antibodies was
performed by dot blot analysis with 10 pg of peptide (Scheme 2.1) / protein dotted onto
methanol-activated PVDF membrane, and the membrane analysed by Western blot
analysis (antibody-exposure and ECL-detection as Section 2.7.2).
2.7.2.2 Western blot membrane stripping
To enable re-probing of Western blot membranes, antibodies were removed by acid-
stripping, incubating the membranes (15 mins, ~16 °C) in Stripping Buffer (0.2 M
glycine, 0.5 % concentrated HCI (v/v), 0.005 % Tween-20 (v/v) in db^O). The
membranes were washed in PBS-T then blocked prior to re-probing as described
previously (Section 2.7.2).
2,7.3 Preparation of samples for mass spectrometry
Protein bands detected by colloidal stain can be analysed by mass spectrometry
following in-gel digestion. The protein band of interest was excised, divided into ~1
mm3 cubes, washed with milliQ water (300 pi, 15 mins) to remove the stain, then
washed with CH3CN (300 pi, 15 mins) to remove hydrophobic compounds. The
supernatant was removed, and replaced with 100 mM NH4HCO3 (300 pi, 15 mins), then
replaced repeatedly with 1:1 (v/v) 100 mM NH4HCO3 / CH3CN (300 pi, 15 mins) until
the stain was released fully from the gel pellets. The clear pellets were suspended in
CH3CN (100 pi, 5 mins) for dehydration then dried (5-30 mins) in a speedvac (Savant
SPD111V).
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Dehydrated bands were reduced and alkylated by addition of DTT and iodoacetamide:
each band was suspended in 50 pi 10 mM DTT in 100 mM NH4HCO3 (56 °C, 1 hr), then
the pellet resuspended in 50 pi 50 mM iodoacetamide in 100 mM NH4HCO3 (~16 °C, 30
mins, in dark). The pellet was washed with 100 mM NH4HCO3 (300 pi, 15 mins), 1:1
v/v 20 mM NH4HCO3 / CH3CN (300 pi, 15 mins), and resuspended in 100 pi CH3CN (5
mins) prior to speedvac dehydration (5 mins).
Bands were rehydrated and digested using 20 pi of 12.5 pg/ml modified trypsin in 20
mM NH4HCO3 (~16 °C, 24 hrs) before mass spectrometry analysis using an Applied
Biosystems Voyager DE-PRO MALD1-TOF (delayed extraction protein matrix-assisted
laser desorption/ionisation - time of flight mass spectroscopy) in conjunction with
Nathan Harris, Moredun Institute, and Hannah Florance, Edinburgh University,
following manufacturer's instructions. Acquired data was analysed using MS-Fit
(UCSF) to identify the protein of interest.
2.8 Phosphorylation & dephosphorylation
Phosphorylation and dephosphorylation reactions were performed in conditions suitable
for maximal catalytic activity of the protein kinase / protein phosphatase as
recommended by the enzyme manufacturers [297, 312]. For safety and consistency,
reactions employing [y-32P]-ATP were diluted in LDS-LB (Section 2.1.2.2), heated (70
°C, 10 mins) and 15 pi samples run on 12 % and 4-12 % Bis-Tris gels (Invitrogen) in
MOPS SDS-Running Buffer (Section 2.1.2.2) using the NOVEX X-Cell Sure Lock™
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electrophoresis system (lnvitrogen). Gels were dried fully (Hoefer Slab Gel Dryer
GD2000), then exposed to j2P-sensitive film (BioMax MR-1 & MS film, Sigma) in an
intensifying screen cassette (Kodak) for periods ranging from 1 hr to 36 hrs, and at
temperatures of-70 °C or -16 °C. Non-radioactive reactions were analysed by Western
blotting (Section 2.7.2).
2.8.1 In vitro phosphorylation of soluble & immunoprecipitatcd proteins
2.8.1.1 In vitro PKA phosphorylation reactions with exogenous PKA
5 pg of purified protein or -20 pg immunoprecipitation slurry (IP) of purified protein
were incubated with 1 mM cold rATP, 10 pCi [y-32P]-ATP (1 pi, Amersham) and 40 U
of pure PKA catalytic subunit (PKAc; bovine PKAc, 40 kDa, Promega) in 2 mM MgC^,
4 mM Tris HC1, pH 7.4 made up to 30 pi with dfTO. Additionally, 100 nM of protein
phosphatase inhibitor, okadaic acid (OA), were added to immunoprecipitation reactions.
The peptide, kemptide, contains a strong PKA consensus motif [227] and therefore, was
used in positive control reactions composed of: 0.1 mM cold rATP, 10 pCi [y-j2P]-ATP
and 40 U PKAc in 2 mM MgCh, 4 mM Tris HC1, pH 7.4 made up to 30 pi with dfTO.
Negative control reactions were performed by replacing PKAc with dfhO. Reactions
were incubated (30 °C, 10 mins), then quenched by placing on ice and the addition of an
equal volume of 2x LDS-LB to analysis by autoradiography.
Time course assays were performed by the removal of 7.5 pi aliquots of 60 pi
phosphorylation reactions at 0, 1, 3, 5, 10, 20, 30 mins following addition of the kinase
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to the reaction mixture with continual incubation at 30 °C. The aliquots were diluted in
7.5 |nl of LDS-LB prior to autoradiographic analysis.
2.8.1.2 In vitro PKA phosphorylation reactions with endogenous PKA
Following co-immunoprecipitation of PKAc with the -HA-tagged BK channels (See
Chapter 5), in vitro phosphorylation reactions were performed on the
immunoprecipitates without exogenous PKAc addition to determine if the endogenous,
pulled down PKAc could phosphorylate the channels.
2.8.1.3 In vitro PKC phosphorylation reactions
In vitro PKC phosphorylation reactions were performed with 5 pg or a ~20 fig IP of
purified protein incubated with 1 mM cold rATP, 10 fiCi [y-32P]-ATP (1 fil, Amersham)
and 45 U of pure PKC (rat, 82 kDa, Stratagene) in 400 mM MES (2-[N-morpholino]
ethane sulphonic acid), pH 6.0, 100 mM MgCE, 10 mM CaCE, 10 mM ethylene glycol-
bis(p-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA) buffer made up to 30 pi with
dEEO. 100 nM of protein phosphatase inhibitor, okadaic acid (OA), were added to
immunoprecipitation reactions. 7.5 fig of the 21-25 kDa phosphorylated heat-and acid-
stable protein regulated by insulin (PHAS-I, Stratagene) was used as a positive control
of PKC phosphorylation [313], with negative control reactions performed in the absence
of the kinase with dEEO replacing PKC. Reactions were incubated (30 °C, 10 mins),
then quenched by placing on ice and the dilution of the 30 jil reactions in 30 pi LDS-LB
prior to autoradiographic analysis.
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2.8.1.4 In vitro CaMKII phosphorylation reactions
5 pg of pure protein or ~20 pg IP slurry were pre-incubated (30 °C, 3 mins) with 0.08
mM cold rATP, 50 mM Tris HC1, pH 7.5, 10 mM MgCh, 0.5 mM dithiothreitol (DTT),
1 mM CaCb, 1 pM calmodulin (Calbiochem), 0.1 mg/ml BSA, or in negative control
reactions, 0.08 mM cold rATP, 50 mM Tris HC1, pH 7.5, 10 mM MgCh, 0.5 mM DTT
and inhibitory 1 mM EGTA, pH 7.2, both to final volume of 25 pi with dlT^O. 10 pCi
[y-32P]-ATP and 20 U CaMKII (Calbiochem) in 50 mM Tris HC1, pH 7.5, 10 mM
MgCh, 0.5 mM DTT, 0.1 mg/ml BSA to 5 pi volume with dTbO were added and
incubated (30 °C, 5 mins). Reactions were quenched by placing on ice and dilution in
2x LDS-LB before autoradiographic analysis.
2.8.1.5 Dephosphorylation assays
Dephosphorylation reactions were performed, based on the method of Murphy et al
(1993) [314],
2.8.1.5.1 Dephosphorylation ofGST-fusion proteins
Phosphorylation of GST-fusion proteins (as Section 2.8.1.1) was quenched on ice and
excess GS4B added (30 pi 50 % slurry (w/v) / 100 pi assay volume) to bind the GST-
fusion proteins. The slurry was washed (4x 100 pi Wash Buffer: 50 mM Tris HC1, pH
7.5, 1 mM DTT, 1 mM MnCh) to replace the phosphorylation assay components, then
resuspended in 100 pi Wash Buffer and divided equally into five aliquots. Aliquots
were treated either with 2 U protein phosphatase (PP2A or PP1, Promega) in the
presence or absence of 100 nM of the phosphatase inhibitor, okadaic acid (OA, Alexis),
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or with 100 nM OA alone in a final volume of 15 jul with Wash Buffer. A control
aliquot was treated with 15 pi Wash Buffer only. Reactions were incubated with
frequent agitation (37 °C, 30 mins) then quenched on ice. OA was added to a control
reaction that had been incubated with protein phosphatase and all assays were diluted in
2x LDS-LB prior to analysis by autoradiography (See Section 2.8).
2.8.1.5.2 Dephosphorylation of peptides
Phosphorylation of peptides (as Section 2.8.1.1) was quenched on ice and the PKA-
inhibitor, H-89, added (to 1 pM final concentration) to inhibit further phosphorylation.
30 pi phosphorylation reactions were divided equally into six 5 pi aliquots and treated
with 2 U protein phosphatase (PP2A or PP1, Promega) in the presence or absence of 100
nM of the phosphatase inhibitor, okadaic acid (OA, Alexis) or with 100 nM OA alone or
no additional reactants. All reactions were made up to a final volume of 20 pi with
Wash Buffer (See above) then incubated (37 °C, 30 mins), quenched on ice and diluted
in 20 pi LDS-LB prior to analysis by autoradiography (See Section 2.8).
2.8.2 In vivo stimulation of endogenous PKA
In the context of these experiments the term "in vivo " is used to refer to heterologous
BK channel expression in intact HEK293 cells and wasperformed by a method based on
that ofMammen et al (1999) [315],
75 cm" flasks expressing a stable cell line of-HA-tagged channels were grown to near
confluency (-48 hrs following passage, as Section 2.6.2). ~16 hrs prior to assay, the
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DMEM + FCS media were replaced by DMEM + 1 % ITS (v/v; insulin-transferrin-
sodium selenite) liquid media supplement to remove glucocorticoids present in the FCS
that can influence PKA regulation of BK channel activity [194, 233, 316]. For assay,
flasks were washed twice (DMEM) then treated with a PKA stimulator, either 30 pM
forskolin (Sigma) or 1 mM 8-(4-chlorophenylthio)-cAMP (8-CPT-cAMP; BIOLOG),
and/or 100 nM of the protein phosphatase inhibitor, okadaic acid (OA; Alexis) in 5 ml
DMEM. Control reactions were performed by incubation of a flask with 100 nM OA in
5 ml DMEM, or incubation in DMEM only. Following incubation (20 mins, 37 °C)
cells were lysed and immunoprecipitated as Section 2.6.3 in the presence of forskolin /
8-CPT-cAMP / OA as appropriate.
2.9 Protein affinity assays
2.9.1 Lvsate preparation
2.9.1.1 HEK cell lysate
A 75 cm" flask of HEK293 cells or a stable cell line were grown to -100 % confluency
and rinsed with -5 ml PBS. Cells were scraped loose in 0.3 ml Lysate Buffer (20 mM
Tris, 2 mM EDTA, 150 mM NaCl, 0.5 % Triton X-100 (v/v), pH 7.4) + protease
inhibitors, sheared with a 26 G needle (Terumo) and spun to pellet the non-solubilised
cellular components. Samples were stored at -70 °C until required.
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2.9.1.2 Rat brain lysate
Rat brains were homogenised in ~3 ml Homogenisation Buffer (150 mM KG, 2 mM
MgCb, 5 mM EGTA, pH 7.4 + protease inhibitors (Boehringer Mannheim) per brain.
Homogenate was centrifuged (800 g, 5 mins, 4 °C), and the pellet re-homogenised in 2-4
ml of Homogenisation Buffer prior to re-centrifugation (800 g, 5 mins, 4 °C). The
pooled supernatant was separated by centrifugation (40 000 g, 45 mins, 4 °C) into the
soluble cytosolic fraction and the insoluble membrane fraction. Samples were stored at
-70 °C until required.
2.9.2 Affinity chromatography columns
Columns of GS4B slurry bound by GST-fusion proteins were prepared as described in
Section 2.5.2 and washed in >10 column volumes Binding Buffer (50 mM Tris, 50 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 5 % glycerol (v/v), pH 7.4). Columns were arranged
as illustrated in Figure 2.2 and loaded with rat brain lysate, HEK293 cell lysate (diluted
1:20 in Binding Buffer), or pure PKAc (Promega; diluted 80 U (1 pi): 0.5 ml Binding
Buffer). Washing (5 x 10 ml Binding Buffer) was followed by high salt elution of
associating proteins (3 x 2.5 ml Elution Buffer: 50 mM Tris, 1 M NaCl, 1 mM EDTA, I
mM EGTA, 5 % glycerol (v/v), pH 7.4). Eluates were concentrated to 0.5 ml volume
using a 10 kDa cut-off Centricon (Millipore) and frozen at -20 °C prior to analysis by
SDS-PAGE. Controls were performed in parallel to experimental proteins.
Affinity chromatography upon His6-tagged proteins bound to NFNTA (prepared as
described in Section 2.5.3) was performed as described above but in the absence of the
divalent cation chelators, EDTA and EGTA.
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2.9.3 Co-immunoprecipitation
Immunoprecipitates (Sections 2.5.4 & 2.6.3) were incubated with 100 pi rat brain lysate,
100 pi HEK293 cell lysate, or 1 pi (80 U) pure PKAc (Promega; diluted in 100 pi
appropriate lmmunoprecipitation Buffer) for 2-4 hrs at 4 °C in the presence of protease
inhibitors. The slurry was washed thoroughly (3x 100 pi appropriate
Immunoprecipitation Buffer, lx 100 pi dHzO), and diluted in 30 pi 2x SDS-LB prior to
analysis by Western blotting (Section 2.7.2). Controls were performed with tagged
control proteins and by incubation of unbound slurry with the lysates/pure PKAc to
exclude non-specific binding.
2.9.3.1 Competing peptides
The competing peptides to the leucine zipper I motif of the channel (Table 2.5) were
added to the cellular lysate of immunoprecipitation assays prior to pre-clearing to a final
concentration of 100 pM.
2.10 Miscellaneous
2.10.1 Primer design & DNA/protein sequence analysis
Primer design and analysis of the sequences of DNA and proteins were performed using
the DNAStar package (Lasergene). DNA sequences that have been published
previously were downloaded from www.ncbi.izov.uk [317]; Murine BK channel ZERO
splice variant accession number: NP 034740. STREX splice variant NCBI accession
number: AAD49225.
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2.10.2 DNA sequencing
DNA sequencing was performed on all constructs to ensure correct insert insertion,
sequence alignment and/or mutagenesis by MWG Biotech Co.
2.10.3 Densitometric analysis
Densitometric analysis of autoradiographic assays was performed by scanning the
images (Hewlett Packard Deskscan & Arctools Photostudio) into Aida
(lsatopenme(3garate) or ImageJ (N1H) densitometric packages.
2.10.4 Statistics
Data are expressed as mean + S.E.M (standard error about the mean), n = number of
independent experiments. Statistical analysis for each group was performed by standard
student T-test analysis (Microsoft Excel) as described in the respective figure legend,
with averaged data at P < 0.05.
2.11 Supplier Details
Alexis Biochemicals. Qbiogene Inc., 2251 Rutherford Road, Carlsbad, CA 92008. U.S.A.
Amersham Pharmacia Biotech. Amersham International pic, Amersham Place, Little
Chalfont, Bucks., England. HP7 9NA
Arctools, http:/www.arctools.com
(BP) Becton Dickinson. 1 Becton Drive, Franklin Lakes, NJ 07417-1886, U.S.A.
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BIOLOG Life Science Institute, Research Laboratory & Biochemicals, P.O.B. 108125, D-
28071 Bremen, Germany
BioRad Laboratories. 2000 Alfred Nobel Drive, Hercules, CA 94547, U.S.A.
Boehringer Mannheim. See Roche
Calbiochem. CN Biosciences, Inc., La Jolle, CA 92039-2087, U.S.A.
Chemicon International Ltd.. 28835 Single Oak Drive, Temecula, CA 92590, U.S.A.
Clontech U.K.. Unit 2, Intec 2, Wade Road, Basingstoke, Hampshire, RG24 8NE
Diagnostics Scotland. Law Hospital, Carluke, Lanarkshire, Scotland. MLS 5QZ
Eppendorf- Helena Biosciences, Colima Avenue, Sunderland Enterprise Park. Sunderland,
Tyne & Wear, SR5 3XB
Genemed Synthesis, Inc.. 213 East Grand Avenue, Sth San Fransisco, CA 94080, U.S.A.
Gibco, See Invitrogen
Harlan Sera Lab Ltd., Dodgeford Lane. Belton, Loughborough, Leicestershire, LEI2 9TE
Hewlett Packard, 2 Cadogan Square, 15 Blythswood Street, Glasgow, Scotland, G2 7AJ
Hoefer Scientific Instruments. 654 Minnesota Street, San Fransisco, CA 94107, U.S.A. &
Unit 12 Croft Road Workshops, Hempstalls Lane, Newcastle-Under-Lyme, Staffs, ST5 0TW
Invitrogen Ltd. (Europe), PO Box 2312 9704 CH Groningen, The Netherlands & 3 Fountain
Drive, Inchinnan Business Park, Paisley, PA4 9RF, U.K.
Konica Europe GmbH, Friedrich-Bergius-Str., Gewerbegebiet, 85662 Hohenbrunn. Germany
Millipore (U.K.) Ltd., The Boulevard, Blackmoor Lane, Watford, Hertfordshire, WD1 8YW
Molecular Probes, Inc.. 4849 Pitchford Avenue, Eugene, OR 97402-8300, U.S.A.
MWG Biotech Company, Anzinger Strasse 7a, 85560 Ebersberg, Germany
93
Chapter Two: Materials & Methods
New England BioLabs (U.K.) Ltd., 73 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire,
SG4 OTY, England
NIH (National Institute for Health. U.S.AL http://rsb.info.nih.gov/ij/
Pharmacia. See Amersham
Pierce / Perbio. PO Box 117, Rockford, 1L 61105, U.S.A.
Premier Brands UK, Ltd., Bridge Road, Long Sutton, Spalding, Lines., PE12 9EQ
Promega, 2800 Woods Hollow Road, Madison, W1 53711-5399, U.S.A.
QIAGEN Ltd, Boundary Court, Gatwick Road, Crawley, West Sussex, RH10 2AX
Raytest IsatopenmeBgarate, GmbH. Benzstr. 4, D-75334, Straubenhardt, Germany
Roche Diagnostics GmbH, Roche Molecular Biochemicals, D-68298 Mannheim, Germany
Santa Cruz, Distribution: Autogen Bioclear U.K. Ltd, Holly Ditch Farm, Mile Elm, Calne,
Wiltshire, SN11 OPY
Sigma Chemical Company. The Old Brickyard, New Road, Gillingham, Dorset, SP8 4XT
Stratagene. 11011 North Torrey Pines Road, La Jolla, CA 92037, U.S.A.
Terumo Europe Sucursal en Espana, Avda de Burgos 16D, 28036 Madrid, Spain
UCSF (University California, San Fransisco), www.prospector.ucsf.edu/ucsfbin3.4/msfit.cgi
Upstate Biotechnology. 10 Old Barn Road, Lake Placid, NY 12946. U.S.A.
Wolf Labs. Ltd.. Commerce House, Market Street, Pocklington, York, Y042 2AB
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Chapter Three:
Characterisation ofFusion Proteins & Phospho-Specific
Antibodies
3.1 Introduction
The aim of this chapter is to serve as an introduction to the individual fusion proteins and
phospho-specific antibodies developed for use during this study. The intention is to
justify the application of the fusion proteins that were eventually employed, and to
illustrate their conception, design, generation and ultimate purification. In addition, the
specificity of phospho-specific antibodies will be demonstrated to validate their use in
this study.
3.1.1 The fusion proteins
As described in the introduction to this study (Sections 1.3.1.2.1 & 1.4.1), the inclusion
of the 58-residue long STREX insert at splice site two within the BK channel C-terminal
tail domain confers the differential responses of two major BK channel splice variants to
PKA [80, 229], Application of the PKA activator, cAMP, to STREX insert-containing
channels that are expressed heterologously initiates inhibition of channel activity [80,
229], Parallel treatment of the ZERO isoform, which does not express the insert, effects
the opposite response with such channel stimulation demonstrating that the presence of
the insert is decisive to the PKA-mediated response of BK channels [80, 229]. The
molecular basis of this influence may result from the STREX sequence affecting PKA-
mediated phosphorylation of the channel protein, or from the insert impacting upon
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protein-protein interactions underlying the PKA-response. To investigate these
hypotheses, several fusion proteins encompassing equivalent regions from the proteins
of the two channel splice variants were generated (Figure 3.1 & Table 3.1).
The STREX insert
Among the 58 residues of the STREX insert sequence is a putative PKA consensus
motif engaging the STREX serine-4 residue as the potential target of PKA-mediated
phosphorylation (See Section 1.4.1; Figure 1.6). The existence of this motif, and the
presence of other phosphorylatable residues within the insert sequence, prompts the
proposition that the STREX region provides additional or alternative PKA-
phosphorylation sites that are absent from the ZERO channel sequence. The presence of
the STREX insert in itself may obstruct phosphorylation of other conserved sites in the
BK channel protein. Thus, alterations to the phosphorylation of the BK channel protein
may underlie the contrasting responses of the two splice variants. Alternatively, the
region may obstruct or produce binding sites for proteins associated with the channel
PKA response and consequently alter the influence of the kinase. Therefore, to
investigate these hypotheses, the 58 residues were isolated from the STREX channel
sequence (Table 3.1 & Figures 3.1 and 3.2) and generated as a recombinant protein with
a heterologous fusion partner (Section 3.2.1.1). This enabled the purification of a
soluble fusion protein by the use of an E.coli expression system, thus permitting
preliminary analysis of the region in the absence of the other segments of the BK
channel protein and thereby simplifying assessment of possible functional roles.
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Figure 3.1
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Figure 3.1: Schematic illustrating the regions of the BK channel a-
subunit sequence encompassed by fusion proteins used in this
study. Full length channel protein from the STREX BK channel splice
variant is identical to the ZERO variant protein except for the inclusion
of the 58 residue STREX insert at splice site 2 (The inverted V
indicating the absence of the insert from the ZERO variant). To enable
assessment of putative roles for individual segments of the C-terminal
tail, particular regions were studied in isolation. These were the
STREX insert and serine-869 sequences, the leucine zipper 1 motif,
and a region of the C-terminal tail that encompassed splice site 2,
serine-869, and the leucine zipper 2 motif (AN-AC). The diagram is
not to scale. Segments are detailed in Table 3.1.
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The serine-869 residue
The serine-869 residue terminates a putative PKA consensus motif that is common to all
BK channel splice variants and has been implicated as a factor in the response of the
ZERO channel to PKA (Figure 3.1 & Table 3.1; See Section 1.4.1) [205, 229],
Therefore, to determine whether the region could be a functional target of the kinase, the
sequence was analysed in isolation to prevent confusion arising from the presence of
other potential phosphorylatable residues (Section 4.2.1).
The C-terminal tail
The C-termina! cytoplasmic tail region of the BK channel protein is integral to the
regulation of the functional channel (See Section 1.3.2.2.2). The region encompasses
several putative protein kinase consensus motifs that are conserved throughout all splice
variants, as well as providing docking domains for particular accessory proteins (See
Section 1.5). A section of the C-terminal domain that spanned the splice site two region,
the location of STREX insertion, and the putative PKA-target motif incorporating
serine-869 was isolated and generated as the AN-AC recombinant fusion proteins (Figure
3.1 & Table 3.1; Section 3.2.1.2). The tetramerisation domain and the very C-terminal
region from these fusion proteins were excluded to prevent the polymerisation effects of
these segments, and thus facilitated fusion protein purification. Comparison of the
STREX and ZERO AN-AC fusion proteins enabled in vitro assessment of the influence
of the STREX insert upon the C-terminal region of the channel protein, in particular, the
relationship between the serine-4 and serine-869 sites.
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The leucine zippers
Recent research has uncovered a fundamental role of leucine zipper motifs in the
establishment of protein-protein interactions (See Chapter 5) [318], Analysis of the BK
channel sequence uncovers two putative leucine zippers that may be influential to the
association of accessory proteins involved in protein kinase-mediated channel responses
(Figure 3.1 & Table 3.1). Leucine zipper 2 is located between the STREX and S869
regions and thus, is encompassed by the AN-AC fusion proteins. Leucine zipper 1 is
sequentially proximal to the STREX insert and was subsequently isolated as a distinct
fusion protein for bacterial expression as a recombinant fusion protein (Section 3.2.1.2).
Therefore, these fusion proteins enabled in vitro analysis of the motifs as potential
accessory protein binding sites.
Protein regionsfor analysis
The fusion proteins described above express particular segments of the BK channel
protein. By studying these specific regions in isolation from the native context,
preliminary in vitro investigation of the possible functional roles of the regions can be
assessed. This regimen simplified analysis by removing complicating factors present in
natively expressed channels, such as accessory protein influences and the effect of other
regions of the channel protein. Therefore, preliminary designation of a particular
function to a specific region could be determined with minimal caveats to the analytical
regime. However, to determine whether the designation is valid for the in vivo channel,
full-length protein was investigated. Subsequent assessment of the functional roles of
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the particular BK channel regions was achieved via examination of full-length, epitope-
tagged BK channel proteins expressed in a mammalian expression system (Section
3.2.2).
3.1.2 Expression systems & fusion partners
Bueteriul expression
Bacterial expression of recombinant protein is a valuable and effective experimental tool
as high levels of protein expression can be achieved; up to 30 % of the total bacterial
cellular protein [218]. This enables the implementation of biochemical techniques
requiring large quantities of protein that for practical application, are unattainable from
the native mammalian system. The fusion tags employed in this study facilitated such
high level expression to enable the effective analysis of the fusion proteins (See
Chapters 4 & 5) and each is described in detail within the appropriate section of this
chapter (Section 3.2.1). All are commonly engaged biochemical devices that encourage
high yields of soluble recombinant protein and thus aid high-level, inducible bacterial
expression of the fusion proteins. They facilitate the solubility of the fusion protein
within physiological conditions, eliminating the requirement of harsh pH and detergent
treatments that can be detrimental to the protein and to further analytical techniques.
Additionally, the fusion tags possess high affinity for a specific element that, when
immobilised to a stable matrix, can enable the effective and elementary purification of
the recombinant protein from the bacterial lysate to achieve fusion proteins of sufficient
homogeneity and yield for further biochemical analysis.
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The tags used throughout this study were not removed from the BK channel protein
fragment prior to biochemical investigation. This facilitated analysis by maintaining
protein solubility, authenticating characterisation where the tag encompasses an epitope,
enabling immobilisation of the fusion protein to an inert matrix for affinity pull-down
assays, prohibiting the requirement of complex electrophoresis conditions when the BK
channel protein was small, and providing a means of further purification of the fusion
protein. The fusion partners are not expected to influence the structure and function of
associated proteins [303, 304], However, analytical difficulties can arise from retaining
the tag, such as the tag possessing or altering the properties of the experimental protein.
The benefits of keeping the tags were considered to outweigh the disadvantages and
therefore, corresponding controls were enforced throughout this study to exclude the
fusion partner as the source of an experimental artefact (Discussed Chapters 4 & 5).
Mammalian expression & epitope tags
Basic differences between bacterial and mammalian protein translation render E.coli
expression systems inappropriate for full-length channel expression [218] and therefore,
epitope-tagged full-length BK channel proteins were expressed in a mammalian system.
The mammalian system that was selected was the established cell line, human
embryonic kidney 293 (HEK293). These cells are employed commonly for the
expression of eukaryotic proteins due to the ease of maintenance, rapid multiplication,
and the ability to express functional protein that has been translated and undergone
appropriate post-translational modification [306], HEK293 cells lack native BK channel
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expression and thus facilitate the study of the epitope-tagged channels in the absence of
a contaminating native population [80, 189], whilst providing a cell system with the
required mammalian signalling pathways to enable investigation of the BK channel PKA
response in a cellular environment analogous to the native tissue [306].
Use of an established cell line allows the creation of stable cell lines facilitating
continuous and consistent recombinant protein expression [306]. Stable lines of the BK
channel fusion proteins conveyed such fusion protein expression enabling consistent
protein recovery to support the functional investigations of the channel proteins. Indeed,
the epitope-tagged BK channel proteins expressed in HEK293 cells formed functional
channels and thus permitted assessment of the specific roles and influences of particular
protein domains, in particular that of the STREX insert, and whether phosphorylation of
specific residues and association of individual accessory proteins may occur in vivo.
The epitope tags that were employed in this study are discussed in detail within the
appropriate section of this chapter (Section 3.2.2). Previous investigations have
described N-terminally tagged BK channel with disrupted voltage and calcium
sensitivities [319], yet electrophysiological analysis of C-terminally tagged channels
suggests limited or no influence [Tian, unpublished data]. Therefore, all tags were
expressed at the C-terminal of the channel protein enabling purification of the fusion
proteins by immunoprecipitation. Immunoprecipitation is a specific and effective tool in
the isolation of proteins that may be difficult to segregate by other purification
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techniques. The use of epitope-tags facilitated the immunoprecipitation of the channel
subunits by providing an epitope common to all channel protein isoforms that was not
influenced by the phosphorylation state of the complex. This allowed both in vitro and
in vivo studies of channel phosphorylation (Chapter 4), as well as investigation of
interacting proteins (Chapter 5). In addition, the use of different epitopes enabled
examination of the heteromultimerisation of the splice variants (Chapter 5).
3.1.3 The phospho-specific antibodies
The study of the phosphorylation state of the BK channel fusion proteins was enriched
by the generation of antibodies raised specifically against the phosphorylation state of
the STREX insert serine-4 site, and the common, serine-869 residue. These antibodies
facilitated the characterisation of BK channel phosphorylation in both fusion proteins
and full-length channel protein (Chapter 4).
3.2 Results
3.2.1 Generation & characterisation of BK channel C-terminal fusion proteins for
expression in E.coli
As described in the introduction to this chapter, regions of the BK C-terminal tail were
isolated and expressed as fusion proteins in an E.coli recombinant expression system to
facilitate preliminary investigation of the putative roles of specific sections of the
channel protein.
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3.2.1.1 GST-fusion proteins
The presence or absence of the 58-residue STREX insert in the BK channel sequence is
influential to the contrasting regulation of the channels by PKA [80, 229], To assess a
possible functional role of the insert in underlying this differentiation, a glutathione-S-
transferase (GST)-fusion protein was employed (Figure 3.2).
GST is used commonly as a fusion partner for recombinant protein expression in
bacterial cultures. In addition to aiding the solubility of its fusion partners, the
placement of the tag at the N-terminal of the STREX sequence is suggested to inhibit the
bacterial protease recognition of the eukaryotic protein as a foreign entity, and thus
facilitate the attainment of full-length recombinant protein [303], The enzyme possesses
a high affinity for glutathione, a property that is exploited to enable efficient and
effective purification ofGST-tagged proteins.
The 174 base pair (bp) sequence of the murine STREX exon was sub-cloned into pGEX
vector, pGEX5x-l, by Rory Duncan and Janet Philp (Figure 3.2). Successful ligation
was confirmed by digestion with endonucleases and by the polymerase chain reaction
(Results not shown). Subsequent sequence analysis (MWG Biotech) established that
insertion was in frame with the GST fusion partner gene.
Optimised induction and purification of the GST-STREX fusion protein was performed
as described in Sections 2.5.1 & 2.5.2. During the protocol, samples were removed
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N-terminal Recombinant GST-Fusion Protein C-terminal
Figure 3.2: Diagram of the pGEX5x-l vector & the location of the
STREX exon insert. A. The 174 bp STREX exon sequence was
amplified by PCR with flanking BamHI and Sail restriction sites.
Ligation of the insert into the pGEX5x-1 piasmid multiple cloning site
was sequentially in frame with the upstream GST-tag. B. The tac
promoter {Ptac) confers IPTG-regulation of recombinant protein
synthesis. Expression of the STREX-pGEX5x-l piasmid in E.coli
BL21-RIL cells resulted in the IPTG-induced generation of the ~35
kDa GST-STREX fusion protein. The lac Iq gene allows piasmid
expression in any E.coli strain. pBR322 ori is the origin of replication
of the piasmid, and Amp'' confers ampicillin resistance.
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periodically and separated by SDS-PAGE to allow visualisation of the proteins by
Coomassie stain (Sections 2.7.1). A representative analysis is illustrated in Figure 3.3.
Under optimised induction conditions, E.coli BL21-R1L cells expressing the STREX-
pGEX5x-l plasmid expressed the ~35 kDa GST-STREX fusion protein, consistent with
the theoretical molecular weight of the fusion protein (Figure 3.2). Cultures incubated in
the absence of the inducing sugar did not express the fusion protein demonstrating
specific promoter control of recombinant protein expression. Such promoter integrity
was confirmed by Western blot analysis employing the a-GST antibody (Results not
shown).
Induced bacterial lysate was lysed by lysozyme and sonication to release the -35 kDa
protein into the soluble fraction. Incubation of the lysate with glutathione sepharose
enabled binding of the GST-STREX fusion protein to the matrix by exploitation of the
affinity of the GST fusion partner for glutathione. The native bacterial proteins were
washed from the matrix together with a proportion of the recombinant protein indicative
of incomplete association of the recombinant protein with the sepharose. Competitive
elution of matrix-associated proteins released the pure -35 kDa fusion protein together
with a -29 kDa protein later identified as a proteolytic degradation product (Section
3.2.1.1.3). Yields of 5-6 mg of recombinant protein / L of bacterial culture were
achieved routinely. Confirmation of the identification of the -35 kDa protein as GST-
STREX was attained by Western blot analysis (Section 3.2.1.1.3).
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Figure 3.3
















Figure 3.3: Representative Coomassie stained gel of GST-STREX
induction and purification. Bacterial cultures expressing the STREX
exon-pGEX5x-l construct were induced with 0.5 mM IPTG for ~16
hours, stimulating synthesis of the 35 kDa GST-STREX fusion protein
(lane 2; induced bacterial cell pellet), illustrated diagrammatically
below the gel (See Figure 3.2). Induction is specific as the protein is
not observed in non-induced cultures (lane 1; uninduced bacterial
pellet). The recombinant protein was soluble following lysis by
lysozyme (lane 3), and sonication (lane 4). Native bacterial proteins
and the 17 kDa lysozyme enzyme were not bound by the glutathione
sepharose (lane 5; wash from matrix incubated with bacterial lysate).
Although a proportion of the fusion protein did not bind with the
matrix (lane 5), most did (lane 6; matrix following lysate incubation
and washing), and was eluted via competition by the glutathione buffer
(lanes 7 & 8; elutions).
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3.2.1.1.2 Generation of the GST-S4A fusion protein
The serine-4 residue of the STREX insert sequence is postulated to be a target of PKA-
medialed phosphorylation [229J. To investigate whether mutation of the site can prevent
phosphorylation, site directed mutagenesis was performed upon the STREX-pGEX5x-l
vector as described in Section 2.4.3. Mutagenic oligonucleotides were designed to
mutate the serine-4-encoding codon to a triplet encoding the non-phosphorylatable
alanine residue (Table 2.2, Figure 3.4). Subsequent sequence analysis (MWG Biotech)
demonstrated successful mutation of the serine-4 residue, and IPTG-induction of the
fusion protein in BL21-RIL E.coli cells resulted in expression of the -35 kDa protein
(Figure 3.4). Induction and purification of the fusion protein were performed as
described for the GST-STREX fusion protein. The identification of the -35 kDa GST-
S4A fusion protein was confirmed by Western blot analysis (Section 3.2.1.1.3).
3.2.1.1.3 Characterisation & comparison of GST-fusion proteins
Western blot analysis employing antibodies raised against the GST fusion partner and
the STREX insert was performed to characterise the GST-fusion proteins described
above (Sections 3.2.1.1.1 & 3.2.1.1.2). Eluates from glutathione-sepharose affinity-
purified GST-STREX, GST-S4A, and GST protein induced from the pGEX5x-l vector,
were assessed by Bradford analysis to determine the protein concentration (Section
2.2.5). Equal quantities of each were separated by SDS-PAGE for analysis by
Coomassie or Western blotting (Figure 3.5).
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Generation of the GST-S4A mutant fusion protein
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Figure 3.4: Site directed mutagenesis of the STREX insert S4
residue and induction of the -35 kDa recombinant protein. A. The
TCC codon of the wild type protein translates to the STREX insert
serine-4 (S4) residue. Following site directed mutagenesis, the codon
is altered to GCC, translating to non-phosphorylatable alanine.
B. Comparison of IPTG-induced (I), and un-induced (U) S4A-
pGEX5x-l-expressing bacterial pellets separated by SDS-PAGE and
stained by Coomassie illustrates the specific and successful induction
of the -35 kDa GST-S4A recombinant protein, represented
diagrammatically beside the gel (See Figure 3.2). Standard one letter
amino acid code used.
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Figure 3.5: Representative SDS-PAGE analysis of the GST-STREX
and GST-S4A proteins. Equal amounts (10 p.g) of affinity purified
GST protein and the GST-STREX and GST-S4A fusion proteins were
separated by SDS-PAGE for analysis by Coomassie or Western
blotting. The —35 kDa GST-fusion proteins are visible by Coomassie
stain and immunoreactive to a-GST and a-STREX-1 antibodies. The
-29 kDa proteolytic degradation products of the GST-fusion proteins
are detected by Coomassie stain and the a-GST antibody, but not by a-
STREX-1. GST is observed at 28 kDa under Coomassie stain and
immunoreactive to a-GST, but not a-STREX-1. Fusion proteins are
illustrated diagrammatically below the blots (See Figure 3.2). Western
blot analysis: goat a-GST 1/2000; rabbit a-STREX-1 1/2000; a-
goat/sheep-HRP 1/15000, a-rabbit-HRP 1/5000; detection by ECL.
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Under the electrophoresis conditions employed, the GST-STREX and GST-S4A fusion
proteins are observed at -35 kDa by Coomassie staining, consistent with the predicted
molecular weight (Figure 3.2). The proteins are immunoreactive to antibodies directed
against both the GST-fusion partner and the STREX insert sequence. Immunoreactivity
was not observed in the absence of the primary antibodies, nor did the primary
antibodies show cross-reactivity against proteins to which they were not specifically
raised (Data not shown) confirming the specificity of the antibodies.
Coomassie stain detected additional protein bands of -29 kDa with both GST-fusion
proteins. These proteins were not recognised by the a-STREX-1 antibody directed
against the STREX insert, yet were identified by a-GST. This demonstrates that the 29
kDa proteins are GST-tagged polypeptides not expressing the full-length STREX
epitope. GST was identified at 28 kDa, suggesting that the proteins are not GST
contamination, but the products of proteolytic degradation of the fusion proteins. This
assumption was confirmed by in vitro phosphorylation assays (See Section 4.2.2.1).
3.2.1.2 Thioredoxin-fusion proteins
Previous studies have described the generation of GST-fusion proteins of regions of the
C-terminal tail of BK channels [202]. Purification of segments from the Drosophila BK
channel produced very low yields requiring the application of detergents to enable
solubilisation [202], Such difficulties were found with the C-terminal tail region of the
murine BK channel following the generation of insoluble GST-tagged fusion proteins
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that encompassed the S869 region and the full-length of the C-terminal domain (Results
not shown). Denaturation to enable solubilisation of the fusion proteins was not
considered viable as the process influences the structure and biological activity of
proteins. Subsequent refolding protocols could be applied, but previous investigations
have suggested that the resultant protein recovery is low and may not resolve the native
protein activity [304], Therefore, the use of GST-fusion proteins of the C-terminal tail
region was abandoned and, where appropriate, replaced by a thioredoxin-V5 epitope-
polyhistidine-tagged (Thio-V5-H6) fusion partner system (Figure 3.6). The exception to
this was a small fusion protein encompassing the serine-869 region (See 3.1.1). The
complete insolubility of fusion proteins of this region instigated the investigation of
peptides of the site as discussed in Section 4.2.1.
Several studies have reported the successful application of thioredoxin as a fusion-
partner for high yield expression of soluble recombinant protein in E.coli [304], Fusion
of the tag to regions of the murine BK channel C-terminal achieved successful
solubilisation of the fusion proteins under native conditions. This enabled effective
purification by exploitation of the affinity of the polyhistidine tag for nickel ions, and by
the efficiency of the V5 region as an epitope, therefore, allowing subsequent application
of the fusion proteins to in vitro assays investigating the possible physiological roles of
the regions.
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Figure 3.6: The pBAD/Thio-TOPO vector & location of the BK
channel C-terminal constructs. A. TOPO cloning permitted the
insertion of PCR-amplified regions of the BK channel C-terminal
domain into the pBAD/Thio-TOPO cloning site. The primers employed
positioned the inserts sequentially in frame with the thioredoxin gene
proceeding the cloning site, and the polyhistidine region that follows.
B. The araBAD (PBAD) promoter confers arabinose-regulation of
recombinant protein synthesis. Expression of pBAD/Thio-TOPO
constructs in E.coli resulted in the arabinose-indueed expression of
proteins tagged with 13 kDa Thioredoxin, and 3 kDa V5 epitope-
polyhistidine (-V5-H6) fusion partners. Fusion proteins are illustrated in
Figure 3.7. araC is crucial to PBAD transcriptional regulation, pMBl ori
is the origin of replication, Amp'' confers ampicillin resistance. The
Ncol restriction site is highlighted in green.
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KEY: N-terminal domain- Transmembrane domains
I l C-terminal domain- Cytoplasmic domain
1—23 Tetramerization domain
i ~i Leucine zipper regions 1 and 2 i 1 Mutated leucine zipper
1 1 STREX insert E33 Mutated STREX insert serine-4
1 1 Serine-869 site i 1 Mutated serine-869
1 1 Thioredoxin fusion partner I I V5-His fusion tag
Figure 3.7: Representation of the thio-V5-H6-tagged fusion
proteins. The fusion constructs in pBAD/Thio-TOPO encompass the
regions of the BK channel C-terminal tail as aligned to the full-length
channel protein representations (not to scale). Mutations are indicated
by red arrows. Thioredoxin at the N-terminal (N) and the V5-H6
epitopes at the C-terminal (C) add 13 and 3 kDa respectively to the
molecular weight of the fusion proteins (white and pink boxes). Table
3.2 describes the corresponding DNA sequences.
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3.2.1.2.1 Generation of the thioredoxin-fusion proteins
Specific regions of the C-terminal tail from STREX, ZERO, and various mutant
isoforms of the murine BK channel were amplified by PCR as described in Section 2.4,
and as illustrated Table 3.2. The oligonucleotides employed (Table 2.2 & Figure 2.1)
were designed to ensure that direct insertion of the PCR amplification products into the
pBAD/Thio-TOPO vector was sequentially in frame with the respective fusion partners:
thioredoxin, polyhistidine, and the V5 epitope (Figure 3.6). Plasmid DNA isolated from
E.coli JM109 cells that were transformed successfully with the ligated vectors was
analysed by PCR and restriction digestion to confirm successful insertion and correct
orientation (Results not shown). Subsequent sequence analysis (MWG Biotech) verified
that each of the insertions had ligated in the correct orientation, in-frame with the fusion
partners.
3.2.1.2.2 Induction of the thioredoxin-fusion proteins
Successful insertion of the BK channel C-terminal tail regions into the pBAD/Thio-
TOPO vector allowed induced expression of recombinant proteins tagged with the
thioredoxin, V5 epitope, and polyhistidine fusion partners (Thio-V5-H6) as described in
Section 2.5.1. The resultant fusion proteins are illustrated diagrammatically in Figure
3.7. E.coli BL21-RIL strain was employed as the recombinant expression system, and
specific induction of the fusion proteins was observed in cultures treated with the pBAD
vector inducer. L-arabinose. A representative induction of the AN-STREX-AC fusion
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protein is illustrated in Figure 3.8, where cell pellets from cultures exposed to L-
arabinose were compared to those not induced with the sugar by SDS-PAGE separation.
Differentiation of the impure recombinant protein among native bacterial proteins was
not possible by Coomassie or Silver staining techniques and therefore immunoblotting
was performed. The a-V5 antibody detected an ~70 kDa protein in the presence of L-
arabinose only, consistent with the predicted molecular weight of the 67 kDa V5-tagged
AN-STREX-AC fusion protein (Figure 3.7). Detection of lower molecular weight
proteins suggests proteolytic degradation. Parallel results were obtained with the other
fusion proteins indicating specific arabinose-induced synthesis of all the Thio-V5-H6-
tagged fusion proteins (Results not shown).
3.2.1.2.3 Purification & characterisation of the thioredoxin-fusion proteins
Nickel affinity chromatography
The Thio-V5-H6-tagged fusion proteins were purified by affinity chromatography
exploiting the strong affinity of the polyhistidine-tag for nickel ions following optimised
induction and purification as described in Section 2.5.3. During the protocol, samples
were removed periodically and suspended or diluted in SDS-LB to allow separation by
SDS-PAGE and visualisation by immunodetection. Figure 3.9 illustrates such an
analysis using the AN-STREX-AC fusion protein.
BL21-R1L E.coli cells expressing the BK channel C-terminal fusion protein-
pBAD/Thio-TOPO plasmids were cultured at 37 °C until bacterial growth was
119
Chapter Three: Characterisation ofFusion Proteins <& Antiboc
Figure 3.8










AN-STREX-AC ilLIISH ~70 kDa
Figure 3.8: Representative Coomassie & Western blot analyses of
the induction of the AN-STREX-AC fusion protein. Differentiation
of the recombinant protein among the native bacterial proteins was not
possible by Coomassie staining of SDS-PAGE separated uninduced
(U) and arabinose-induced (I) cell pellets from E.coli expressing the
AN-STREX-AC plasmid (0.2 % L-arabinose, 16 °C, -16 hours).
Western blot analysis of the samples employing the a-V5 antibody
detects specific induction of the -70 kDa V5-tagged AN-STREX-AC
recombinant protein, indicated by an arrow and illustrated
diagrammatically below the blots (See Figure 3.7). Western blot
analysis:mouse a-V5 l/5000;a-mouse-HRP 1/2000; detection by ECL.
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Figure 3.9: Representative Western blot illustrating the
purification of the AN-STREX-AC fusion protein by Ni+ affinity
chromatography. 1- uninduced bacterial cell pellet; 2- induced
bacterial cell pellet (0.2 % arabinose, 16 °C ~6 hours); 3- induced
bacterial cell pellet (~16 hours); 4- cell pellet lysed by lysozyme and
sonication; 5- cellular lysate; 6- Ni+-sepharose following cellular lysate
incubation; 7-column wash (after extensive washing); 8- first elution;
9- second elution. Bacterial cultures expressing the AN-STREX-AC
construct were induced with 0.2% L-arabinose, stimulating synthesis of
the -70 kDa AN-STREX-AC fusion protein (lanes 2&3). Induction is
specific as the protein is not observed in non-induced cultures (lane 1).
Some recombinant protein was retained in the insoluble cell pellet
(lane 4), but the majority remained soluble (lane 5) following cellular
lysis. The fusion protein binds Ni+-sepharose (lane 6) and is not
washed from the matrix (lane 7), but is eluted by 250 mM imidazole
(lanes 8&9) .The fusion protein is illustrated diagrammatically below
the blot (See Figure 3.7). Western blot: mouse a-V5 1/5000, a-mouse-
HRP 1/2000, Detection by ECL.
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determined to have reached the exponential, protein-producing, phase. Induction with
0.2% L-arabinose was followed by incubation at 16 °C for -16 hours and induced
synthesis of the -70 kDa AN-STREX-AC protein as detected by its immunoreactivity
with the a-V5 antibody. The recombinant protein is visible in the insoluble and soluble
fractions following lysozyme and sonication-induced lysis of the bacterial cells. It binds
nickel-sepharose, and is eluted by a competitive elution buffer. Other immunoreaclive
proteins of lower molecular weights are detected throughout the lysis stage of the
purification. However, in the final eluates, only the -70 kDa protein is observed,
suggesting specific purification. Equivalent results were obtained with the other AN-AC
fusion proteins (Results not shown).
The eluates from the nickel-column purified AN-AC fusion proteins were analysed by
Coomassie staining of SDS-PAGE separated samples to determine the homogeneity of
the solutions. Figure 3.10 illustrates such an analysis upon the AN-STREX-AC and AN-
ZERO-AC fusion proteins. The -70 kDa AN-STREX-AC protein and the -65 kDa AN-
ZERO-AC fusion protein are detected, in addition to a -75 kDa contaminant. The -75
kDa protein is present in all eluates including purification performed upon non-induced
bacterial lysate. This is indicative of the association of a native bacterial protein with
the nickel-sepharose matrix.
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Figure 3.10
The AN-ZERO-AC and AN-STREX-AC fusion proteins



























AN-STREX-AC '■Q -70 kDa
AN-ZERO-AC P i n ii M -65 kDa
Figure 3.10: Representative Coomassie stain of Ni2+-sepharose
purified elutions. Eluates from nickel sepharose purifications of the
AN-ZERO-AC and AN-STREX-AC, together with an eluate from non-
induced bacterial lysate passed through the Ni2+ column, were
separated by SDS-PAGE and visualised by Coomassie stain. The -65
kDa AN-ZERO-AC, and the -70 kDa AN-STREX-AC fusion protein,
as illustrated diagrammatically below the gel (See Figure 3.7), are
purified successfully with an additional -75 kDa contaminating protein
detected. The contaminant is also observed with non-induced bacterial
lysate passed through the column.
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Immunoprecipitation
Immunoprecipitation (IP) of the Thio-V5-H6-fusion proteins from arabinose-induced
bacterial cultures was performed as described in Section 2.5.4 by incubation of pre-
cleared lysates with protein-G-sepharose (PGS) and the a-V5 antibody that was raised
against the V5 fusion tag. The final IP pellets were separated by SDS-PAGE prior to
analysis by immunoblotting and Coomassie staining. Figure 3.11 illustrates such
analysis upon the AN-STREX-AC and AN-ZERO-AC fusion proteins.
The -70 kDa AN-STREX-AC and -65 kDa AN-ZERO-AC fusion proteins were
immunoprecipitated successfully by the a-V5 antibody at concentrations sufficient to
allow detection by Coomassie stain (> 300 ng) [308], The -75 kDa contaminating
protein is not detected by this method, suggestive of non-co-purification. Additionally,
the stain only distinguishes the fusion protein and IgG bands indicating the absence of
detectable contaminating proteins. Parallel results were obtained from the
immunoprecipitation of the other Thio-V5-H6-fusion proteins (Results not shown).
Further characterisation of the Thio-V5-H6 fusion proteins was achieved by Western blot
analysis employing fusion protein-specific antibodies. These data are described in
following chapters.
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Figure 3.11
























Figure 3.11: Representative Coomassie and Western blot analysis
of AN-STREX-AC and AN-ZERO-AC immunoprecipitates, with
comparison to Ni2+ sepharose purification. 1- AN-STREX-AC
immunoprecipitation (IP) using a-V5 antibody; 2- AN-ZERO-AC IP;
3- non-induced bacterial lysate IP; 4- AN-STREX-AC eluate from Ni2+
affinity chromatography. IP of the -70 kDa AN-STREX-AC and -65
kDa AN-ZERO-AC fusion proteins pulls down sufficient protein to
enable detection by Coomassie as well as Western blot analysis. The
IP immunoglobulin (IgG) is observed at -50 kDa, and is
immunoreactive to a-mouse. No additional contaminating proteins are
observed in the IPs. Purification of AN-STREX-AC by affinity
chromatography isolates the fusion protein, but an additional -75 kDa
contaminating protein that is not immunoreactive to a-V5 is detected
by Coomassie stain (See Figure 3.10). Fusion proteins are illustrated
below the gels (See Figure 3.7). Western blot analysis: mouse-a-V5
1/5000, a-mouse-HRP 1/2000, detection by ECL.
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3.2.2 Generation & characterisation of full-length BK channel fusion proteins for
expression in a mammalian cell line
Investigation of the full-length BK channel protein was employed to validate the roles of
specific C-terminal regions that were proposed from the in vitro studies using bacterially
expressed fusion proteins. Expression of the functional channels in a mammalian
system enabled in vivo assessment of the PKA response of BK channel splice variants
and mutant channels (Chapters 4 & 5).
The channel proteins were expressed with epitope-tagged fusion partners at the C-
termini. Three epitope tags were employed: hemagglutinin (-HA), V5-polyhistidine (-
V5-H6) and enhanced green fluorescent protein (-EGFP). The use of the tags was to
facilitate efficient isolation of the channels by immunoprecipitation or immunodetection,
without the requirement of channel-specific antibodies that may be influenced by the
splice variant or phosphorylation state of the channel protein (See Section 3.1.2). HA
and V5-H6 are employed for this purpose commonly as they are relatively short protein
sequences that induce minimal disruption to protein synthesis, structure or activity [320-
322; Tian, unpublished results]. EGFP is a much larger fusion partner (27 kDa), but
studies have indicated that it causes minimal disruption to the functionality of the BK
channel when expressed at the C-terminal compared to N-terminal expression (See
Section 3.1.2) [319; Tian, unpublished results]. The tag displays green fluorescence
when excited at 478 nm enabling analysis of the location of the epitope tagged channels
without the requirement of immunodetection techniques.
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Therefore, the application of the epitope-fusion partners facilitated the study of the BK
channel splice variants and their differential responses to PKA, by enabling in vitro and
in vivo investigation of phosphorylation (Chapter 4) and channel-accessory protein
associations (Chapter 5) upon channels that are expressed functionally and can be
isolated in any phosphorylation state. Additionally, by employing different tags, the
heteromultimerisation of the splice variants could be examined (Chapter 5).
3.2.2.1 Generation of the BK channel fusion proteins
The murine ZERO BK channel gene was inserted into the pcDNA3 mammalian-
expression vector with an epitope fusion partner gene 3' and in-frame to the channel
sequence as to generate channel protein with the carboxyl-terminal tag, -HA, -V5-H6 or
-EGFP. A restriction endonuclease and ligation regime, as described in Section 2.4, was
enforced to generate the STREX and mutant isoforms of these fusion proteins. The
regimen is illustrated by Figure 3.12, demonstrating the restriction of a region of the C-
terminal tail of the BK channel that encompasses splice site two, the location of STREX
exon, and the serine-869 expressing codon. Therefore, the ZERO channel sequence
could be replaced with the equivalent segment from STREX and mutant channel
variants, allowing the generation of the epitope-tagged isoforms of the BK channel that
were employed in this study (Table 3.3 & Figure 3.13).
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Figure 3.12
Restriction endonuclease regime to generate
epitope-tagged BK channel isoforms
Figure 3.12: Epitope-tagged BK channel variants created by
restriction digestion and ligation regime. The PacI endonuclease cut
at base number 1743 within the murine BK channel sequence,
downstream from the leucine zipper 1 region. Sfil digested at site 3282
in the ZERO isoform, equivalent to site 3456 within the STREX
channel sequence, downstream from the serine-869 codon. The
respective ZERO and STREX DNA fragments of ~1.5 and -1.7 kbp
were ligated into the appropriate pcDNA3 vector containing the
corresponding N-terminal and C-terminal BK channel regions with the
C-terminal epitope tag. This allowed the generation of the epitope-
tagged isoforms of the murine BK channel that were used in this study.
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Figure 3.13























KEY: E3 N-terminal domain - Transmembrane domains
l i C-terminal domain - Cytoplasmic domain
i 1 Tetramerization domain
i i Leucine zipper regions 1 and 2 i 1 Mutated leucine zipper
1 1 STREX insert I I Mutated STREX insert serine-4
Serine-869 site □ Mutated serine-869
Epitope tags: i 1 HA ' 1 V5-H6 1=1 EGFP
Figure 3.13: Diagram illustrating the epitope-tagged full-length
channel fusion proteins. Channel proteins were tagged at the C-
terminal by the -HA, -V5-H6, or -EGFP epitopes. The splice variants
are represented as described in Figure 3.1, with sites of mutation
highlighted by arrows (Not to scale). Table 3.3 summarises this figure
providing the molecular weights of the proteins. Corresponding DNA
sequences are illustrated in Figure 1.3.
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3.2.2.2 Functional expression of the BK channel fusion proteins
The BK channeI-pcDNA3 vectors were transfected into the human embryonic kidney
293 cell line (HEK293) mammalian expression system and stable cell lines were
generated using standard tissue culture protocols as described in Section 2.6.2. The
pcDNA3 vector confers geneticin-resistance to cells that express it and therefore,
HEK293 cells transfected with BK channel-pcDNA3 were selected and maintained by
application of the antibiotic. The system facilitates successful translation and post-
translational modification of tagged mammalian proteins and allows functional
investigation of the channels in a mammalian cellular environment that lacks native BK
channel expression [80, 189],
3.2.2.2.1 Immunoprecipitation
Antibodies directed against the -HA, -V5 and -EGFP tags were employed to assess
expression of the channel fusion proteins in HEK293 cells. As described in Section 2.6,
cell lines expressing the fusion proteins were grown in 5 % CO2 at 37 °C until cultures
were sufficiently confluent for harvesting. Cells were lysed by sonication and detergent
treatment, prior to the addition of PCS and the appropriate antibody to the pre-cleared
lysate. The final IP pellets were diluted with SDS-LB and separated by SDS-PAGE for
Western blot analysis. Figure 3.14 illustrates the detection of some of the
immunoprecipitated channel fusion proteins.
131
Figure 3.14















































IP: mouse a-V5 mouse a-GFP mouse a-HA
Blot: mouse a-V5 mouse a-GFP rabbit a-HA
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Figure 3.14: Representative Western blots illustrating expression
of epitope-tagged BK channels in HEK293 cells. Epitope-tagged
STREX and ZERO BK channel splice variants expressed in HEK293
cells were immunoprecipitated (IP) by antibodies directed against the
respective tags (-V5, -EGFP, -HA epitopes). The channels, indicated
by arrows and illustrated diagrammatically below the blots (For
simplicity within the C-terminal domain only splice site 2 and the S869
site are illustrated, see Figure 3.13), are detected at -125 kDa. The
channels are not detected in IPs from untransfected HEK293 cells.
Lower molecular weight bands observed in both transfected and
untransfected cells in the left hand and middle panels are non-specific
products including immunoglobulins (IgGs) detected by the a-mouse
antibody. Western blot analysis: mouse a-V5 1/5000, mouse a-EGFP
1/1000, rabbit a-HA 1/333, a-mouse-HRP 1/2000, a-rabbit-HRP
1/5000, detection by ECL.
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Immunoreactive proteins of -125 kDa are observed in all BK channel-expressing
systems, consistent with the predicted molecular weight of the channel fusion proteins
(See Table 3.3). The proteins are not detected from native HEK293 cells nor cells
transfected with pcDNA3 vector alone (As Figure 5.1). Comparison of the STREX and
ZERO-HA-tagged channels demonstrates a slight difference in molecular weight
indicative of the respective presence or absence of the STREX insert. These data
demonstrate successful expression of the tagged channels by HEK293 cells at a level
sufficient for detection by the appropriate immunoblotting antibody.
3.2.2.2.2 Fluorescence & Immunofluorescence
To assess the cellular location of the BK channel protein, HEK293 cells expressing the
EGFP-tagged channels were fixed on glass coverslips, stained with the DNA-binding
dye TO-PRO-3, and analysed by fluorescence microscopy as described in Section 2.6.4.
Figure 3.15A illustrates a representative confocal microscopy image of ZERO-EGFP
channels.
Excitation of the -EGFP tag and TO-PRO-3 dye induces green and blue fluorescence
respectively. The blue TO-PRO-3 excitation demonstrates the location of the nuclear
compartment. Although small pockets of green fluorescence are visible within the
cytoplasmic region, indicative of channel protein trapped within cellular organelles, the
majority of the EGFP signal is observed peripherally. This suggests that the majority of
the EGFP-tagged channel protein is present at the cell membrane, demonstrating
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successful targeting of the EGFP-tagged channel protein by the HEK293 cellular
machinery. Equivalent analysis, performed by Lijun Tian, demonstrated a cellular
membrane location for the EGFP-tagged BK channel isoforms in PC12 cells, indicating
that other mammalian cell types can target the channels successfully (Results not
shown).
3.2.2.2.3 Eleetrophysiology
To investigate the functionality of the BK channel fusion proteins expressed in HEK293
cells, electrophysiological analysis was employed. Cells expressing the epitope-tagged
channels were cultured on coverslips and analysed by an inside-out configuration as
described in Section 2.6.5. Figure 3.15B illustrates such an analysis upon the STREX-
HA fusion protein. Stepping the voltage to +20, +40 and +60 mV, resulted in increased
opening of channels with -125 pS conductance, consistent with that of BK channels, and
not of channels native to HEK293 cells [3]. This indicates that the STREX-HA channels
are functionally expressed at the HEK293 cell membrane.
Electrophysiological analysis of the other BK channel fusion proteins that were used in
this study was performed by Lijun Tian (Results not shown), and demonstrated that all
the isoforms produced functional and correctly regulated channels.
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3.2.3 Preliminary characterisation of phospho-specific antibodies
The phospho-specific antibodies employed in this study were directed against the
phosphorylated and non-phosphorylated murine BK channel serine-869, and the STREX
insert serine-4 sites. The antibodies were raised against phosphorylated and non-
phosphorylated peptides encompassing these regions by Diagnostics Scotland (See
Scheme 2.1). Preliminary assessment of the specificity of the antibodies was performed
by dot-blot analysis upon these peptides as described in Section 2.7.2.1. A
representative blot is illustrated in Figure 3.16.
Each of the antibodies recognised the peptide to which it was directed specifically: a-
S869 recognised the S869 peptide but not the phosphorylated form, nor the STREX
sequences; a-STREX1 recognised the STREX peptide but not the phosphorylated form,
nor the S869 peptides. Equally, the phospho-directed antibodies exhibited specific
recognition of the specific phosphorylated sequences. This demonstrates that the
antibodies successfully recognised the phosphorylation state of the sites within the
peptides.
1 This antibody differs from the a-STREX-1 antibody that was employed previously, as
it is targeted to a different epitope of the STREX insert sequence. Illustrated
diagrammatically - Figure 4.23.
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Figure 3.16
Specificity of antibodies raised against phosphorylation





























Figure 3.16: Preliminary dot blot analysis of the specificity of the
the phospho- and non-phospho- directed antibodies. Antibodies
raised against peptides of the phosphorylated and non-phosphorylated
states of the serine-869 and STREX insert serine-4 site were used to
probe the peptides to which the antibodies were raised. Peptides (4 jag)
were dotted onto PVDF membrane and probed by the respective
antibodies. Each antibody specifically recognised the peptide to which
it was raised, with the phospho-dirccted antibodies immunorcactivc
only to the specific phosphorylated peptide to which they were raised,
and the non-phospho antibodies recognising the specific non-
phosphorylated peptide. Western blot analysis: primary antibodies
1/1000 with 1 pg/ml competing peptides (See Materials & Methods)*;
a-sheep-HRP 1/15000; detection by ECL.
*Competing peptides added to maximise the specificity of the
antibodies. Antibodies were still specific to target peptides in the
absence of competing peptides.
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3.3 Discussion
3.3.1 The GST-fusion proteins
As illustrated by Section 3.2.1.1, the GST-fusion proteins were purified successfully by
glutathione column affinity chromatography. The induction and purification protocols
were optimised following trials altering the induction, cell lysis and the protein
purification procedures. The range of conditions examined included varying the
temperature, 1PTG concentration and period of induction, changing the method and
buffer for lysis, and altering the matrix-lysate incubation period, wash conditions, and
the temperature and elution protocols of purification. By studying the influence of
changing these conditions, the procedure was optimised to produce eluates of maximal
yield and purity as illustrated by Figure 3.3.
Following all purification procedures with the GST-STREX and GST-S4A fusion
proteins, the -29 kDa protein was always observed. The consistency of its appearance,
and the subsequent identification as a proteolytic degradation fragment (Sections
3.2.1.1.3 & 4.2.2.1), suggest that there is proteolytic cleavage site within the STREX
insert sequence. Further evidence of this assumption is provided in Chapter 4
(Discussed Section 4.3.2). However, the presence of this degradation fragment does
influence analysis of the fusion proteins. Determination of the protein concentration of a
solution by techniques such as Bradford assay measures the total protein content and
therefore, the ratio of full-length -35 kDa fusion protein to the fragment may be
influential to analysis of a particular property, for example, when the density of mutant
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and wild-type proteins is compared. This influence has been taken into account
throughout this study.
The -35 kDa purified protein was identified as GST-STREX by molecular weight,
successful purification by glutathione affinity, indicative of a GST-tag, and the
immunoreactivity to antibodies directed against the GST and STREX insert elements.
The mutant protein, GST-S4A, was consistent with the wild type, verifying its
application as a comparison to GST-STREX. These identifications justify the
subsequent use of these proteins as tagged-models of the STREX insert for in vitro
investigations of the STREX insert as a target for regulation by phosphorylation.
3.3.2 The Thio-V5-H<.-fusion proteins
Generation of the Thio-V5-EE-fusion proteins was undertaken following the insolubility
of GST-fusion proteins of these regions of the C-terminal tail of the BK channel protein
(Section 3.2.1.2). As discussed in Section 3.2.1.2, the solubilisation of insoluble
proteins can be unreliable, ineffective and damaging to the protein structure and
biological activity. Therefore, in order to simplify the purification protocol and maintain
consistency between different purifications, the use of GST-fusion partner system was
abandoned, and the Thio-V5-H6-tags employed.
As illustrated in Section 3.2.1.2, use of the Thio-V5-H6-fusion partner system allowed
the soluble expression and ultimate purification of fusion proteins of the BK channel C-
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terminal tail region. Following the regimen, optimised similarly to that described for the
GST-fusion proteins, produced less recombinant protein than with the GST-STREX
fusions, with ~1 mg of purified recombinant protein / L of bacteria culture obtained
compared to 5-6 mg / L with the GST fusion proteins. This lower level production was
apparent following Coomassie stain of induced bacterial cell pellets, as illustrated in
Figure 3.8, where recombinant protein expression cannot be differentiated from the
native bacterial proteins, but requires analysis by Western blotting (c.f GST-STREX
induction, Figure 3.3). The AN-AC fusion proteins are significantly larger than the
GST-fusions, -70 kDa compared to -35 kDa, and protein length can be an inhibitory
influence in eukaryote protein expression by a prokaryote system. The longer length can
encumber the translation machinery, and provides a greater availability of recognisable
non-native protein for degradative bacterial proteases. Flowever, even with the
relatively short Thio-LZl fusion proteins (31 kDa), comparatively less purified protein
was attained than with the GST fusions. Therefore, the amino acid content of the
proteins may be a factor. Although the E.coli strain was employed due to its increased
tRNA expression (See Section 2.2.1.1), the proteins may encode codons common to
mammalian system that are relatively rare in prokaryotes. The consistency of this level
of protein production may be due to the effectiveness of the pBAD vector promoter, Para
(See Figure 3.6), or simply the efficiency of thioredoxin production by the bacteria.
Whatever the cause, the expression, in combination with the solubilising asset of the
thioredoxin protein, may be influential to the solubility of the resultant recombinant
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protein, and results in sufficient soluble fusion protein for further biochemical
investigations.
As illustrated by Figures 3.8 and 3.9, the AN-STREX-AC fusion protein is degraded by
proteases to produce low molecular weight fragments that express the V5 epitope.
However, unlike the GST-STREX proteins, there are no detectable proteolytic
degradation products detected following purification by either nickel column affinity
chromatography or immunoprecipitation observed under Coomassie staining or Western
blot analysis (Figures 3.9, 3.10 and 3.11). This suggests that the fragments are either of
too low a concentration to be detected, especially probable with the lower sensitivity of
Coomassie stain in comparison with immunodetection, or that fragments do not possess
the appropriate V5 and polyhistidine tags to enable their purification, and that those that
do are too small to be detected by the electrophoresis conditions.
Purification of the Thio-V5-H6-fusion proteins by nickel affinity chromatography,
yielded a ~75 kDa bacterial contaminant (Figure 3.10). Although the contaminant is not
immunoreactive to the a-V5 antibody, the presence of such a protein could hamper
further investigations with the Thio-V5-H6-tagged fusion proteins. It could interfere
with investigation of Thio-V5-H6-fusion protein associations and the comparable
molecular weight of the protein to the AN-AC fusion proteins may confuse the
assessment of phosphorylation. This is possible as mass spectrometry characterisation
of the protein gave the likely identification as an E.coli tyrosine-protein kinase, ETK
141
Chapter Three: Characterisation ofFusion Proteins & Antibodies
(NCBI accession no.: P38134). Purification of the Thio-V5-H6-fusion proteins by
immunoprecipitation, did not yield the ~ 75 kDa bacterial contaminant (Figure 3.11).
Therefore, this purification technique was determined to be preferable for such studies
upon the Thio-V5-H6-fusion proteins.
All the Thio-V5-H6-fusion proteins were purified successfully by immunoprecipitation
of the V5 epitope, as illustrated for AN-STREX-AC and AN-ZERO-AC in Figure 3.11,
and as demonstrated for the others in the following chapters. This enabled their
application as models for the investigation of the comparative functional role of the
STREX and ZERO C-terminal tail regions.
3.3.3 Full-length BK-channel fusion proteins
The full-length epitope-tagged BK channel fusion proteins were purified successfully by
immunoprecipitation of the epitope tags (Figure 3.14), demonstrating effective
expression of all the tagged channel proteins in HEK293 cells. The Western blotting of
the immunoprecipitated -V5-His and -EGFP channels employed the same detection
antibody as was used for the immunoprecipitation, necessitating the application of a
F1EK cell lysatc control to illustrate the immunoglobulin (IgG) bands and thus
differentiate the channel proteins. Similar controls were employed in the following
functional studies in addition to controls for non-specific epitope and
immunoprecipitation associations.
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The immunoprecipitation assays pull down tagged protein present in the total cellular
lysate. The preparation of the lysate involves the application of detergents that
solubilise membrane and hydrophobic cellular fractions and should therefore include the
transmembrane channel protein. However, as the lysate results from the whole-cell
milieu, effective membrane targeting of the channels cannot be assumed. Therefore, the
fluorescence of the EGFP tag was crucial to the determination of channel location.
The fluorescence studies confirmed successful targeting of the majority of the
recombinant protein to the membrane. As with any fusion protein system, the tag can be
removed by the action of cellular proteases and therefore, result in an apparent false
localisation of the protein of interest. This is unlikely under these experimental
conditions due to the precise membrane targeting that is observed. EGFP is a soluble
protein that is not membrane-associated [323, 324], and thus would not illustrate such
precise membrane targeting if completely disassociated.
The -EGFP image (Figure 3.15A) demonstrates that the majority of the tagged protein is
present at what is assumed to be the cellular membrane. This is suggested, due to the
pattern and the diameter of the green fluorescent oval, and its relationship with the
nuclear envelope. Some EGFP signal is observed within the cytoplasmic region of the
cell within what is assumed to be intracellular compartments: endoplasmic reticulum,
Golgi and vesicular organelles. This suggests that the signal represents BK channel
protein that is being processed and targeted to the membrane, but has not reached its
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destination. This protein fraction will also be isolated by the immunoprecipitation
purification technique, and is unlikely to be associated with the same proteins as the
functional, membrane-associated, tetrameric channel proteins. This may be influential
to the associative studies of Chapter 5. However, the image does suggest that this
fraction is the minority and therefore, should have minimal influence among the
majority of functional channel protein.
The electrophysiological data (Figure 3.15B) demonstrates that the epitope channels are
expressed, reiterating the immunoprecipitation results, and are targeted to the membrane,
supporting the fluorescence data. Importantly, the electrophysiology demonstrates that
the BK channels are expressed functionally. The large conductance and the increasing
open probability with increasing voltage are characteristic of BK channels. HEK293
cells do not possess a native BK channel population [80, 189] and therefore, the large
conductance is not native to the expressing cells but the result of recombinant protein
expression. The successful characterisation demonstrates that the epitopes are not
inhibitory to channel expression and function. Further studies by Lijun Tian illustrated
that the channels were also regulated consistently to untagged channels with respect to
the PKA-response (Results not shown).
Therefore, these data demonstrate that the epitope-tagged channels are expressed
functionally at the cellular membrane of HEK293 cells, and can be isolated successfully
by immunoprecipitation. This information is vital as it verifies the use of these channels
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as models for native BK channel phosphorylation and protein-protein interactions as
described in Chapters 4 and 5.
3.3.4 Phospho-specific antibodies
The phospho-specific antibodies identified the appropriate peptides specifically, with the
a-phospho antibodies recognising the appropriate phosphorylated serine-869 or STREX
serine-4, and the antibodies to the non-phosphorylated peptides immunoreactive to the
appropriate unphosphorylated peptides. This specificity validates the antibodies as
identifiers of the phosphorylation state of the serine-869 and STREX serine-4 residues
and therefore, proposes the application of the antibodies for phosphorylation studies of
the fusion proteins and full-length BK channel proteins. The antibodies may not
associate correspondingly with the proteins and regions of the fusion proteins may be
sufficiently similar to the epitopes to cause non-specific associations. However, these
preliminary data do suggest that the antibodies may be used validly to indicate the
phosphorylation state of the STREX serine-4 and serine-869 sites.
3.4 Chapter Summary
This chapter has introduced and characterised the individual fusion proteins and
phospho-specific antibodies that were developed for use during this study to demonstrate
the identification and validity of the use of these proteins in the investigation of the
influence of PKA on BK channel splice variants.
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Chapter Four:
Characterisation of PKA-mediated phosphorylation of BK
channel splice variants
4.1 Introduction
Direct protein kinase-mediated phosphorylation of proteins is an effective, efficient,
accommodating and therefore, common, mechanism of protein modulation [ 187]. Ion
channels including sodium, calcium and potassium-conducting channels [187, 188. 222,
223, 325] are regulated by phosphorylation and a large body of evidence adds BK
channels to this phosphorylation-regulated protein sub-set. Several protein kinases have
been implicated as regulators of BK channel function including protein kinase C (PKC),
protein kinase G (PKG), calmodulin-regulated protein kinase II (CaMKII) and, of
particular interest to this study, protein kinase A (PKA) (See Section 1.4.1). The
mechanisms underlying PKA-dependent regulation are undetermined, however,
mutagenesis of putative PKA consensus motifs can occlude the PKA-mediated
regulation of the mutant channels implicating the sites as targets of direct kinase-induced
phosphorylation [198, 205, 229], Further to this, mutagenesis of specific PKA
consensus motifs of different splice variants can confer contrasting responses upon the
PKA-regulation of the variants as is observed between STREX and ZERO channels [38,
69, 80, 229] (Discussed Section 4.1.1). This is suggestive of differential PKA-mediated
phosphorylation between splice variants. Therefore, this chapter aims to investigate
whether the BK channel a-subunit protein is a direct target for PKA phosphorylation,
identifying PKA consensus motifs that may allow the differential responses of the
STREX and ZERO splice variants.
147
Chapter Four: Characterisation of the phosphorylation of BK channel splice variants
4.1.1 Differential BK channel splice variant regulation by PKA
The serine-869 residue as a putative PKA-phosphorylation target
Analysis of the amino acid sequence of the BK channel a-subunit unveils several
putative PKA consensus motifs. One such sequence, R-Q-P-S8691, is conserved in all
mammalian BK channel splice variants and has been proposed through mutagenesis
studies as a possible PKA phosphorylation target in mammalian and insect channels
[190, 205, 229]. Although not an optimal PKA consensus sequence (Table 1.1),
mutation of the murine ZERO BK channel serine-869 to an unphosphorylatable alanine
residue abolishes the cAMP-induced activation of the channels demonstrating that an
intact serine-869 site is required for the PKA response and implicating it as a possible
target of direct PKA-targeted phosphorylation [190, 205, 229],
To determine whether the serine-869 residue is a target for PKA-mediated
phosphorylation, peptides encompassing the S869 region were employed in a series of in
vitro phosphorylation assays (Section 4.2.1). These peptides are described in detail in
the appropriate section and enabled preliminary determination of whether the site could
function as a PKA consensus motif.
The STREX insert as a putative PKA-phosphorylation target
As described in the introduction to this study (Section 1.3.1.2.1), heterologously
expressed ZERO channels are stimulated by the activation of PKA whereas STREX
isoforms are inhibited [80, 229], Therefore, if phosphorylation of the channel protein
underlies the PKA-mediated responses, the STREX insert is likely to influence the
1 Murine R-Q-P-S869 equivalent to R-R-G-S942 ofDrosophila BK channel [10].
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functional effect of the kinase upon the channel proteins. The STREX insert may
produce additional PKA-consensus motifs among its sequence. Such STREX
phosphorylation consensus sites could compete with and override the phosphorylation of
residues conserved in the ZERO and STREX channels, or could co-phosphorylate with
sites common to both isoforms. Equally, the STREX insert may obstruct residues that
are targeted in the ZERO variant, or conformationally produce alternative or additional
consensus motifs that are structurally inaccessible in the ZERO form of the channel.
Investigation of the sequence of the STREX insert uncovers several putative protein
kinase target residues including serine-4, a residue within a putative PICA consensus
motif at the beginning of the STREX insert region (Figure 1.6). As described in Chapter
One, PKA requires a motif analogous to the optimal consensus sequence for targeted
phosphorylation (Table 1.1) and the STREX sequence, R-R-P)-K.2-M3-S4, displays
sufficient analogy to be considered as a putative target (Figure 1.6). Although not
archetypal due to the structurally constraining proline residue and three, not two,
intermediate residues, the observed plasticity of the kinase with respect to its consensus
sequence implicates the STREX serine-4 as a possible target of PKA-directed
phosphorylation (Table 1.1).
To investigate whether the STREX insert, in particular the serine-4 residue, can be a
target of PKA-mediated phosphorylation in conditions favourable to kinase activity, the
GST-STREX and mutant GST-S4A fusion proteins (Section 3.2.1.1) were employed in a
series of in vitro phosphorylation assays (Section 4.2.2).
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The influence ofthe STREX insert upon BK channelphosphorylation
As described above, serine-869 was implicated as a putative PKA-phosphorylation
target following the observation of the critical effect its mutation incurred upon murine
ZERO channels [80, 229], However, mutagenesis of S869 site in the murine STREX
splice variant does not abolish the inhibitory effect of the kinase, indicating that serine-
869 is not essential for PKA-regulation of STREX channels [80, 229]. This supports the
hypothesis that the STREX insert occludes consensus motifs or produces alternative
PKA-consensus sites that override the phosphorylation of sites conserved in the ZERO
and STREX channel proteins. Furthermore, this is indicative of differential PKA-
mediated phosphorylation underlying the contrasting PKA-mediated regulation of the
splice variants.
To investigate the implied differential phosphorylation of the serine-869 site induced by
the presence of the STREX insert, the AN-AC recombinant fusion proteins were
employed (Section 3.2.1.2). These fusion proteins comprise the C-terminal tail region of
the BK channel spanning splice site two, the location of STREX insertion, and the
serine-869-containing PKA-target motif (See Figure 3.1). Comparison of the in vitro
phosphorylation of fusion proteins cloned from the ZERO and STREX channel isoforms
enabled the study of the phosphorylation of the C-terminal tail region of BK channels, in
particular the relationship between the phosphorylation states of the serine-869 and
STREX serine-4 sites (Section 4.2.3).
150
Chapter Four: Characterisation of the phosphorylation of BK channel splice variants
Further analysis of the relationship between the putative phosphorylation targets, serine-
869 and STREX serine-4, was achieved by implementation of BK channel protein in
externa, expressed as the HA-tagged fusion proteins (Section 3.2.2, Figure 3.13). These
tagged proteins formed functional channel complexes that could be immunoprecipitated
by exploitation of the HA-epitope (Section 3.2.2) enabling the assessment of the
phosphorylation of full-length, functional channel protein expressed in a mammalian
expression system analogous to native tissue. Thus, in vitro post-immunoprecipitation
phosphorylation assays employing excess, exogenous, constitutively active PKA, and in




Phosphorylation as a regulatory mechanism is more than the kinase targeting and the
physical phosphorylation event. The characteristics of the process are integral to
regulatory effectiveness and must be efficient, possess a degree of specificity and,
vitally, must be reversible. Characterisation of the phosphorylation of some of the
bacterially-expressed fusion proteins (Section 3.2.1) was performed to indicate whether
particular sites and regions could be functional targets of phosphorylation in the in vivo,
full-length functional channels, and to assess the efficiency of the in vitro experimental
protocols. Simple time course experiments were performed to determine the rate and
thus facilitate assay of the relative efficiency of PKA-mediated phosphorylation under
the experimental conditions that were employed (Section 4.2.2). The specificity of the
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proteins as PKA-targets was studied by examination of two common protein kinases,
protein kinase C (PKC) and calmodulin kinase 11 (CaMKII), kinases that are implicated
as regulators of BK channel function (See Section 1.4.1). The consensus motifs that
they target differ slightly to PKA, but all phosphorylate at serine or threonine residues
enabling the assessment of the degree of specificity of the proteins as protein kinase
phosphorylation targets.
Protein kinases are stimulated via various signal transduction systems and induce the
transfer of the terminal phosphate of ATP onto specific amino acids of particular target
proteins. Concomitantly, protein phosphatases catalyse the removal of phosphate from
target residues. Therefore, the two protein classes act in opposition to each other
providing a regulatory feedback mechanism that is critical to the modulation of many
cellular proteins (See Section 1.4.1). Electrophysiological investigation of BK channel
modulation by PKA has suggested that protein phosphatases, in particular protein
phosphatase 2A (PP2A) and protein phosphatase 1 (PP1), associate with the channel and
reverse the effects of the kinase (See Section 1.4.1). Therefore, if the STREX insert and
the S869 site are targets of reversible PKA-directed phosphorylation in vivo, they are
likely to be dephosphorylated by PP2A and/or PP1. Consequently, the in vitro PKA-
directed phosphorylation of the GST-STREX fusion protein and the S869 peptide should
be reversible phenomena if the regions are phosphorylated functionally by PKA in vivo.
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Mutagenesis
Throughout this study, serine to alanine mutations were used to replace the
phosphorylatable hydroxyl side chain of serine with the phosphorylation-inert carboxyl
of alanine whilst maintaining a similar mass and spatial arrangement that should impart
minimal conformational disruption. Although, as with any mutation, the substitution
could impart structural differences between the native and mutant fusion proteins as to
inhibit phosphorylation of a distinct site or sites, or indeed, create additional
phosphorylation consensus motifs, the similar conformation of the substitution makes
this unlikely. Consequently, the inability of a protein kinase to phosphorylate a
particular alanine mutant fusion protein in vitro when the non-mutant (serine) form is
phosphorylated, suggests that serine-alanine substitution is sufficient to preclude
phosphorylation of the residue and thus, implicates the residue as the protein kinase
phosphorylation consensus site and, additionally, suggests that other residues within the
protein are not phosphorylated.
Assays ofphosphorylation
In vitro phosphorylation assays were performed upon all fusion proteins in order to
assess phosphorylation under optimal conditions. Factors including buffering
conditions, assay temperature, inclusion of excess hydrolysable ATP, and the use of
constitutively active protein kinase facilitated such optimisation (See Section 2.8).
Although such optimisation of catalytic activity was not possible, nor desired, during in
vivo stimulation of PKA in HEK293 cells expressing the HA-tagged channels, the assay
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conditions and incubation temperature were conducive to catalytic stimulation (See
Section 2.8).
The method of analysis was integral to the assessment of fusion protein phosphorylation.
32Two protocols were performed, the use of radiolabeled ATP ([y- P]-ATP) as the
hydrolysable phosphate source and subsequent autoradiography, and the application of
the phospho-specific antibodies that are immunoreactive to the phosphorylation state of
the serine-869 and STREX serine-4 sites by Western blot analysis of the kinase-exposed
fusion proteins (See Section 3.2.3). Autoradiography enables the detection of
radiolabeled phosphate incorporation into proteins. This method does not identify the
residues that are phosphorylated, whereas Western blotting was used to identify the
phosphorylation state of the serine-869 and STREX serine-4 PKA-consensus sites.
Therefore, in combination, the methods enabled the detection and characterisation of the
phosphorylation state of the fusion proteins.
To determine the catalytic competence of the protein kinases during autoradiographic
analysis, positive control peplides/proteins were employed. Kemplide possesses the
motif, R-R-A-S (See Scheme 4.1), corresponding to the optimal PKA consensus
sequence, R-R-X-S, and that of CaMKlI, X-R-X-X-S (Table 1.1). Similarly, expression
of an optimal PKC phosphorylation consensus motif in PHAS-I (phosphorylated heat-
and acid-stable protein regulated by insulin) allows its use as a positive control of PKC
catalytic activity. Conversely, negative controls were used to assess non-specific
phosphate incorporation. Use of the fusion partners of the recombinant fusion proteins,
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GST and Thioredoxin-V5-H6, enabled the assessment of the tags as putative targets of
phosphorylation and, as will be seen within the results of this chapter, were not
phosphorylated under experimental conditions implicating phosphorylation of the cloned
BK channel portion of the fusion protein.
Thus, this chapter aims to investigate whether the molecular basis of the differential
PKA regulation of the STREX and ZERO BK channel splice variants is distinct PKA-
mediated phosphorylation of the isoforms, with particular reference to the relationship
between two putative phosphorylation target residues, the conserved serine-869 and the
STREX insert serine-4.
4.2 Results
4.2.1 Reversible phosphorylation of the S869 site
As mentioned in Section 3.2.1.2, the analysis of PKA phosphorylation of the serine-869
site was performed using peptides due to the insolubility of fusion proteins spanning the
S869 region of the BK channel sequence. The peptides, as illustrated below, encompass
a sequence of eleven residues that surround the putative PKA consensus motif, R-Q-P-
Sg69 (Figure 1.5). The mutant peptide, S869A, has an alanine residue replacing the
phosphorylatable serine-869 to facilitate investigation of the phosphorylation of serine-
869.
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Scheme 4.1: The S869 peptide sequences
Standard one letter amino acid code used.
S869 peptide M L R Q P Ss69 I T T G V
S869A peptide M L R Q P A869 I T T G V
Kemptide - control peptide L R R A s L G
4.2.1.1 PKA phosphorylation of the S869 peptides
In vitro phosphorylation assays were performed using the S869 peptides as described in
Section 2.8.1. The peptides were incubated in a magnesium-containing buffer in the
presence of radiolabeled ATP ([y- PJ-ATP) and the constitutively active catalytic
subunit of PKA (PKAc) at 30 °C. Reactions were separated by electrophoresis on Tris-
Glycine gels, and radiolabeled phosphate incorporation analysed by autoradiography.
Figure 4.1 illustrates the results of such an experiment.
In the presence of PKAc, robust radiolabeled phosphate incorporation was detected
with the kemptide positive control peptide and with the S869 peptide as substrate.
Phosphate incorporation is not detected in the absence of the kinase, nor with the mutant
32S869A peptide. No other signals are observed at this length of exposure of the P-
sensitive film to the experimental gel (between one to thirty minutes).
Thus, the S869 site of the S869 peptide is phosphorylated by PKA in vitro, with alanine
substitution of the residue inhibiting peptide phosphorylation and thus suggesting that
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Figure 4.1

































Figure 4.1: Representative autoradiograph of PKAc
phosphorylation of S869 peptide. In vitro PKAc phosphorylation
assays were performed in the presence of 10 pCi [y-32P]-ATP (10 mins,
30 °C). Samples were separated by electrophoresis and exposed to 32P-
sensitive film. Radiolabelled phosphate incorporation was observed
with the S869 peptide and with the positive control peptide, kemptide,
only in the presence of PKAc. The mutant S869A peptide was not
phosphorylated.
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phosphate incorporation is specific, and does not occur at other sites within the peptide
sequence. Preliminary assays investigating the time course of PKA-phosphorylation of
the S869 peptide determined that phosphorylation was maximal within 1 minute of
kinase addition to the reaction (Results not shown). This indicates that the 10 minute
incubation period used for the analysis illustrated in Figure 4.1 represents maximal
phosphorylation of the S869 peptide by PKAc under the conditions of the experiment.
4.2.1.2 Phosphorylation of the S869 peptide by other protein kinases
To investigate the specificity of the S869 peptide as a PKA phosphorylation target, in
vitro phosphorylation assays were performed using two serine/threonine protein kinases
that are reported to influence BK channel activity; protein kinase C (PKC), and
calmodulin kinase II (CaMKII).
4,2.1.2.1 PKC phosphorylation of the S869 peptide
Phosphorylation reactions employing radiolabeled ATP were performed as described in
Section 2.8.1.3. Reactions were separated by electrophoresis on a Tris-Glycine gel and
radiolabeled phosphate incorporation was detected by autoradiography. Figure 4.2
illustrates the results of such an experiment.
PKC phosphorylated the positive control, PHAS-I, indicating that the kinase is
catalytically active in vitro. However, no phosphorylation was observed with S869
peptide or mutant, S869A peptide, even upon extended autoradiographic exposures,
demonstrating that the S869 peptide is not a PKC-phosphorylation target in vitro.
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Figure 4.2







Figure 4.2: Representative autoradiograph of in vitro PKC
phosphorylation of the S869 peptides. Reactions employing
radiolabelled ATP were incubated at 37 °C for 10 mins prior to
separation on 4-12 % Tris-Glycine gels and exposure to 32P sensitive
film. Under the experimental conditions employed, the radiolabel
incorporated with the positive control, PHAS-I only. No other
phosphorylation signals were observed.
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Figure 4.3
CaMKII phosphorylation of S869 peptide
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Figure 4.3: Representative autoradiograph of in vitro CaMKII-
phosphorylation of S869 peptide. CaMKII assays using 10 pCi y-32P-
ATP were incubated at 37 °C for 10 mins prior to separation on 4-12 %
Tris-Glycine gels and exposure to 32P sensitive film. Control reactions
with the calcium chelator, EDTA, to inhibit the kinase were performed
in parallel. Phosphorylation was observed with the positive control
peptide, kemptide and with the S869 peptide. The lower molecular
weight phosphorylation bands observed with the S869 peptide in this
assay are suggested to be degradation fragments.
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4.2.1.2.2 CaMKll phosphorylation of the S869 peptide
In vitro phosphorylation reactions employing radiolabeled ATP were performed using
CaMKll activation buffer (Section 2.8.1.4). Control reactions exploited the divalent
cation chelator, EDTA, to buffer calcium ions and subsequently inhibit kinase activity.
Reactions were separated by electrophoresis on Tris-Glycine gels and radiolabeled
phosphate incorporation was detected by autoradiography as illustrated in Figure 4.3.
Incorporation of the radiolabeled phosphate is apparent with the S869 peptide, as well
as with the positive control peptide, kemptide (Figure 4.3). Phosphorylation is not
observed when the kinase is inhibited by EDTA, nor is phosphorylation of the S869A
mutant peptide observed. This indicates that the S869 peptide is phosphorylated by
CaMKll in vitro, possibly at the S869 site, and thus implicates the S869 site as a
putative CaMKll phosphorylation site in vivo.
4.2.1.3 Dephosphorylation of the S869 peptide
Dephosphorylation of the S869 peptide was investigated using the serine/threonine
protein phosphatases, PP2A and PP1. The S869 peptide was phosphorylated by PKAc
as described above (Section 4.2.1.1), then mixed with the PKA inhibitor, H-89 (1 pM),
and divided equally among various dephosphorylation reaction conditions (Section
2.8.1.5.2). Reactions were incubated with the respective protein phosphatase in the
presence or absence of the phosphatase inhibitor, okadaic acid (100 nM), with control
reactions incorporating okadaic acid alone, or no supplementary
phosphatase/phosphatase-inhibitor. Figure 4.4 illustrates an autoradiograph of such an
I
161
Chapter Four: Characterisation of the phosphorylation of BK channel splice variants
Figure 4.4
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Figure 4.4: Representative autoradiograph of in vitro
dephosphorylation of PKAc-phosphorylated S869 peptide. S869
peptide, phosphorylated by PKAc as previously, was incubated (30
mins, 37 °C) in the presence or absence of protein phosphatase, either
PP2A or PP1, with or without okadaic acid (OA) as described above.
PP2A and PP1 dephosphorylate the S869 peptide and the effect was
inhibited by OA. OA alone had no effect upon phosphorylation.
Densitometric analysis of the signals was performed to quantitate the
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Figure 4.5













Figure 4.5: Summary of PP2A and PPl-mediated
dephosphorylation of PKAc-phosphorylated S869 peptide.
Summary of densitometric analysis from six independent assays of
S869 peptide dephosphorylation performed as Figure 4.4. All data
were normalised to the control PKAc-phosphorylated sample (100 %,
Mean + SEM, n=6, Statistical analysis by T-test comparison to control
phosphorylation: * P<0.05, ** PO.Ol). PP2A and PP1
dephosphorylated the peptides. This is inhibited by okadaic acid (OA)
which does not influence phosphorylation when applied alone (OA
control).
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assay, with Figure 4.5 demonstrating the results of densitometric analysis (Section
2.10.3) from six independent experiments.
The PKAc-phosphorylated S869 peptide control was assigned as the maximal
phosphorylation and all experimentally determined values were normalised to the
density of this signal. PP2A significantly decreased the level of phosphorylation to 43
(+ 7.1) %" of control phosphorylation (P<0.001). Equivalent treatment with PP1 also
resulted in significant dephosphorylation to 63 (+ 9.0) %2 of control (P<0.001). Okadaic
acid (100 nM) inhibited PP2A and PP1-mediated dephosphorylation, with
phosphorylation in the presence of okadaic acid 80 (+ 4.4) and 89 (+ 4.2) %" of control
phosphorylation respectively (P~l). Application of okadaic acid alone had no effect on
the phosphorylation state of the S869 peptide (97 (+ 6.1) %2 of maximum
phosphorylation, P~l).
4.2.2 Reversible phosphorylation of the GST-STREX fusion protein
To determine whether the STREX insert sequence, in particular the serine-4 putative
consensus motif, can function as a phosphorylatable target of PKA, the GST-tagged
fusion proteins of the insert were employed (Section 3.2.1.1).
4.2.2.1 PKA-mediated phosphorylation of the GST-STREX fusion protein
GST-fusion proteins were phosphorylated in vitro as described in Section 2.8.1. The
purified protein of interest was incubated in a magnesium-containing buffer in the
2 Values quoted as mean +SEM, n=6.
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presence of excess ATP and the constitutively active catalytic subunit ofPKA (PKAc) at
30 °C. Protein phosphorylation was analysed by autoradiography and/or Western blot
analysis.
4.2.2.1.1 Autoradiographic analysis ofGST-STREX phosphorylation
Phosphorylation reactions using radiolabeled ATP ([y-32P]-ATP) were separated by
electrophoresis on a Tris-Glycine gel and the radiolabeled proteins detected by
autoradiography. Figure 4.6 illustrates the results of such an experiment using the GST-
STREX fusion proteins.
In the presence, but not in the absence of PKAc, phosphate incorporation was observed
from the ~35 kDa GST-STREX and its ~29 kDa proteolytic fragment indicating that the
kinase is required for phosphorylation of the fusion proteins, and signifies the catalytic
competence of the kinase. Crucially, neither GST-S4A, or GST protein alone were
phosphorylated under the experimental conditions demonstrating that the fusion tag,
GST, was not the target of phosphorylation, and that an intact Serine-4 residue is
required for GST-STREX fusion protein phosphorylation by PKA. PKAc
autophosphorylation was visible at ~45 kDa in all lanes where the kinase was included,
except with the strongly phosphorylatable positive control peptide, kemptide, providing
further evidence for the catalytic competence, activity and specificity of the kinase. The
comparative densities of PKAc autophosphorylation between different substrates
illustrated that the intensity of the phosphorylation band was related to the extent of
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Figure 4.6
Phosphorylation of GST-STREX by PKAc:
Autoradiography









a. -45 kDa, protein kinase A catalytic subunit (PKAc)
b. -35 kDa, GST-STREX constructs: GST-STREX:
GST-S4A:
c. -29 kDa, GST-STREX proteolytic product:
d. -28 kDa, GST:
e. Kemptide
Figure 4.6: Representative autoradiograph of the in vitro PKA-
mediated phosphorylation of GST-STREX. 1: Control peptide,
kemptide + PKAc; 2: GST-STREX + PKAc; 3: GST-S4A + PKAc; 4:
GST-STREX - PKAc; 5: GST-S4A - PKAc; 6: GST + PKAc; 7: PKAc
alone. Phosphorylation assays were performed in vitro in the presence
of 10 pCi [y-32P]-ATP (10 mins, 30 °C). Samples separated by
electrophoresis were exposed to 32P-sensitive film. Radiolabeled
phosphate incorporation was observed with the GST-STREX protein
(-35 kDa) and the degradation product (-29 kDa) in the presence of
PKAc. Phosphorylation was not observed in the absence of the kinase.
The mutant GST-S4A fusion protein (-35 kDa) and GST protein (-28
kDa) were not phosphorylated. The PKAc substrate, kemptide, was
phosphorylated, and PKAc autophosphorylation (-45 kDa) was
observed. Fusion proteins are represented diagrammatically below the
autoradiograph (See Figure 3.5).
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phosphorylation of the target substrate. Neither GST nor the GST-S4A fusion protein
were phosphorylated within the assays and thus, PKAc autophosphorylation was
comparable to that of the kinase assessed in the absence of available and appropriate
substrate (P~l). However, in the presence of phosphorylatable GST-STREX the PKAc
autophosphorylation signal density was depleted significantly (P<0.0001) and was
completely undetectable with the model substrate, kemptide.
These data indicate that the 35 kDa GST-STREX fusion protein and the putative 29 kDa
proteolytic product were phosphorylated by PKAc specifically in vitro at a site likely to
be the serine-4 residue.
4.2.2.1.2 Western blot analysis ofGST-STREX phosphorylation
To determine whether the serine-4 site of GST-STREX functions as the phosphorylation
site of PKA in vitro. Western blot analysis was performed with the a-phospho-STREX
antibody that is immunoreactive to phosphorylated serine-4 (Section 3.2.3). In vitro
phosphorylation reactions were conducted with non-radiolabelled ATP. Non-
phosphorylalion reactions where PKAc was omitted were performed in parallel as
controls of both antibody and kinase specificity. Samples were separated by SDS-PAGE
and analysed by Western blotting. A representative assay is illustrated in Figure 4.7A.
a-GST analysis
Probing for GST demonstrated the presence of equivalent amounts of the GST-fusion
proteins, GST-STREX and GST-S4A, at the appropriate molecular weights, -35 kDa
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Figure 4.7A
PKA phosphorylation of GST-STREX:
Western blot analysis
Non-phosphorylated Phosphorylated
GST- GST- GST- GST-




















Figure 4.7A: Representative Western blots comparing non-
phosphorylated and PKA-phosphorylated GST-fusion proteins. In
vitro PKAc-phosphorylation assays performed in the absence (non-
phosphorylated) or presence (phosphorylated) of PKAc were analysed
by Western blotting. The -35 kDa (a) fusion proteins and the 29 kDa
(b) proteolytic fragments were detected by a-GST and a-STREX, with
additional -32 kDa fragments (*). GST (c) was detected by a-GST
only. a-phospho-STREX detected the phosphorylated GST-STREX
proteins only, suggesting specific, PKA-mediated phosphorylation at
serine-4. Fusion proteins are illustrated diagrammatically below the
blots (See Figure 3.5). Western blot analysis: goat a-GST 1/1000;
sheep a-STREX 1/1000; sheep a-phospho-STREX 1/1000; a-
sheep/goat-ElRP 1/15000; detection by ECL.
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Figure 4.7B
PKA phosphorylation of GST-STREX:






Proteolytic fragment -29 kDa
9
Blot: a-phospho-STREX
Figure 4.7B: Detection of GST-STREX by a-phospho-STREX.
Analysis of PKA-phosphorylated GST-STREX by a-phospho-STREX
detected the -35 kDa full-length fusion protein as well as the 29 kDa
proteolytic fragment. The non-phosphorylated GST-STREX fusion
proteins were not detected by this antibody. This demonstrates that
although the -35 kDa fusion protein was not detected by a-phospho-
STREX in the example illustrated in Figure 7A, this may be an artefact
of the relatively lower proportion of this protein to the -29 kDa
fragment in that particular experiment (as observed by a-GST analysis,
See Figure 7A). Assays and analysis as Figure 7A: sheep a-phospho-
STREX 1/1000; a-sheep/goat-HRP 1/15000; detection by ECL.
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full-length and the -29 kDa proteolytic fragment, as described previously (Section
3.2.1.1; Figure 3.5). The purifications employed in this set of experiments resulted in a
-32 kDa protein that was absent from the previous assays and was identified as an
additional proteolytic product due to its immunoreactivity to the a-GST and a-STREX
antibodies (See below). No difference was observed between phosphorylated and non-
phosphorylated samples indicating that phosphorylation and the presence of the kinase
does not influence detection by the antibody under these conditions. Additionally,
although the total concentration of protein in each reaction was identical, the proportion
of full-length protein to degraded fragments differs between the GST-STREX and GST-
S4A fusion proteins, with greater degradation of the GST-STREX protein observed.
a-STREX analysis
The a-STREXJ antibody is immunoreactive to the ~35 kDa full-length GST-STREX
and GST-S4A fusion proteins, and the -29 kDa fragment of the GST-STREX fusion
protein. The -29 kDa GST-S4A fragments were not detected by this antibody, which
may be indicative of the relatively lower proportion of this fragment that was detected
by a-GST analysis in comparison to the -35 kDa fusion proteins and the -29 kDa GST-
STREX degradation fragment. As predicted, GST is not detected by this antibody.
The autoradiography (Figure 4.6) demonstrated that the mutant fusion protein was not
phosphorylated by PKAc under these experimental conditions, and comparable a-
3 As described previously (Section 3.2.3), this antibody differs from the a-STREX-1
antibody that was employed formerly as it is targeted to a different epitope of the
STREX insert sequence (See Table 2.4 & Figure 4.23).
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STREX detection of -35 kDa non-phosphorylated GST-STREX to -35 kDa GST-S4A
(P>0.1) supports the implementation of this antibody as a detector of non-
phosphorylated STREX. Additionally, the immunoreactivity of a-STREX to GST-
STREX was significantly depleted by phosphorylation of the fusion protein (P<0.001)
indicating that phosphorylation does inhibit the antibody-antigen association as
suggested by the preliminary peptide analyses (Section 3.2.3). The still-present but
depleted -35 kDa phosphorylated GST-STREX a-STREX immunoreactivity may result
from a proportion of the fusion protein remaining un-phosphorylated, or from
incomplete inhibition of the antibody-epitope interaction.
a-phospho-STREXanalysis
Analysis of the phosphorylation state of the serine-4 site of the fusion protein using the
a-phospho-STREX antibody demonstrated specific immunoreactivity with the -29 kDa
phosphorylated GST-STREX degradation fragment. In this experiment, the antibody
did not detect the -35 kDa full-length phosphorylated fusion protein which may be an
artefact of the relatively lower proportion of this protein to the -29 kDa fragment as
observed by a-GST analysis (See above). The -35 kDa full-length PKA-
phosphorylated GST-STREX was detected by this antibody in other experiments (See
Figure 4.7B). No immunoreactivity was detected with the non-phosphorylated GST-
STREX proteins, nor with mutant GST-S4A fusion protein or the control, GST.
These data suggest that phosphorylation of the GST-STREX fusion protein by PKA
occurs at the serine-4 residue under the experimental conditions applied. Additionally,
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the specific immunoreactivity of the a-phospho-STREX antibody to phosphorylated
GST-STREX indicates that the antibody can characterise the phospho-serine-4 motif
within this fusion protein.
4.2.2.1.3 Time course ofPKA-mediated phosphorylation ofGST-STREX
Time course assays using radiolabeled ATP were performed to demonstrate that in vitro
PKA-phosphorylation of the GST-STREX fusion protein was saturatable. Aliquots from
the assays were removed at set time points following the start of the reaction initiated by
the addition of the kinase. Control reactions of GST-STREX in the absence of PKAc
and of PKAc with no substrate were run in parallel. Samples were separated by
electrophoresis on Tris-Glycine gels and the radiolabelled proteins were detected by
autoradiography. Figure 4.8 illustrates the autoradiograph of an individual assay, and
Figure 4.9 demonstrates the resultant time course that was determined by densitometric
analysis of eight independent experiments.
The autoradiograph (Figure 4.8) illustrates the in vitro phosphorylation of GST-STREX
by PKAc with the -35 kDa full-length protein and -32 and -29 kDa fragments
incorporating the radiolabel. As described previously (Section 4.2.2.1.1), no
phosphorylation of the fusion protein is observed in the absence of PKAc over the
experimental period (30 mins) demonstrating that incorporation of the radiolabelled
phosphate group requires the catalytically active kinase. The -45 kDa PKAc
autophosphorylation signals have been excluded from the autoradiograph to enable
clarification of the fusion protein bands, with the absence of the GST-STREX signals
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Figure 4.8
Time course ofGST-STREX phosphorylation by PKAc:
Autoradiography
GST-STREX + PKAc ^ «E-n






Figure 4.8: Representative autoradiograph of a time course of
PKAc-phosphorylation of GST-STREX. Aliquots were removed
from a phosphorylation reaction using [y-32P]-ATP at 1, 3, 5, 10, 20,
and 30 minutes following the addition of the kinase to the reaction
mixture (0 mins). Phosphorylation of control reactions of GST-
STREX without the kinase and of the kinase without the substrate were
run in parallel and no phosphorylation was observed. Phosphorylation
of full-length GST-STREX protein (-35 kDa) and the -32 and -29
kDa proteolytic fragments increased over the experimental period.
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from the PKAc-only control highlighting the identification of the GST-STREX signals
(As described previously, Section 4.2.2.1.1) and demonstrating that they are not kinase-
associated bands.
The phosphorylation signals from the 35 kDa full-length GST-STREX protein were
analysed densitometrically (Section 2.10.3) as shown in Figure 4.9. As the density of
the GST-STREX phosphorylation signal plateaus between 20-30 minutes following the
addition of PKAc, densities at the other time points were normalised to the 30 minute
density (Figure 4.9). The curve illustrates an increase in the observed proportion of
phosphorylated substrate between ~0 and ~80 % of the maximum phosphorylation over
the first ten minutes of analysis. Phosphate incorporation then declines with only a -20
% increase over the 10-30 minute time points, indicative of saturation of the reaction and
demonstrating that a component of the reaction is limiting further phosphorylation.
Equivalent assays were performed using non-radioactive ATP and Western blot analysis
against the GST fusion tag (Results not shown). These results indicated that, throughout
the assay period and conditions, there was no breakdown of the ~35 kDa fusion protein
within the limits of detection demonstrating that saturation is not due to substrate
degradation.
4.2.2.2 Phosphorylation of the GST-STREX fusion protein by other protein kinases
To investigate the specificity of the GST-STREX fusion protein as a PKA
phosphorylation target, in vitro phosphorylation assays were performed using two
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common protein kinases that are reported to influence BK channel activity; protein
kinase C (PKC), and calmodulin kinase II (CaMKlI) (See Section 1.4.1).
4.2.2.2.1 PKC phosphorylation of GST-STREX
Phosphorylation reactions employing radiolabeled ATP were performed as described in
Section 2.8.1.3 using a lipid-containing buffer to activate the kinase. Assays were
separated by electrophoresis on a Tris-Glycine gel and phosphate incorporation detected
by autoradiography. Figure 4.10 illustrates the results of such an experiment.
In the presence of PKC, incorporation of the radiolabeled phosphate was observed with
the ~35 kDa GST-STREX fusion protein and the -29 kDa proteolytic product, in
addition to the positive control protein, PHAS-1. No signals were observed in the
absence of the kinase, nor was PKC-phosphorylation of the mutant, GST-S4A protein or
the GST control protein observed, even upon longer exposure periods of the
autoradiographs. These data indicate specific catalytic phosphorylation of the GST-
STREX fusion protein by PKC, possibly at the serine-4 residue.
4.2.2.2.2 CaMKII phosphorylation ofGST-STREX
Phosphorylation reactions employing radiolabeled ATP were performed using a
CaMKII activation buffer (Section 2.8.1.4). Control reactions exploited the divalent
cation chelator, EDTA, to buffer calcium ions and subsequently inhibit kinase activity.
Reactions were separated by electrophoresis on Tris-Glycine gels and phosphate
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Figure 4.10
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Figure 4.10: Representative autoradiograph of in vitro PKC
phosphorylation of GST-STREX fusion proteins. Reactions in the
presence of 10 pCi y-32P-ATP were incubated at 37 °C for 10 mins prior
to separation on 4-12 % Tris-Glycine gels and exposure to 32P sensitive
film. Phosphate incorporation into the -35 kDa and -29 kDa GST-
STREX proteins was observed only in the presence of PKC. No
phosphorylation was observed with GST-S4A or GST. The positive
control PKC-substrate, PHAS-I, was phosphorylated. The fusion
proteins are illustrated diagrammatically below the autoradiograph (See
Figure 3.5).
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Figure 4.11: Representative autoradiograph of in vitro CaMKII-
phosphorylation of GST-STREX. CaMKII assays using 10 pCi y-32P-
ATP were incubated at 37 °C for 10 mins prior to separation on 4-12 %
Tris-Glycine gels and exposure to 32P sensitive film. Control reactions
with the calcium chelator, EDTA, to inhibit the kinase were performed
in parallel. Phosphorylation was only observed using the positive
control peptide, kemptide. The assayed fusion proteins are illustrated
diagrammatically below the autoradiograph (See Figure 3.5).
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incorporation detected by autoradiography. Figure 4.11 illustrates the results of such an
experiment.
None of the GST-fusion proteins was phosphorylated by CaMKIl. The control peptide,
kemptide, is strongly phosphorylated, suggesting that the kinase is catalytically active
under the conditions of the experiment and is able to phosphorylate an optimal PKA
consensus motif (See Table 1.1). However, the absence of any detectable
phosphorylation of the experimental proteins infers that CaMKIl cannot phosphorylate
GST-STREX in vitro.
4.2.2.3 Dephosphorylation of GST-STREX
Dephosphorylation assays employing the serine/threonine protein phosphatases, protein
phosphatase 2A (PP2A) and protein phosphatase 1 (PP1), were undertaken using PKAc-
phosphorylated GST-STREX as substrate (Section 2.8.1.5.1). The GST-STREX fusion
protein was phosphorylated by PKAc using radiolabelled phosphate, as described
previously (See above). The kinase inhibitor, H-89, was then added to inhibit further
phosphorylation during the dephosphorylation experiment. Aliquots were incubated
with a protein phosphatase in the presence or absence of the phosphatase inhibitor,
okadaic acid (100 nM). Control reactions were performed in the absence of the protein
phosphatases and okadaic acid, and with okadaic acid alone. Figure 4.12 illustrates
representative autoradiographs of such assays, with Figure 4.13 demonstrating the
results of densitometric analysis (Section 2.10.3) from six independent experiments.
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PP1 Assay 35 kDa
GST-STREX
-35 kDa
Figure 4.12: Representative autoradiographs of the
dephosphorylation of GST-STREX by PP2A and PP1. PKAc-
phosphorylated GST-STREX was incubated (30 mins, 37 °C) with or
without protein phosphatase (PPase), either PP2A or PP1, in the
presence or absence of okadaic acid. Okadaic acid was added with the
PPase or only in the final five minutes of the 30 min incubation.
Phosphorylation of -35 kDa GST-STREX (and the -29 kDa
proteolytic product, not shown) was reduced by PP2A and PP1.
Okadaic acid inhibited this reduction, but had no effect when applied
alone. Densitometric analysis of the -35 kDa GST-STREX bands was
performed to quantitate the autoradiograph results and is shown in
Figure 4.13.
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Figure 4.13: Graphical analysis of PP2A and PPl-mediated
dephosphorylation of PKAc-phosphorylated GST-STREX.
Densitometric analysis of full-length GST-STREX (-35 kDa)
phosphorylation from four independent dephosphorylation assays as
represented in Figure 4.12. Data was normalised to the PKAc
phosphorylation control (100 %; mean + SEM, n=6, Statistical analysis
by T-test comparison to control phosphorylation: ** PO.Ol).
Phosphorylation of -35 kDa GST-STREX (and the -29 kDa
proteolytic product, not shown) was reduced by PP2A and PP1.
Okadaic acid inhibited this reduction but had no effect when applied
alone (OA control).
181
Chapter Four: Characterisation of the phosphorylation ofBK channel splice variants
The phosphorylation control was assigned as the maximal phosphorylation (100%) and
therefore all experimentally determined values were normalised to the density of this
signal. PP2A and PP1 significantly decreased the level of phosphorylation to 33 (+ 6.3)
and 32 (+ 5.7) %4 of the maximal respectively, suggestive of dephosphorylation of GST-
STREX (PO.OOl). The degree of dephosphorylation is equivalent between the two
protein phosphatases (P~l).
Inclusion of the protein phosphatase inhibitor, okadaic acid (100 nM), inhibits
dephosphorylation, with 83 (+ 4.9) and 89 (+ 3.7) %4 of maximal phosphorylation
observed with PP2A and PP1 respectively (P>0.01). Okadaic acid alone has no
significant effect upon phosphorylation (P—1). Furthermore, application of okadaic acid
in the final five minutes of the 30 minute dephosphorylation period only did not prevent
dephosphorylation of GST-STREX. However, the extent of dephosphorylation was not
as pronounced under these conditions as for the respective protein phosphatase alone (43
(± 8.2) %4 compared to 33 (+ 6.3) %4 for PP2A alone (P<0.001), and 41 (± 7.2) %4
compared to 32 (+ 5.7) %4 for PP1 alone (P<0.001)). This suggests that the
dephosphorylation reactions have not reached completion at this point in the assay.
Therefore, these data demonstrate that protein phosphatases PP2A and PP1
dephosphorylate PKA-phosphorylated GST-STREX in vitro.
4 Values quoted as mean +SEM, n=6.
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4.2.3 Reversible phosphorylation of the AN-AC fusion proteins
Investigation of the phosphorylation of the C-terminal region, in particular the influence
of the STREX insert and the relationship between the serine-869 and STREX serine-4
putative phosphorylation sites, was investigated by the use of the AN-AC fusion proteins
(Section 3.2.1.2).
4.2.3.1 PKA phosphorylation of the AN-AC fusion proteins
Nickel-sepharose affinity chromatography-purified and a-V5 immunoprecipitated AN-
AC fusion proteins were subjected to in vitro phosphorylation and analysed by
autoradiography or Western blotting.
4.2.3.1.1 PKA phosphorylation of nickel affinity purified AN-AC fusion proteins:
Autoradiography
In vitro phosphorylation assays were performed in the presence or absence of PKAc
using AN-STREX-AC and AN-ZERO-AC purified by nickel-sepharose affinity
chromatography (As Section 2.8.1). Radiolabeled ATP was used in the assays and
proteins were separated by electrophoresis on Tris-Glycine gels prior to
autoradiography. Figure 4.14 illustrates the results of such an experiment.
In the presence, but not in the absence of PKAc, AN-STREX-AC (~70 kDa) and AN-
ZERO-AC (~65 kDa) were phosphorylated. This indicates that the kinase is required for
phosphorylation suggesting that the effect is not non-specific interaction of the
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Figure 4.14
PKA-mediated phosphorylation of the AN-AC proteins:
Autoradiography ofNi2+-purif!ed fusion proteins
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Figure 4.14: Representative autoradiograph of the in vitro PKA-
mediated phosphorylation of Ni2+-purified AN-AC fusion proteins.
Assays upon AN-STREX-AC and AN-ZERO-AC in the presence (+) or
absence (-) of PKAc were incubated by in vitro phosphorylation in the
presence of [y-32P]-ATP (10 mins, 30 °C), separated by electrophoresis
and analysed by autoradiography. Longer exposure periods did not
detect additional signals. In the presence of PKAc, AN-STREX-AC
(-70 kDa) and AN-ZERO-AC (-65 kDa), and the -75 kDa
contaminating protein are phosphorylated. Phosphorylation was not
observed in absence of kinase. PKAc autophosphorylation (-45 kDa)
was observed. Fusion proteins represented diagrammatically below
autoradiograph (See Figure 3.5).
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radiolabel with the proteins, but a specific catalytic event. Thus, this demonstrates that
AN-STREX-AC and AN-ZERO-AC are phosphorylated by PKAc in vitro.
Autophosphorylation of PKAc is observed at 45 kDa, and the ~75 kDa contaminating
protein that was observed by Colloidal stain of nickel-affinity purified recombinant
proteins (Figure 3.10) is phosphorylated by the kinase also. The proximity of this
phosphorylatable protein to AN-STREX-AC following electrophoresis could cause
confusion in signal differentiation. Therefore, immunoprecipitation of the AN-AC
fusion proteins was performed for all further phosphorylation analyses.
4,2.3.1.2 PKA phosphorylation of immunoprecipitated AN-AC fusion proteins:
Autoradiography
Immunoprecipitated AN-STREX-AC, AN-S4A,S868A-AC and AN-ZERO-AC, and
control protein, Thioredoxin-V5-H6, were phosphorylated by PKAc in vitro as described
in Section 2.8.1. Assays were separated by electrophoresis on Tris-Glycine gels and
phosphorylation determined by autoradiography. Such an analysis is illustrated in
Figure 4.15.
In the presence of PKAc, AN-STREX-AC (~70 kDa) and AN-ZERO-AC (-65 kDa) were
phosphorylated indicating, as in Figure 4.14, that AN-STREX-AC and AN-ZERO-AC are
phosphorylated by PKAc in vitro. Omitting the kinase from the assays prevented such
phosphorylation (Results not shown) demonstrating the specific catalysis of the
reactions. The inability ofPKAc to phosphorylate the negative control protein,
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Figure 4.15
PKA phosphorylation of the AN-AC fusion proteins:
























































Figure 4.15: Representative autoradiograph of in vitro PKA
phosphorylation of immunoprecipitated AN-AC fusion proteins.
AN-STREX-AC, AN-S4A,S869A-AC, AN-ZERO-AC and control
Thioredoxin-V5-H6 were incubated by in vitro phosphorylation in the
presence of PKAc and [y-32P]-ATP (10 mins, 30 °C), separated by
electrophoresis and analysed by autoradiography. Longer exposure
periods did not detect additional signals. AN-STREX-AC (~70 kDa)
and AN-ZERO-AC (-65 kDa) were phosphorylated by PKAc and no
phosphorylation was observed in the absence of the kinase (Results not
shown). AN-S4A,S869A-AC (-70 kDa) and Thioredoxin-V5-H6 (inset)
were not phosphorylated by PKAc. Fusion proteins represented
diagrammatically below autoradiographs (See Figure 3.5).
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Thioredoxin-V5-H(„ demonstrates that the fusion tags are not phosphorylated in vitro,
indicating that the tags are not the regions of PKAc phosphorylation in AN-STREX-AC
and AN-ZERO-AC.
The very weak signal observed at -70 kDa with the AN-S4A,S869A-AC fusion protein
is of comparable density to protein bands in the negative control, Thioredoxin-V5-H6,
and less dense than those of AN-STREX-AC and indeed. AN-ZERO-AC. This suggests
that AN-S4A.S869A-AC is not phosphorylated by PKAc in vitro and the -70 kDa signal
is due to non-specific ATP incorporation. This indicates that mutation of the S869 and
STREX S4 sites to non-phosphorylatable alanine is sufficient to inhibit PKAc-
phosphorylation of the fusion protein. Thus, S869 and STREX S4 are implicated as the
in vitro phosphorylation targets of PKAc in the AN-STREX-AC fusion protein, and S869
is implicated as the in vitro phosphorylation target of PKAc in AN-ZERO-AC.
4.2.3.1.3 PKA phosphorylation of immunoprecipitated AN-AC fusion proteins:
Western blot analysis
Determination of the putative in vitro PKAc phosphorylation of the S869 and STREX
S4 sites of the AN-AC fusion proteins was performed by Western blot analysis using the
phospho-specific antibodies that are immunoreactive to the phosphorylation state of the
residues (Section 3.2.3). In vitro phosphorylation of the AN-AC fusion proteins was
conducted with non-radiolabelled ATP as described in Section 2.8.1. Control, non-
phosphorylation reactions were performed in parallel, omitting PKAc and samples were
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separated by SDS-PAGE and analysed by Western blotting. A representative assay is
illustrated in Figures 4.16 & 4.17.
The antibody against the V5 fusion tag, a-V5, detected the phosphorylated and non-
phosphorylated AN-AC fusion proteins at the appropriate molecular weights (-65 kDa
for AN-ZERO-AC and -70 kDa for all the STREX-insert expressing proteins) with
approximately equivalent band densities between samples demonstrating equivalent
loading of the fusion proteins (Figures 4.16 & 4.17).
S869 site phosphorylation (Figure 4.16)
The intact S869 residues of AN-STREX-AC and AN-ZERO-AC are demonstrated by the
immunoreactivity of a-S869 for the non-phosphorylated proteins. The alanine
substitution of the site within AN-S4A,S869A-AC and AN-STREX,S869A-AC reduces,
but does not occlude, the association of the antibody with the proteins as the
phosphorylated and non-phosphorylated reactions display an immunoreactivity that is
notably less than that of the non-phosphorylated AN-STREX-AC and AN-ZERO-AC.
However, whereas AN-S4A,S869A-AC and AN-STREX,S869A-AC are still detected
following in vitro phosphorylation analysis with PKAc, AN-STREX-AC and AN-ZERO-
AC lose their immunoreactivity to a-S869. This is counterbalanced by a-phospho-S869
analysis, which detects only the phosphorylated fusion proteins with intact S869 sites:
AN-STREX-AC and AN-ZERO-AC. These data suggest that PKAc phosphorylates
intact S869 residues of AN-AC fusion proteins in vitro.
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Figure 4.16
In vitro PKA phosphorylation of AN-AC fusion proteins:
Western blot analysis of S869 site phosphorylation
Non-phosphorylated Phosphorylated




































































































Figure 4.16: comparing non-
phosphorylated and PKA-phosphorylated AN-AC fusion proteins.
In vitro PKA phosphorylation of the AN-AC fusion proteins was
performed with (phosphorylated) or without (non-phosphorylated)
PKAc. a-V5 detected the proteins at the appropriate molecular weights
(as illustrated below blots (See Figure 3.5)). Non-phosphorylated AN-
STREX-AC and AN-ZERO-AC, and AN-S4A,S869A-AC and AN-
STREX,S869A-AC with mutated S869 sites, were detected by a-S869.
S869 site phosphorylation, indicated by a-phospho-S869, was observed
with AN-STREX-AC and AN-ZERO-AC only. Control thioredoxin-V5-
H6 (-16 kDa) was detected by a-V5 only (Not shown). Western
analysis: mouse a-V5 1/5000; sheep a-S869/a-phospho-S869 1/1000;
a-mouse-HRP 1/2000; a-sheep/goat-HRP 1/15000; ECL detection.
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Figure 4.17
In vitro PKA phosphorylation ofAN-AC fusion proteins:
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Figure 4.17: Representative Western blots comparing non-
phosphorylated and PKA-phosphorylated AN-AC fusion proteins.
In vitro PKA phosphorylation was performed with (phosphorylated) or
without (non-phosphorylated) PKAc. a-V5 detected the proteins at the
appropriate molecular weights (as illustrated below blots (See Figure
3.5)). a-STREX detected fusion proteins expressing the STREX insert
only (AN-STREX-AC, AN-S4A,S869A-AC & AN-STREX,S869A-AC).
STREX S4 phosphorylation, indicated by a-phospho-STREX, was
observed of proteins with intact STREX S4 (AN-STREX-AC & AN-
STREX,S869A-AC). Control thioredoxin-V5-H6 (~16 kDa) was
detected by a-V5 only (Not shown). Western analysis: mouse a-V5
1/5000; sheep a-STREX/a-phospho-STREX 1/1000; a-mouse-HRP
1/2000; a-sheep/goat-HRP 1/15000; ECL detection.
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STREXS4 site phosphorylation (Figure 4.17)
The presence of the STREX insert in AN-STREX-AC, AN-S4A,S869A-AC and AN-
STREX,S869A-AC is confirmed by the specific immunoreactivily of the a-STREX
antibody to these fusion proteins. AN-ZERO-AC (Figure 4.17) and Thioredoxin-V5-H6
(Results not shown) were not detected by this antibody demonstrating the specificity of
the antibody to STREX-insert-containing proteins. Further to this, the immunoreactivity
of a-STREX to phosphorylated AN-STREX-AC and AN-STREX,S869A-AC is reduced
in comparison to the non-phosphorylated reactions. Phosphorylated and non-
phosphorylated AN-S4A,S869A-AC, with the STREX S4 residue substituted by alanine,
are detected equally.
Phosphorylation of STREX S4 is detected by a-phospho-STREX only with the
phosphorylated fusion proteins with intact STREX S4 residues; AN-STREX-AC and
AN-STREX,S869A-AC. These data suggest that PKAc phosphorylates the STREX S4
residue of STREX insert-containing AN-AC fusion proteins in vitro.
In vitro phosphorylation ofthe AN-ACfusion proteins (Figures 4.16 & 4.17)
Thus, Figures 4.16 & 4.17 indicate that the conserved S869 site and the STREX S4
residue are targets of in vitro PKAc phosphorylation of the AN-AC fusion proteins. If
both sites are present, as with AN-STREX-AC, the residues are co-phosphorylated. If
one is absent or mutated, the other will continue to be a PKAc-phosphorylation target,
as illustrated by the S869 site of AN-ZERO-AC, and the STREX S4 residue of AN-
STREX,S869A-AC.
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Concomitantly, these results demonstrate the successful application of the phospho-
specific antibodies; a-phospho-S869 and a-phospho-STREX are immunoreactive to the
phosphorylated forms of the sites only and not when the site(s) are mutated or when the
kinase is omitted and thus phosphorylation cannot have occurred. a-S869 is
immunoreactive to intact, non-phosphorylated S869 sites, although does exhibit a
reduced immunoreactivity against the alanine substituted mutant. a-STREX recognizes
STREX insert-containing AN-AC fusion proteins specifically, whether intact or
expressing the S4A mutation. The immunoreactivity is reduced by phosphorylation of
intact STREX S4 residues and the signal attained with phosphorylated AN-STREX-AC
may result from incomplete PKAc-phosphorylation of the fusion protein population, or
by the incomplete specificity of the a-STREX antibody to the dephosphorylation state of
the STREX S4 residue.
4.2.3.2 Phosphorylation of the AN-AC fusion proteins by other protein kinases
To investigate the protein-kinase specificity of the relative phosphorylation of the S869
and STREX S4 putative phosphorylation sites of the AN-AC fusion proteins, in vitro
phosphorylation assays were performed using PKC and CaMKII.
4.2.3.2.1 PKC phosphorylation of the AN-AC fusion proteins
In vitro PKC-phosphorylation assays using non-radiolabelled ATP were performed on
immunoprecipitates of the AN-AC fusion proteins as described in Section 2.8.1.3.
Control, non-phosphorylation reactions omitting PKC were performed in parallel and
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samples were separated by SDS-PAGE and analysed by Western blotting. A
representative assay is illustrated in Figure 4.18.
Detection by the a-V5 antibody determined the presence of the PKC-phosphorylated
and the non-phosphorylated AN-AC fusion proteins at the appropriate molecular weights
(As described in Section 4.2.3.1.3). Immunodetection with a-phospho-S869 revealed
that the S869 site was not phosphorylated by PKC in any AN-AC fusion protein. In
contrast, although detecting a non-specific protein at -60 kDa in all immunoprecipitates
including that of the control, Thioredoxin-V5-E|6, a-phospho-STREX recognised
phosphorylation of STREX S4 in fusion proteins that expressed the intact, non-mutated
residue; AN-STREX-AC and AN-STREX,S869A-AC. Non-phosphorylated reactions did
not display phosphorylation of the site and neither did AN-AC fusion proteins that do not
express the STREX insert (AN-ZERO-AC) or express an alanine mutation of the STREX
S4 residue (AN-S4A,S869A-AC). This demonstrates that an intact STREX S4 residue is
required for in vitro PKC phosphorylation of the AN-AC fusion proteins and indicates
that although other regions encompassed by the AN-AC fusion proteins may function as
PKC phosphorylation targets, with respect to the conserved S869 site and STREX S4,
PKC does not phosphorylate the S869 residue of the AN-AC fusion proteins in vitro, but
does phosphorylate the STREX S4 site.
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Figure 4.18
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Figure 4.18: Representative Western blots comparing non-
phosphorylated and PKC-phosphorylated AN-AC fusion proteins.
In vitro PKC phosphorylation was performed with (phosphorylated) or
without (non-phosphorylated) PKC. a-V5 detected the proteins at the
appropriate molecular weights (as illustrated below blots (See Figure
3.5)). No phosphorylation of the AN-AC fusion proteins' S869 site is
detected by a-phospho-S869. STREX S4 phosphorylation, indicated by
a-phospho-STREX, was observed of proteins with intact STREX S4
(AN-STREX-AC & AN-STREX,S869A-AC). Control thioredoxin-V5-
H6 (~16 kDa) was detected by a-V5 only (Not shown). Western
analysis: mouse a-V5 1/5000; sheep a-phospho-STREX/S869 1/1000;
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Figure 4.19: Representative Western blots comparing non-
phosphorylated and CaMKIl-phosphorylated AN-AC fusion
proteins. In vitro CaMKII phosphorylation was performed in
activation buffer (phosphorylated), or in the presence of the inhibitory
divalent cation chelator, EDTA (non-phosphorylated). a-V5 detected
the proteins at the appropriate molecular weights (as illustrated below
blots (See Figure 3.5)). S869 phosphorylation, indicated by a-phospho-
S869, was observed of phosphorylated proteins with intact S869 sites
(AN-ZERO-AC and AN-STREX-AC ). No phosphorylation of the AN-
AC fusion proteins' STREX S4 site is detected by a-phospho-STREX.
Control thioredoxin-V5-H6 (-16 kDa) was detected by a-V5 only (Not
shown). Western analysis: mouse a-V5 1/5000; sheep a-phospho-
STREX/S869 1/1000; a-mouse-HRP 1/2000; a-sheep/goat-HRP
1/15000; ECL detection.
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4.2.3.2.2 CaMKII phosphorylation of the AN-AC fusion proteins
In vitro phosphorylation reactions employing non-radiolabelled ATP were performed
using CaMKII activation buffer (Section 2.8.1.4). Control reactions using EDTA in the
buffer were performed in parallel (As described previously, Section 4.2.1.2.2).
Reactions were separated by SDS-PAGE and analysed by Western blotting as illustrated
in Figure 4.19.
The CaMKII-phosphorylated and the non-phosphorylated AN-AC fusion proteins were
detected at the appropriate molecular weights by a-V5 (Described previously: Section
4.2.3.1.3). Only CaMKII-phosphorylated AN-AC fusion proteins with intact S869 sites
were immunoreactive to a-phospho-S869 (AN-ZERO-AC and AN-STREX-AC). EDTA
blocked CaMKII in vitro phosphorylation of the site in the fusion proteins. The inability
of CaMKII to phosphorylate S869 in the alanine-substituted mutants (AN-S4A,S869A-
AC and AN-STREX,S869A-AC) indicates that such a mutation of the conserved site is
sufficient to inhibit in vitro phosphorylation of the residue by CaMKII. Thus, although
other CaMKII consensus phosphorylation sites may be present in the AN-AC fusion
proteins' sequence, S869 is determined as a definite in vitro phosphorylation target.
In contrast, the STREX S4 residue is not an in vitro target of CaMKII phosphorylation
of the AN-AC fusion proteins as no phosphorylation is detected by the a-phospho-
STREX antibody. In this assay, a-phospho-STREX detected non-specific bands at -72
and ~62 kDa in all immunoprecipitates; phosphorylated and non-phosphorylated, AN-
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AC fusions and Thioredoxin-V5-H6. The consistency in the detection of these bands and
their non-alignment to the molecular weights of the AN-AC fusion proteins suggests
non-specific immunoreactivity that did not obstruct detection of STREX S4 site
phosphorylation.
4.2.4 PKA-phosphorylation of HA-tagged BK channel splice variants
HA-tagged full-length BK channel proteins, expressed in HEK293 cells and
immunoprecipitated with the a-HA antibody were used to assess PKA-phosphorylation
of the channel in the in extenso protein and crucially, in vivo.
4.2.4.1 In vitro PKA-phosphorylation of immunoprecipitated HA-tagged BK
channel variants by exogenous PKAc
Washed PGS pellets with bound a-HA-immunoprecipitated HA-tagged BK channel
variants were assayed by in vitro phosphorylation as described in Sections 2.8.1.1 and
2.8.1.2. Immunoprecipitations from untransfected HEK293 cells were treated in parallel
as controls. Reactions were separated by electrophoresis and analysed by
autoradiography when radiolabeled ATP was used in the analysis (Figure 4.20), or by
Western blotting when non-radiolabelled ATP was employed (Figure 4.21).
4.2.4.1.1 Autoradiography (Figure 4.20)
Phosphorylation of proteins corresponding to the molecular weight of the HA-tagged
BK channels was detected for ZERO-HA and STREX-HA in the presence, but not in the
absence of the phosphatase-inhibitor, okadaic acid. Phosphorylation of the mutant,
S4A,S869-HA channel was not observed, and a protein of equivalent molecular weight
197
Chapter Four: Characterisation of the phosphorylation of BK channel splice variants
Figure 4.20
In vitro phosphorylation of HA-tagged, full-length BK
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Figure 4.20: Representative autoradiograph of in vitro PKA
phosphorylation of -HA-tagged BK channel splice variants.
Immunoprecipitated (IP) -HA-tagged BK channel splice variants
(ZERO, STREX & S4A,S869A; as represented below the
autoradiograph (See Figure 3.17)) expressed by HEK293 cells were
phosphorylated by in vitro phosphorylation in the presence of [y-32P]-
ATP & PKAc (10 mins, 30 °C) with (+) or without (-) the phosphatase
inhibitor, okadaic acid. IP HEK293 cells not expressing BK channels
were employed as a control. Assays separated by electrophoresis and
exposed to 32P-sensitive film demonstrated phosphorylation of okadaic
acid-treated ZERO-HA and STREX-HA. Non-specific protein
phosphorylations were detected in all reactions.
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Figure 4.21
In vitro phosphorylation ofHA-tagged, full-length BK
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Figure 4.21: Western blot analysis of PKA phosphorylation of the
S869 site of -HA-tagged BK channel splice variants. In vitro PKA
phosphorylation of immunoprecipitated (IP) -HA-tagged BK channel
splice variants (ZERO, STREX & S4A,S869A; as represented below
the autoradiograph (See Figure 3.17)) was performed with or without
exogenous PKAc in the presence of okadaic acid. a-HA detected the
proteins at the appropriate molecular weights. Non-phosphorylated
ZERO-HA and STREX-HA, and S4A,S869A-HA with a mutated S869
site, were detected by a-S869. S869 site phosphorylation, indicated by
a-phospho-S869, was observed with ZERO-HA and STREX-HA only
even if no exogenous PKAc was added. Western analysis: rabbit a-HA
1/333; sheep a-S869/a-phospho-S869 1/1000; a-rabbit-HRP 1/5000;
a-sheep/goat-HRP 1/15000; ECL detection.
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within the HEK293 cell control immunoprecipitations was not detected. Non-BK
channel protein phosphorylations that could result from phosphorylation of the
immunoprecipitation components, co-immunoprecipitating proteins with affinity for the
BK channels and non-specific co-immunoprecipitants were detected in all reactions
including the non-transfected HEK293 cell controls.
These data suggest that the ZERO-HA and STREX-HA fusion proteins are putative
targets of phosphorylation by exogenous PKAc in vitro, but mutation of the conserved
S869 and STREX S4 residues in the S4A,S869A-HA channel is sufficient to inhibit this
phosphorylation. The necessity of okadaic acid in the reaction mixture to allow this
phosphorylation suggests that a protein phosphatase(s) with the ability to
dephosphorylate the PKA-phosphorylated residues co-immunoprecipitates and is
catalytically active under experimental conditions.
4.2.4.1.2 Western blot analysis (Figure 4.21)
Due to the apparent protein phosphatase activity associated with the immunoprecipitated
BK channels (See above; Figure 4.20), okadaic acid was included in all further in vitro
PKA phosphorylation assays. The phosphorylation state of the BK channel S869 site
was assessed by use of the phospho-specific antibodies to the residue (See Section 3.2.3)
as illustrated in Figure 4.21.
The phosphorylated HA-tagged BK channel variants, ZERO-HA (-125 kDa), STREX-
HA (-132 kDa) and S4A,S869A-HA (-132 kDa), were identified at the appropriate
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molecular weights by the immunoreactivity of a-HA to the -HA epitope tag with
equivalent band densities indicating equal loading of each channel variant. No HA-
tagged proteins were observed in the HEK293 cell immunoprecipitation control.
Similarly, the presence of the S869 site in ZERO-HA and STREX-HA was detected by
a-S869, although no discernable immunoreactivity was observed with the mutated
S4A.S869A-HA.
Phosphorylation of the S869 residue, indicated by the a-phospho-S869 antibody, was
observed with the ZERO-HA and STREX-HA channels that express an intact S869 site.
However, the antibody did not detect S4A,S869A-HA with the S869A mutation
indicating that an intact S869 site is required for phosphorylation by PKAc. However,
phosphorylation of the S869 residue of ZERO-HA and STREX-HA is observed when no
exogenous kinase is added to the immunoprecipitations. This suggests that the site may
be phosphorylated in vivo and remain so during immunoprecipitation, or that a
serine/threonine PKA-like protein kinase associates by co-immunoprecipitation with the
channels and is activated by the in vitro phosphorylation assay conditions.
STREX S4 site phosphorylation
Equivalent analysis of STREX S4 site phosphorylation was not possible due to non¬
specific immunoreactivity of the a-phospho-STREX with the full-length BK channel
fusion proteins (Results not shown). The antibody detected the ZERO-HA channel that
lacks the STREX insert and thus cannot exhibit STREX S4 phosphorylation. A distinct
conformation of the region in the full-length channel protein in comparison with the
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recombinant -GST and AN-AC fusion proteins may inhibit the correct antigen-antibody
association and, certainly, a-phospho-STREX is interacting non-specifically with a
region(s) of the BK channel protein that is conserved between the ZERO and STREX
splice variants.
4.2.4.2 PKA-phosphorylation of immunoprecipitated HA-tagged BK channel
variants by endogenous PKAc
As described in Section 2.8.2, determination of the in vivo phosphorylation of the
conserved S869 site of ZERO-HA and STREX-HA was performed by stimulation of
endogenous PKA in the heterologous expression system, HEK.293 cells, by 30 pM
forskolin (Results not shown) or 1 mM of membrane permeable 8-CPT-cAMP in the
presence or absence of 100 nM okadaic acid. Controls were performed in parallel with
okadaic acid only and with no reagent addition. Channels were immunoprecipitated
using a-HA and phosphorylation of the S869 site assessed by Western blot analysis. A
representative assay using 8-CPT-cAMP as the PKA-stimulator is illustrated in Figure
4.22.
Successful immunoprecipitation of the channels was confirmed by the immunoreactivity
of a-HA to proteins corresponding to ZERO-HA, -125 kDa, and STREX-HA, ~ 132
kDa. Further to this, the intact, conserved S869 site was identified in each splice variant
immunoprecipitation by a-S869. Phosphorylation of S869, detected by a-phospho-
S869, revealed that the phosphorylated form of the motifwas present under all
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Figure 4.22
PKA stimulation in vivo: Phosphorylation of heterologously






















Figure 4.22: Western blot analysis of BK channel splice variants
expressed in PKA-stimulated HEK293 cells. Heterologously
expressed ZERO-HA or STREX-HA channels were incubated (20
mins, 37 °C) in the presence or absence of the PKA-stimulator, 1 mM
8-CPT-cAMP, with or without 100 nM okadaic acid (phosphatase
inhibitor) prior to immunoprecipitation. The channels were detected by
a-HA and a-S869. Following PKA stimulation by 8-CPT-cAMP there
was an apparent increase in phosphorylation of the S869 site,
demonstrated by a-phospho-S869 antibody analysis. Western analysis:
rabbit a-HA 1/333; sheep a-S869/a-phospho-S869 1/1000; a-rabbit-
HRP 1/5000; a-sheep/goat-HRP 1/15000; ECL detection.
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experimental conditions with both the ZERO and STREX splice variants. However,
stimulation of PKA by 8-CPT-cAMP, especially where protein phosphatase activity was
inhibited by okadaic acid, produced an increase in the phospho-S869 signal suggesting
that PKA phosphorylation of the site occurs following stimulation of the kinase. This
implicates the conserved BK channel S869 site of ZERO and STREX splice variants as
a target of PKA phosphorylation in vivo.
4.3 Discussion
Protein kinase and protein phosphatase regulation of ion channels has been studied and
described for numerous ion channels including the ubiquitous BK channels (See Section
1.4.1). The precise molecular mechanism of such regulation varies between direct
phosphorylation/dephosphorylation of the ion channel a-subunit protein and
activation/inactivation of intermediate, accessory proteins that, in turn, control the
required physiological response of the ion channels. Previous electrophysiological
analyses of various mutated BK channel variants have proposed that PKA
phosphorylates the a-subunit of the channel directly at precise consensus motifs [190,
205, 229], Through such studies the conserved BK channel S869 residue and,
independently, the STREX splice variant S4 residue have been proposed as integral sites
in the PKA-mediated regulation of BK channel function through direct phosphorylation
by the kinase. The aim of this chapter was to determine whether these residues are,
indeed, phosphorylated directly by PKA in vivo, and to investigate whether such
phosphorylation may underlie PKA-mediated regulation of BK channel splice variants.
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The in vitro and in vivo phosphorylation data presented in this study demonstrate that the
two residues are phosphorylated by PKA in vivo, and suggest that the residues are co-
phosphorylated by the kinase in the STREX splice variant channel.
4.3.1 Phosphorylation of the conserved BK channel S869 residue
The ability of PKA to target and phosphorylate the conserved S869 motif directly and
specifically was demonstrated by in vitro phosphorylation of the S869 peptides and
phospho-specific antibody identification of S869 phosphorylation in vitro, with the AN-
AC fusion proteins, and in vivo, with the -HA-tagged, heterologously expressed, full-
length channels.
In all assays, the substitution of the S869 residue with non-phosphorylatable alanine was
sufficient to preclude phosphorylation of the fusion proteins, demonstrating that this
serine residue is phosphorylated specifically by PKA. Although, as with any
mutagenesis, alanine substitution could induce conformational alterations to the fusion
protein as to inhibit phosphorylation of other, distinct sites, the conserved nature of this
mutation should minimise such structural disruptions (See Section 4.1.2). Thus, the
mutations were used to demonstrate that the S869 residue is phosphorylated directly by
PKA both in vitro and in vivo. Further to this, the reversibility of S869 peptide
phosphorylation by PP2A and PP1 demonstrated that the process is reversible and thus
may be employed functionally in vivo.
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Stimulation of endogenous HEK293 cell PKA and the addition of excess exogenous
PKAc increased the apparent S869 residue phosphorylation determined by a-phospho-
S869 Western blot analysis. Under both assay conditions basal levels of S869
phosphorylation were observed prior to or without the addition/stimulation of the kinase.
This indicates that the site functions as a phosphorylation target under basal conditions
in HEK293 cells, indicative of native PKA-like protein kinase activity in the
heterologous expression system. In vitro phosphorylation assays using the S869
peptides and AN-AC fusion proteins revealed that the site could be phosphorylated by
PKA or CaMKlI in vitro, and thus, indicated that multiple protein kinases may be
responsible for basal phosphorylation of S869. However, S869 displays some selectivity
as PKC did not phosphorylate the site in vitro and thus, is unlikely to phosphorylate
S869 in vivo. The S869 motif shares limited homology with optimal consensus motifs
for PKA, PKC and CaMKIl (Scheme 4.2). However, the specificity of the kinases is
such that PKC cannot phosphorylate the site in vitro. Although complex, future studies
could investigate multi-sourced phosphorylation of S869 by inhibition and stimulation
of specific protein kinases in vivo, and may uncover a phosphorylation target site, used
by several, distinct signal transduction pathways collectively and individually.
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Scheme 4.2: Alignment of the conserved BK channel S869 motifwith protein kinase
consensus sequences
(Although several possible consensus sequences are suitable for phosphorylation by the
kinases (See Table 1.1), only the consensus sequence with the greatest alignment to the
motif is shown). Green residues = alignment. Red residues = non-alignment. Standard
one letter amino acid code used.
Motif/Consensus Residues Motif = In vitro
sequence consensus phosphorylation
S869 motif L R Q p S869 - -
PKA consensus - R X X s YES YES
PKC consensus " R X X s YES NO
CaMKll consensus X R X X s YES YES
4.3.1.1 Regulatory significance of S869 residue phosphorylation
Such direct and specific PKA-phosphorylation of the conserved S869 residue of the
ZERO BK channel splice variant has distinct implications upon the molecular
mechanism of splice variant regulation by the kinase. The data accumulated in this
chapter proposes that following the in vivo, physiological, signal transduced elevation of
intracellular cAMP that activates PKA (See Appendix A), target substrates including the
conserved S869 residue of BK channels are phosphorylated. This specific catalysis is
suggested to stimulate and underlie the cAMP-induced activation of heterologously
expressed ZERO BK channel splice variant that has been observed previously [229].
This is proposed due to the lack of additional PKA phosphorylation consensus motifs in
the ZERO splice variant and the increased S869 site phosphorylation that follows
addition and stimulation of exogenous PKAc. Additionally, the block of cAMP-
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mediated stimulation of heterologously expressed ZERO BK channels that has been
described in previous mutagenesis studies and phosphorylation investigations of the
equivalent motif of Drosophila BK channels [190, 202, 205, 229] suggests that this
highly conserved PKA consensus motif may be phosphorylated in ZERO splice variant
BK channels in other, even non-mammalian, species.
Phosphorylation ofthe conserved S869 residue in STREXBK channels
The determination of the conservation of the S869 site as a PKA phosphorylation target
in STREX channels was observed in vitro with the AN-AC fusion proteins, and in vivo
with the HA-tagged channels. In the presence of the STREX insert, S869 was
phosphorylated consistently by PKA: in vitro AN-STREX-AC (Figure 4.16), in vivo
STREX-HA (Figure 4.21). However, the distinct responses of the STREX and ZERO
BK channel splice variants to PKA regulation; heterologously expressed ZERO channels
are activated. STREX channels are inhibited [80, 229], implies that the STREX insert
influences the functional effect of the kinase upon the channel through a molecular
mechanism that is distinct from/additive to S869 residue phosphorylation.
Heterologous expression of STREX-insert expressing channels with alanine substitution
of the S869 residue has demonstrated that such S869A mutation does not impinge upon
the inhibitory effect of PKA on STREX BK channel activity [229], This contrasts the
equivalent S869A mutation of the ZERO channel where PKA-mediated stimulation of
the splice variant is prevented by the substitution [229], Thus, although the STREX
channel S869 residue is phosphorylated by PKA in vivo (Figure 4.21), it appears that its
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phosphorylation may not be necessary to the inhibitory effect of PKA upon STREX
channels. Thus, the presence of the STREX insert does not appear to conformationally
nor competitively inhibit the phosphorylation of the conserved S869 residue and thus,
inhibition of S869 site phosphorylation does not underlie the differential responses of
the STREX and ZERO BK channel splice variants in vivo.
4.3.2 Phosphorylation of the STREX insert S4 residue
The data presented in this thesis suggest that the S4 residue of the STREX insert
sequence is a target of PKA phosphorylation in vitro and thus, a putative PKA
phosphorylation target in the in extenso STREX channel in vivo. PKA phosphorylation
of the site was determined with the STREX insert-expressing GST- and AN-AC fusion
proteins via autoradiography and the use of phospho-specific antibodies to STREX S4 in
combination with mutagenesis of the residue. As such, mutation of the residue by
substitution with unphosphorylatable alanine inhibited in vitro PKA-phosphoryiation of
the STREX insert sequence of GST-S4A (Figures 4.6 & 4.7) and AN-S4A,S869A-AC5
(Figures 4.15 & 4.17).
The 29 kDa GST-STREXproteolytic degradation product
lntriguingly, an artefact of the purification protocol that was initially undesired provided
further evidence of the serine-4 site providing the phosphorylation target in GST-
STREX. Preliminary characterisation of -29 kDa proteolytic fragments observed
following purification of GST-STREX and GST-S4A (Section 3.2.1.1.3) illustrated that
5 The phosphorylation of the S869 site, which is mutated in this fusion protein also, is
discussed in Section 4.3.1.
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these proteins encompassed the GST tag, or at least the epitope to the a-GST antibody,
yet running slightly higher than the 28 kDa GST protein, were not contamination from
the fusion tag. The lack of a-STREX-1 immunoreactivity, whose epitope is located
between residues 27-43 of the insert sequence (Table 2.4 & See Figure 1.6),
demonstrated that the fragments did not comprise the STREX insert sequence in its
entirety (Figure 3.5). However, the immunoreactivity of a-STREX to the ~29 kDa
proteins suggests that they encompass the region at the N-terminal of the STREX insert
sequence, at least up to the a-STREX epitope, residue 9, as illustrated in Figure 4.23.
Investigation of the STREX insert sequence uncovers several putative protease target
sites that may be incised including trypsin and chymotrypsin recognition sites. Thus,
proteolytic degradation may have occurred even with the anti-proteolytic measures used;
the array of protease inhibitors used in the purification, the choice of E.coli strain for
expression, and controlled temperatures for protein induction and purification. The
differential immunoreactivity of a-STREX and a-STREX-1 to the -29 kDa fragments
implicates a fragmentation point between their epitopes. However, additional
proteolytic cleavage targets may be present within the GST-fusion tag sequence, prior to
the epitope of the a-GST antibody. Although the absence of proteolytic fragments of
the control GST protein does argue against this, as mentioned previously, the creation of
a fusion protein can influence the structure of the tag and, therefore, conformational
alterations that render protease targets that are inaccessible in GST available within the
fusion protein are possible.
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The phosphorylation of the -29 kDa proteolytic fragment was apparent by
autoradiography and Western blot analyses (Figures 4.6 & 4.7). As its
immunocharacterisation demonstrates that it encompasses the residues at the beginning
of the STREX motif near the GST:STREX interface only, these residues are implicated
as phosphorylation targets of PKAc. Serine-4 at the start of the STREX insert sequence
is, therefore, a prime candidate for PKA phosphorylation, reiterating the
autoradiographic mutagenesis results and validating the use of the a-phospho-STREX
antibody with this fusion protein.
Assessment ofSTREXS4 phosphorylation
Indeed, use of the a-phospho-STREX antibody confirmed in vitro PKA-phosphorylation
of the STREX S4 residue in the AN-STREX-AC and AN-STREX,S869A-AC fusion
proteins (Figure 4.17) as well as in the -35 kDa full-length GST-STREX (Figure 4.7B)
and its -29 kDa proteolytic fragment (Figure 4.7A). Although the specificity of the
antibody with the full-length channel HA-fusion proteins was not sufficient to enable
assessment of the phosphorylation state of the site in vivo, the in vitro results suggest
that the site is likely to function as a PKA phosphorylation target in native, in vivo
STREX channels. Future investigations may be able to confirm this, but the proposition
of STREX S4 site phosphorylation produces a possible mechanism for the distinct
inhibition ofSTREX BK channel activity by PKA.
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Figure 4.23
Characterisation of the -29 kDa proteolytic fragment of
the GST-STREX fusion proteins
-35 kDa






Figure 4.23: Diagrammatic representation of the proposed
character of the ~29 kDa proteolytic fragment of the GST-STREX
fusion proteins. The a-GST and a-STREX antibodies detect proteins
of ~35 and -29 kDa, whereas a-STREX-1 detects full-length -35 kDa
fusion proteins only. The approximate locations of the respective
antibody epitopes are illustrated (Epitopes: a-STREX-1; STREX insert
residues 27-43 & a-STREX; 5 residues pre-STREX to STREX insert
residue 9: See Table 2.4). The positions suggest that a single
proteolytic cleavage occurs at a point following the phosphorylatable
STREX S4, producing the -29 kDa protein. However, the STREX
sequence contains several putative proteolytic fracture points as does
GST and thus, several proteolytic degradation products are possible.
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Specificity ofSTREXS4 phosphorylation
In vitro phosphorylation assays using the GST-STREX and AN-AC fusion proteins
determined that the STREX S4 site could be phosphorylated by PKA or PKC but not
CaMKll in vitro. The alignment of the PKC consensus sequence is sufficient to enable
the kinase to target and phosphorylate the site successfully, perhaps due to the inclusion
of the lysine residue (Scheme 4.3). On the other hand, the specificity ofCaMKll is such
that the kinase cannot phosphorylate STREX S4. Thus, similarly to the conserved S869
residue, STREX S4 may function as a phosphorylation target following the activation of
multiple, distinct serine/threonine protein kinases. The influence of various protein
kinases upon STREX BK channel regulation and particularly, STREX S4 site
phosphorylation will be an interesting area of future investigation.
Scheme 4.3: Alignment of the STREX insert S4 motif with protein kinase consensus
sequences
(Although several possible consensus sequences are suitable for phosphorylation by the
kinases (See Table 1.1), only the consensus sequence with the greatest alignment to the
motif is shown). Green residues = alignment. Red residues = non-alignment. Standard
one letter amino acid code used.
Motif/Consensus Residues Motif = In vitro
sequence consensus phosphorylation
STREX S4 motif R R P K M S4 - -
PKA consensus - - K M s YES
PKC consensus - R K X s YES YES
CaMKll consensus - X R X X s NO NO
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Additional PKA consensus motifs created by STREX insertion
Analysis of the protein sequence of the STREX BK channel splice variants uncovers
several putative PKA consensus motifs in addition to the conserved S869 and STREX
S4 residues that may be in vivo phosphorylation targets of the kinase. Mutation of S869
and STREX S4 in the AN-S4A,S869A-AC and S4A,S869A-HA fusion proteins
prevented radiolabeled phosphate incorporation within the limits of detection following
in vitro phosphorylation and autoradiographic detection (Figures 4.14 & 4.20).
Although mutagenesis may have altered the protein structure as to make additional
consensus motifs inaccessible to phosphorylation the similar conformation of the
substitution makes this unlikely (Discussed Section 4.E2). Thus, the data suggest that
these sites are the only residues in the STREX channel phosphorylated by PKA in vivo.
4.3.2.1 Regulatory significance of STREX insert S4 residue phosphorylation
The phosphorylation of the STREX insert S4 residue by PKA is therefore proposed to
underlie the inhibitory effect of the kinase upon activity of the STREX BK channel
splice variant. By the insertion of this additional phosphorylation consensus motif in
STREX splice variants compared to the ZERO channels, the influence of PKA upon
channel activity is altered leading to inhibition instead of the stimulatory effect of PKA
upon ZERO splice variants.
The results presented in this study suggest that PKA phosphorylation of the STREX
insert S4 residue is critical to the differential regulation of the splice variant by the
kinase, and that this phosphorylation must functionally dominate that of the conserved
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S869 site. The STREX S4 residue is common to all mammalian BK channel STREX
splice variants and previous studies on the rat STREX BK channel demonstrated that
PKA-inhibition is conserved [251], Thus, phosphorylation of the STREX S4 site by
PKA may be a common regulatory mechanism that is conserved throughout all such
mammalian channels and not specific to the murine system. Future investigations of
STREX splice variants from other species will be required to confirm this assumption.
4.4 Chapter Summary
This chapter has investigated the phosphorylation of BK channel splice variants by PKA
and has characterised the conserved S869 site and the STREX insert S4 residue as
targets of PKA in vitro. Radiolabeled phosphate incorporation and Western blot
analyses demonstrated that the S869 residue is a PKA phosphorylation target in vitro
and in vivo, with its phosphorylation most likely underlying the stimulatory effect of
PKA on ZERO BK channels. The residue may act as a phosphorylation motif for
CaMKll also, but not for PKC, and its PKA-phosphorylation is conserved in STREX
channels. However, the co-phosphorylation and suggested functional dominance of the
STREX insert S4 residue is proposed to confer the distinct inhibitory action of PKA on
STREX channel activity in vivo. Additionally, STREX S4 may be phosphorylated by
PKC, but not by CaMKll.
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5.1 Introduction
5.1.1 The Ion Channel Complex
5.1.1.1 Accessory proteins
Accessory proteins, distinct from the pore-forming subunits, are critical to the
physiological effectiveness of ion channel regulation. These include channel specific
subunits, such as the BK channel (3-subunit, and multi-targeted enzymes, including
protein kinases and protein phosphatases, which influence ion channel regulation by
altering channel properties including gating, calcium sensitivity and open probability
(See Section 1.5). Stimulation of signal transduction pathways may regulate such
accessory proteins in order to induce the appropriate physiological response through the
pore-forming subunit. Thus, the accessibility and proximity of accessory proteins to
their target ion channel is crucial to the efficiency and effectiveness of ion channel
function. Indeed, the regulatory effects of phosphorylation continue to occur following
reconstitution of BK channels into artificial lipid bilayers where no exogenous protein
kinase or protein phosphatase is applied [193, 204], This suggests a close association of
such regulatory enzymes with the ion channel reiterated by the observation of direct
association of the catalytic subunit of protein kinase A (PKAc) with the Drosophila BK
channel a-subunit [142, 204], This suggests that a regulatory complex where the BK
channel a-subunit functions as a "scaffold" to various regulatory accessory proteins may
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exist, facilitating the dynamic regulation of BK channel function [142, 194, 204].
Therefore, this chapter aims to determine whether PKAc associates with the mammalian
BK channel a-subunit contributing to a regulatory ion channel complex, and to
investigate the nature and character of such an association.
5.1.1.2 Splice variation
The differential regulation of the STREX and ZERO BK channel splice variants by PKA
was hypothesised to be due to distinct PKA phosphorylation consensus motifs (Chapter
4), or differences in the association of PKA with the two variants (See Chapter 1).
Comprising 58 residues, the STREX insert is of substantial length and encompasses
several residues including prolines, cysteines, aromatic and charged amino acids (See
Figure 1.6), that impose conformational constraints upon proteins; proline due to its
cyclic pyrrolidine side chains, aromatic residues due to their bulk, and cysteines due to
their ability to form disulphide bridges. Charged residues may influence local or general
charge and thus influence associations of channel regions or other related proteins.
Therefore, the presence of the insert may influence the structure and associations of the
STREX a-subunit C-terminal region conformationally or electrostatically making it
different to that of the ZERO variant. Consequently, binding sites for protein kinases or
associated proteins involved in phosphorylation-mediated regulation of the channel may
be distinct to each splice variant. The STREX insert itself may occlude a protein-
docking site employed in the ZERO variant or produce an additional binding site
resulting in the differential regulation of the two splice variants to PKA. Therefore, to
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determine whether PKAc association with the BK channel is influenced by STREX
insertion, co-immunoprecipitation of PKAc with the STREX and ZERO -HA-tagged
proteins was compared. Encompassing the STREX insert sequence in isolation (See
Figure 3.1) the GST-STREX fusion protein was used to assess whether the STREX
insert itself could function as a PKAc binding site. The longer AN-STREX-AC and AN-
ZERO-AC fusion proteins of the C-terminal tail region (See Figure 3.1) were employed
to determine if the possible association of the kinase with this region is influenced by
splicing.
5.1.1.3 Leucine zippers
Leucine zippers are a common motif constituting a repeating sequence where every
seventh residue is a leucine or isoleucine [218, 326]. Originally characterised in DNA-
regulatory proteins such as transcription factors and proto-oncogene products, the motif
is known to enable protein dimerisation inducing the formation of a protein a-helical
structure that "clasps" the DNA double helix to exert transcriptional control [214, 218,
327-330], The efficiency and effectiveness of this interaction is well documented and
recently the exploitation of the motif in forming protein-protein interactions between
non-DNA binding proteins has been advocated [318]. Indeed, recently several ion
channels have been proposed to assemble with regulatory complexes via leucine zipper
interactions [331, 332],
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Sequence analysis of the BK channel a-subunit identifies two putative leucine zippers;
one proximal to the tetramerisation domain at the transmembrane-cytoplasmic C-
terminal domain interface, leucine zipper 1, and the second between the S869
phosphorylation site and the putative S10 a-helix, leucine zipper 2, as shown in Figure
3.1. To determine whether these motifs are involved in the association of PKAc with the
BK channel protein, the association of the kinase with the AN-AC fusion proteins that
encompass the leucine zipper 2 motif was investigated. The putative influence of
leucine zipper 1 was investigated by the study of competing peptides equivalent to the
LZ1 sequence upon the association of the kinase with STREX-HA channels. Further to
this, the effect of leucine zipper 1 mutation upon channel-PKAc association was
investigated via co-immunoprecipitation assays using the mLZl-HA channel (See
Figure 3.13), as well as implementation of the Thio-LZl and Thio-mLZl fusion proteins
that express the motif sequence in isolation (See Figure 3.7). Thus, the characterisation
of the association of PKAc with the BK channel protein was studied.
5.1.2 Heteromultimerisation
Although using a distinct conserved RCK domain to assemble multimers (See Section
1.3.2.2.3), BK channels form functional ion channel pores by the tetramerisation of a-
subunits in common with other members of the Kv channel superfamily. Rather than
forming only homomultimers composed of four identical a-subunits, several examples
of members of the Kv channel family forming functional heteromultimeric tetramers
within their subfamily have been described ([150-154] Reviewed: [2,3,155]). Subtle
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differences between the regulatory and functional properties of heteromultimeric
channels and their homomultimeric counterparts increases the functional diversity of an
ion channel subfamily and may be invaluable in situations such as the cochlea where
slight differences in channel properties may be essential to their physiological role.
Previous electrophysiological investigations have described heterologous expression of
STREX and ZERO BK channel splice variants [84, 89, 229], However, in the native
system both variants may be co-expressed in the same cell. To examine if
heteromultimerisation occurs in vivo, preliminary analysis was performed by the
heterologous co-expression and assessment of co-immunoprecipitation of STREX and
ZERO channels with different epitope tags (Section 5.2.2).
5.1.3 Affinity pull-down techniques
Protein-protein associations, between PKAc and channel proteins and between distinct
BK channel a-subunit splice variants, were performed by biochemical affinity pull¬
down or co-immunoprecipitation assays. These techniques involve the immobilisation
of the protein of interest to an insoluble matrix, achieved by the binding of antibodies
directed against the protein of interest to protein-G-sepharose as co-immunoprecipitation
assays, or binding of GST-STREX to glutathione sepharose for biochemical affinity
pull-down assessment of the fusion protein. Thus, following incubation of the protein of
interest with a protein solution, unbound proteins can be washed from the matrix whilst
those associating with the protein of interest are bridged to the matrix and therefore, can
be isolated by extracting the matrix or by altering binding conditions to remove the
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associating proteins (See Figure 2.2). The resulting eluate or immunoprecipitation can
then be assessed by Western blot analysis to determine the presence, or indeed the
absence, of a particular associating protein.
Therefore, the aim of this chapter is to investigate the BK channel complex by affinity
pull-down and co-immunoprecipitation techniques to attempt to characterise the
association of PKAc with the BK channel a-subunit, and to determine whether BK
channels may form heteromultimeric channels of STREX and ZERO splice variants.
5.2 Results
5.2.1 PKAc interaction with BK channels
Investigation of the interaction of the catalytic subunit of protein kinase A with splice
variants of the BK channel was performed initially using full-length, HA-tagged
channels to determine if interaction occurs in vivo, then with the bacterially-expressed
fusion proteins to characterise the region and mode of the kinase association with the ion
channel.
5.2.1.1 PKAc interaction with HA-tagged BK channels
Stable cell lines of STREX-HA and ZERO-HA splice variants and the mutant S4A-
S869A-HA channel (described in Section 3.2.2) were transfected with PKAc or the
catalytically inactive PKAc-K72E mutant to ensure an excess of free catalytic subunit
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(Section 2.6.2). Controls of untranfected HEK293 cells and the cell line transfected with
excess PKAc were performed in parallel, in addition to controls of HEK293-expressed
mLZ-HA (Discussed Section 5.2.1.4.2) and the voltage-gated Kvl.4-HA channel, that is
structurally analogous to BK channels through the central pore-forming domain (See
Section 1.3.2.1). As described in Section 2.6.3, cultures were harvested and the whole
cell lysate halved for immunoprecipitation by a-HA or a-PKAc antibodies. Samples of
whole cell lysate and immunoprecipitations were analysed by Western blotting probing
for HA-tagged channels and free PKAc. A representative assay is illustrated in Figures
5.1, 5.2 & 5.3.
HEK293 cells do not express endogenous FIA-tagged protein, but express PKAc in
sufficient quantities to enable its detection by immunoblotting. Although co-
immunoprecipitation of this endogenous PKAc with the channels occurred (Figure 5.1),
levels were near to the limit of detection. This may be due to the high level of channel
over-expression in comparison with endogenous PKAc expression and may reflect the
proportion of PKAc bound to the channel with respect to PKAc in complex with other
proteins and regulatory components. Thus, to increase the overall concentration of free
PKAc and thus facilitate detection of channel-kinase co-immunoprecipitation, further
analyses were performed with HEK293 cells transfected with excess PKAc. As such,
the —HA-tagged channels and PKAc/PKAc-K72E were detected in the whole cell lysates
demonstrating successful expression of the proteins (Figures 5.1, 5.2 & 5.3).
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Figure 5.1
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Figure 5.1 Representative Western blot analysis of the co-
immunoprecipitation of HA-tagged BK channel splice variants with
PKAc. Stable cell lines of ZERO-HA, S4A-S869A-HA, STREX-HA
BK channel variants (illustrated below blots, See Figure 3.13) and
control Kvl.4-HA channels were transfected with excess free PKAc and
immunoprecipitated (IP) by a-HA antibody. HEK293 cell controls were
run in parallel. HA-tagged BK channels and PKAc, detected in whole
cell lysates, co-immunoprecipitated. PKAc did not co-
immunoprecipitate with Kvl.4-HA* and did not pull down non-
specifically with a-HA IP of HEK293 cells. Western blot analysis:
sheep a-PKAc 1/5000, rabbit a-HA 1/333, a-sheep-HRP 1/2000, a-
rabbit-HRP 1/2000, ECL detection.
*Kvl.4-HA data provided by Irwin Levitan and Yi Zhou. Channels
were successfully immunoprecipitated and channels & PKAc detected
in whole cell lysate (Results not shown).
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Figure 5.2




















































—ZB^nnnp — IIm mi - i mi mi i-D
A A
S4AS869A
Figure 5.2: Representative Western blot analysis of the co-
immunoprecipitation of HA-tagged BK channel splice variants with
PKAc. Stable cell lines of ZERO-HA, S4A-S869A-HA, STREX-HA
BK channel variants (illustrated below blots, See Figure 3.13) and
control mLZ-HA potassium channels (See Figure 5.10) were
transfected with excess free PKAc and immunoprecipitated (IP) by a-
PKAc antibody. HEK293 cell controls were run in parallel. HA-tagged
BK channels and PKAc, detected in whole cell lysates, co-
immunoprecipitated. Control mLZ-HA channels did not co-
immunoprecipitate with PKAc. Western blot analysis: sheep a-PKAc
1/5000, rabbit a-HA 1/333, a-sheep-HRP 1/2000, a-rabbit-HRP
1/2000, ECL detection.
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Figure 5.3
Co-immunoprecipitation of the STREX-HA channel with

































Figure 5.3: Western blot analysis of co-immunoprecipitation
assays of STREX-HA with the catalytically inactive PKAc-K72E.
Whole cell lysates from STREX-HA stable cell lines (illustrated below
blots, See Figure 3.13) and control Kvl.4-HA channels, transfected
with excess free, mutant PKAc-K72E were immunoprecipitated (IP)
by either a-PKAc or a-HA. HEK293 cell controls were run in parallel.
STREX-HA channels and PKAc-K72E, detected in lysates, co-IP
together by a-PKAc and a-HA IP. PKAc did not co-IP with Kvl .4-HA
and did not pull down with a-HA IP of HEK293 cells. Western blot
analysis: sheep a-PKAc 1/5000, rabbit a-HA 1/333, a-sheep-HRP
1/2000, a-rabbit-HRP 1/2000, detection by ECL.
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Immunoprecipitation by a-HA pulled down all types of -HA-tagged channel and co-
immunoprecipitation of PKAc is observed with the BK channel variants, STREX-HA,
ZERO-HA and S4A-S869A-HA (Figure 5.1). Reciprocal co-immunoprecipitation of the
-HA-tagged BK channels occurred when the a-PKAc antibody is used to pull down
PKAc from the cellular lysate (Figure 5.2), and no difference is detected where PKAc-
K72E is transfected in place of PKAc (Figure 5.3). Immunoprecipitation by a-HA did
not pull down PKAc in the absence of the BK channels (Figure 5.1), nor was co-
immunoprecipitation observed with the control channels, Kvl.4-HA and mLZ-HA (See
Section 5.2.1.4.2) (Figures 5.1 & 5.2). This indicates that non-specific associations with
the PGS, the antibodies, the HA-tag, or another associating protein do not occur under
the immunoprecipitation conditions, and that co-immunoprecipitation is specific and not
due to the over-expression of non-HEK293 cell-native potassium channels. Thus, this
suggests that the STREX and ZERO BK channels may associate with PKAc in vivo and
that this association does not depend upon the phosphorylation of the channel protein at
sites identified in Chapter 4, as illustrated by the S4A-S869A-HA channel, or the
catalytic competence of the kinase, as suggested by the PKAc-K72E mutant.
5.2.1.2 PKAc interaction with the GST-STREX fusion protein
Investigation of association between PKAc and the STREX insert was performed using
the GST-STREX fusion protein described in Section 3.2.1.1. GST-STREX was retained
bound to glutathione-sepharose matrix and incubated with purified PKAc, HEK293 cell
lysate or rat brain lysate in affinity pull-down assays with control, GST protein, assays
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Figure 5.4
Affinity pull-down assays of GST-STREX fusion protein:
assessment of PKAc association













































Figure 5.4: GST-STREX affinity pull-down assays with analysis of
PKAc association. GST-STREX and control GST protein (illustrated
below the blots, see Figure 3.2) bound to glutathione-sepharose
matrices were incubated with purified PKAc (A), rat brain lysate (B),
or HEK293 cell lysate (C) in affinity pull-down assays. Proteins with
affinity for GST-STREX or GST were eluted by high salt buffer and
the presence of PKAc analysed by Western blotting. Numbering 1-4
indicates separate elutions. No association of the kinase with the GST-
STREX fusion protein was observed. The binding of GST-
STREX/GST to the matrix was confirmed by Coomassie staining of
matrix samples as illustrated in Figure 3.3. Western blot analysis:
sheep a-PKAc 1/5000, a-sheep-HRP 1/2000, detection by ECL.
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Figure 5.5
Affinity pull-down assays of GST-STREX fusion protein:
assessment of total bound protein
GST-
GST STREX
Input: Rat brain lysate
GST-STREX ■■■■■■
GSTBHM
Figure 5.5: Silver stain analysis of affinity pull-down assay of rat
brain proteins bound to GST-STREX. GST-STREX and control
GST protein (illustrated below the gel, see Figure 3.2) bound to
glutathione-sepharose matrices were incubated with rat brain lysate in
affinity pull-down assays. Proteins with affinity for GST-STREX or
GST were eluted by high salt buffer and analysed by Silver staining.
Several proteins associated with GST and GST-STREX. Some proteins
appear to have affinity for GST-STREX and not the control GST.
These have yet to be identified. The binding of GST-STREX/GST to
the matrix was confirmed by Coomassie staining of matrix samples as
illustrated in Figure 3.3.
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performed in parallel (Section 2.9.2). Proteins bound to the GST-STREX or GST were
eluted by a high salt buffer, concentrated, separated by electrophoresis on Tris-Glycine
gels and analysed by Silver staining and by Western blotting to investigate the
association of PKAc (Sections 2.7.1 and 2.7.2). The analyses of such assays are
illustrated in Figure 5.4 with a Silver stain demonstrating the resultant affinity pull-down
of proteins from rat brain lysate shown in Figure 5.5.
GST-STREX did not associate with purified PKAc or PKAc from HEK293 cell or rat
brain lysates (Figure 5.4). Although the kinase did not associate, other proteins did and
were detected by Silver stain analysis (Figure 5.5). Characterisation of these proteins is
yet to be performed although their presence indicates that the assay conditions are
favourable for protein-protein interactions.
5.2.1.3 PKAc interaction with the AN-AC fusion proteins
The AN-AC recombinant fusion proteins encompass a region of the C-terminal domain
of the BK channel that spans the splice site two region, the location of the STREX
insert, and the putative leucine zipper 2 motif as illustrated in Section 3.2.1.2. To
determine if PKAc association with the channel occurs via this region, AN-ZERO-AC
and AN-STREX-AC fusion proteins immunoprecipitated by the a-V5 antibody were
incubated with purified PKAc or rat brain lysate (As Section 2.9.3). Equivalent
treatment of control thioredoxin-V5-H6 was performed in parallel.
Immunoprecipitations were separated by electrophoresis and analysed by Colloidal stain
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Figure 5.6
Co-immunoprecipitation assays of AN-AC fusion proteins:
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Figure 5.6: AN-AC fusion protein co-immunoprecipitation assays
with analysis of PKAc association. AN-ZERO-AC, AN-STREX-AC
and control Thioredoxin-V5-H6 (illustrated below the blots, see Figure
3.7) were immunoprecipitated (IP) by a-V5/protein-G-sepharose and
incubated with purified PKAc or rat brain lysate. The co-
immunoprecipitation of PKAc was analysed by Western blotting. No
association of the kinase with the AN-AC fusion proteins was observed.
AN-ZERO-AC and AN-STREX-AC were detected at the appropriate
molecular weights (-65 & -70 kDa respectively). Western blot
analysis: sheep a-PKAc 1/5000, mouse a-V5 1/5000, a-sheep-HRP
1/2000, a-mouse-HRP 1/2000 detection by ECL.
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Figure 5.7
Co-immunoprecipitation assay ofAN-STREX-AC fusion




















Figure 5.7: Colloidal stain analysis of affinity pull-down assay of
rat brain proteins bound to AN-STREX-AC. Immunoprecipitated by
a-V5 antibody, AN-STREX-AC (illustrated below the gel, see Figure
3.7) was incubated with rat brain lysate. Proteins with affinity for the
fusion protein were analysed by Colloidal blue staining. Several
proteins were associated with AN-STREX-AC one of which, at -80
kDa, was identified as rat PKC-8, a protein that is known to associate
with thioredoxin, the C-terminal tag of the fusion protein [333],
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and Western blotting to determine PKAc association (As Sections 2.7.1 & 2.7.2). Such
an analysis is illustrated in Figures 5.6 & 5.7.
Figure 5.6 illustrates that AN-ZERO-AC and AN-STREX-AC were successfully
immunoprecipitated by the a-V5 antibody but PKAc did not bind to the fusion proteins
under the assay conditions. Although PKAc did not associate other proteins did as
observed following Colloidal blue staining of the total protein eluted (Figure 5.7). Mass
spectrometry has identified one of these as PKC6, a protein known to associate with
thioredoxin [333], indicating that the assay conditions are favourable for protein-protein
interactions.
5.2.1.4 PKAc interaction with leucine zipper 1
As the AN-AC affinity pull-down analysis suggested that this region of the C-terminal
tail domain was not involved in the association of PKAc with the BK channel protein,
other regions of the C-termina! were investigated. This led to the identification and
subsequent investigation of the leucine zipper 1 motif by use of competing peptides to
the leucine zipper I motif, -HA-tagged STREX channels with a mutated leucine zipper 1
sequence, and the Thio-LZl fusion proteins that express the region in isolation from the
remainder of the channel sequence.
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5.2.1.4.1 Competing peptides of the leucine zipper motif
Investigation of the putative role of the BK channel leucine zipper 1 motif in PKAc -
BK channel association was initiated by the application of competing peptides generated
to mimic the leucine zipper 1 sequence as to inhibit protein-protein interactions that
occur via the motif (Table 2.5). The mutant peptide, mLZl, is ineffectual as a leucine
zipper motif as two leucines of the heptad repeat sequence were mutated to alanine
(Table 2.5). The influence of the peptides upon the co-immunoprecipitation of PKAc
and the STREX-HA channel was investigated by incubation of the peptides throughout
immunoprecipitation by the a-HA antibody (Section 2.9.3.1). A representative Western
blot analysis of such an assay is illustrated in Figure 5.8.
STREX-HA channel and PKAc were detected in whole cell lysate from PKAc-
transfected STREX-HA-expressing HEK293 cells and were successfully co-
immunoprecipitated in the absence of competing peptide (Figure 5.8) as observed
previously (Figure 5.1). Inclusion of mLZl peptide in the immunoprecipitation
demonstrated levels of channel pull-down and PKAc co-immunoprecipitation
comparable to that in the absence of peptide. Addition of LZ1 peptide to
immunoprecipitations maintained equivalent levels of channel pull-down but depleted
the apparent quantity of PKAc co-immunoprecipitation suggesting that the intact peptide
is inhibitory to the PKAc-BK channel association.
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Figure 5.8
Co-immunoprecipitation of PKAc with STREX-HA:










Figure 5.8: Representative Western blot comparison of the co-
immunoprecipitation of STREX-HA with PKAc in the presence of
of leucine zipper 1 competing peptides. STREX-HA stable cell line
(illustrated below blots, See Figure 3.13) transfected with excess free
PKAc was immunoprecipitated (IP) by a-HA in the presence (+) or
absence (-) of the LZ1 competing peptide or alanine mutant, mLZl. IPs
were separated by electrophoresis and analysed by Western blotting.
STREX-HA (-130 kDa) and PKAc (-45 kDa) were detected in
HEK293 cell lysate and co-IP observed in the absence of peptide and in
the presence of mLZ. Inclusion of competing LZ1 depletes the
apparent quantity of PKAc pulled down with STREX-HA. Western
blot analysis: sheep a-PKAc 1/5000, rabbit a-HA 1/333, a-sheep-HRP
1/2000, a-rabbit-HRP 1/2000, ECL detection.
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The LZ1 peptide mimics the leucine zipper 1 motif but has little homology to other
regions of the protein sequence with the exception of the putative LZ2 motif (See Figure
1.3 & Appendix B). To investigate the specificity of the LZ1 peptide for the LZ1 motif,
peptides to the LZ2 sequence were applied in equivalent co-immunoprecipitation
analyses by Dr Lijun Tian (Results not shown). No inhibition of the PKAc-BK channel
association was observed suggesting that the specificity of the peptides to their
respective motifs is exclusive and reiterates the inability of the leucine zipper 2-
encompassing AN-AC fusion proteins to associate with PKAc (See Section 5.2.1.3).
This demonstrates that LZ2 is not involved in the association of PKAc with the BK
channel.
Thus, the inhibitory effect of the inclusion of the LZ1 peptide upon PKAc-STREX-HA
channel association, implicates the LZ1 motif in PKAc-channel association.
5.2.1.4.2 mLZ-HA Channels
To investigate whether mutation of the leucine zipper 1 impacted upon the channel
association with PKAc, mLZHA channels were employed (See Figure 3.13). The
central two leucines of leucine zipper 1 (L503, L510) were mutated to alanine, rendering
the motif ineffective as a leucine zipper (See Figure 3.1 & Appendix B). Patch clamp
electrophysiology (performed by Dr Lijun Tian, results not shown) demonstrated that
the mLZ-HA channels were expressed functionally in HEK293 cells and thus indicated
that the channels could be isolated by immunoprecipitation. mLZ-HA stable cell lines
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were transfected with excess free PKAc, immunoprecipitated by a-HA or a-PKAc, and
the association of PKAc with the channels analysed by Western blotting as described
previously (Section 5.2.1.1). As a positive control, STREX-HA/PKAc co-
immunoprecipitation assays were performed in parallel and a representative assay is
illustrated in Figures 5.9 & 5.10.
Both -HA-tagged channels and free PKAc were detected in the whole cell lysates from
stable cell lines of STREX-HA and the mutant channel, mLZ-HA (Figures 5.9 & 5.10).
As observed in Figure 5.1, co-immunoprecipitation of STREX-HA with PKAc occurred
following immunoprecipitation by a-HA and by a-PKAc. However,
immunoprecipitation of the mLZ-HA channel did not result in co-immunoprecipitation
of PKAc and equally, immunoprecipitation of PKAc did not pull down the channel.
This indicates that mutation of the BK channel leucine zipper 1 motif inhibits PKAc
association with the channel implicating the sequence as a possible binding domain for
the kinase.
mLZ-HA as a control in Section 5.2.1.1
Crucially, the inability of the mLZ-HA channel to co-immunoprecipitate PKAc enabled
its use as a negative control to demonstrate the specificity of BK-channel to PKAc
binding that is illustrated in Figure 5.2. As the channel protein is identical except for the
mutations of the leucine zipper, the ability of the non-mutated channels to pull down the
kinase is validated.
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Figure 5.9
Co-immunoprecipitation assays ofPKAc with STREX-HA
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Figure 5.9: Representative Western blots of STREX-HA & mLZ-
HA BK channel co-immunoprecipitation with PKAc. HEK293 cell
lysates from stable cell lines of STREX-HA & mLZ-HA BK channels
(illustrated below blots, See Figure 3.13) transfected with excess free
PKAc were immunoprecipitated (IP) by a-HA. IPs were probed for
free PKAc & -HA-tagged channels by Western blotting. HA-tagged
channels (-130 kDa) and PKAc (-45 kDa) were detected in cell lysates
and co-IP of PKAc and STREX-HA was observed following IP. PKAc
did not co-IP with mLZ-HA. Western blot analysis: sheep a-PKAc
1/5000, rabbit a-HA 1/333, a-sheep-HRP 1/2000, a-rabbit-HRP
1/2000, detection by ECL.
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Figure 5.10
Co-immunoprecipitation assays of PKAc with STREX-HA
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Figure 5.10: Representative Western blots of STREX-HA & mLZ-
HA BK channel co-immunoprecipitation with PKAc. HEK293 cell
lysates from stable cell lines of STREX-HA & mLZ-HA BK channels
(illustrated below blots, See Figure 3.13) transfected with excess free
PKAc were immunoprecipitated (IP) by a-PKAc. IPs were probed for
free PKAc & -HA-tagged channels by Western blotting. HA-tagged
channels (-130 kDa) and PKAc (-45 kDa) were detected in cell lysates
and co-IP of PKAc and STREX-HA was observed following IP. mLZ-
HA did not co-IP with PKAc. Western blot analysis: sheep a-PKAc
1/5000, rabbit a-HA 1/333, a-sheep-HRP 1/2000, a-rabbit-HRP
1/2000, detection by ECL.
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ZERO-mLZ-HA
Equivalent PKAcxhannel co-immunoprecipitation assays were performed by Dr Lijun
Tian upon a ZERO-HA channel with corresponding mutations of the leucine zipper 1
motif and analogous results were obtained (Appendix C). This indicates that splice
variation between the STREX and ZERO variants is unlikely to impact upon the
association of PKAc with the channel protein and thereby provides further evidence of
the role of the conserved leucine zipper 1 motif.
Phosphorylation ofmLZ-HA
The mLZ-HA channel possesses intact S869 and STREX S4 residues equivalent to the
STREX-HA channel residues that were suggested to be PKA phosphorylation targets
(See Chapter 4). However, mutation of the LZ1 motif confers an inability to co-
immunoprecipitate with PKAc (Section 5.2.1) and thus, to investigate whether
association of the kinase with the channel is necessary for phosphorylation, mLZ-HA
channel immunoprecipitated with a-HA (Section 2.6.3) was exposed to in vitro
phosphorylation assays with exogenous PKA (Section 2.8.1.1). The assays were
assessed by Western blot analysis using phospho-specific antibodies (See Section 3.2.3)
as illustrated in Figure 5.11.
Detection of the mLZ-HA channel by the a-phospho-S869 antibody indicates that the
S869 site of the mLZ-HA channel was successfully phosphorylated following the
addition of exogenous PKAc demonstrating that, with a mutated LZ1 motif, the channel
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Figure 5.11
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Figure 5.11: In vitro phosphorylation of the mLZ-HA channel by
exogenous PKAc. mLZ-HA was immunoprecipitated by a-HA and
incubated with or without exogenous PKAc as an in vitro
phosphorylation assay. The mLZ-HA channels are detected by a-HA
and a-S869, and phosphorylation of the S869 site is detected by the a-
phospho-S869 antibody when exogenous PKAc is included in the
assay. The mLZ-HA channel S869 site is not phosphorylated when no
exogenous PKAc is added. Western analysis: rabbit a-HA 1/5000;
sheep a-S869/a-phospho-S869 1/1000; a-rabbit-HRP 1/2000; a-
sheep/goat-HRP 1/15000; ECL detection.
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can still be phosphorylated by PKA in vitro reiterating the electrophysiologically
determined functionality of the mLZ-HA channels. The absence of detectable S869 site
phosphorylation without exogenous kinase addition provides corroborating evidence of
the lack of kinase co-immunoprecipitation with the channel.
5.2.1.4.3 Thio-LZI fusion proteins
Confirmation that the leucine zipper 1 motif is the region of PKAc association with the
channel was examined by Thioredoxin-V5-H6 fusion proteins of the LZ1 region (See
Section 3.2.1.2). These fusion proteins were used to assess the binding of PKAc to the
leucine zipper 1 motif by exposure of immunoprecipitated LZ fusion proteins to purified
PKAc or rat brain lysate (Section 2.9.3) and analysis of the association of PKAc by
Western blot analysis (Section 2.7.2) as illustrated in Figure 5.12.
Incubation of the Thio-LZI fusion proteins with purified PKAc did not result in co-
immunoprecipitation of the kinase. However, PKAc from rat brain lysate associated
with the Thio-LZI fusion protein although not with the mutant Thio-mLZl protein.
This suggests that an intact leucine zipper 1 motif is required for the association of
PKAc with the sequence, an interaction that requires the presence of auxiliary factors
present within the rat brain lysate.
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Figure 5.12
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Figure 5.12: Co-immunoprecipitation of PKAc with LZ1 fusion
protein. Thio-LZl & Thio-mLZl fusion proteins (illustrated below the
blots, see Figure 3.7) were immunoprecipitated using a-V5 antibody
and exposed to pure PKAc or rat brain lysate. Immunoprecipitations
were separated by SDS-PAGE and stained by Silver to determine
successful & equivalent immunoprecipitation (B) or were probed for
the presence of PKAc by Western blotting (A). PKAc from rat brain
lysate co-immunoprecipitated with LZ1, but not the mutant, mLZl.
Pure PKAc did not co-immunoprecipitate with either fusion protein.
Western blot analysis: sheep a-PKAc 1/5000, a-sheep-FIRP 1/2000,
detection by ECL.
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5.2.2 Heteromultimerisation
Formation of functional BK channels composed of different individual a-subunit splice
variants may contribute to the wide functional and regulatory differentiation attributed to
these unique channels. Thus, to determine if splice variants could associate together,
HEK293 cells were co-transfected with STREX-V5-H6 and either STREX-HA or
ZERO-HA BK channel splice variants and the cell lysate divided for
immunoprecipitation by a-HA or a-V5 (Section 2.9.3). Controls of the channels co-
transfected with pcDNA3 vector were performed in parallel. Co-immunoprecipitation
was determined via Western blotting as illustrated in Figures 5.13 and 5.14.
The -HA and -V5-H6 -tagged channels were successfully detected in the appropriate
whole cell lysates demonstrating successful transfection of the channels into HEK293
cells (Figures 5.13 & 5.14). Immunoprecipitation by a-HA pulled down the STREX-
HA and ZERO-HA channels with co-immunoprecipitation of STREX-V5-H6 (Figure
5.13). STREX-V5-H6 was not pulled down in the absence of an -HA-tagged BK
channel (Figure 5.13). Reciprocally, immunoprecipitation by a-V5 successfully co-
immunoprecipitated STREX-HA and ZERO-HA with STREX-V5-H6 with no pull down
of the -HA-tagged channels in the absence of STREX-V5-H6 (Figure 5.14). This
indicates that non-specific pull-down of channels did not occur following
immunoprecipitation with either a-HA or a-V5 and thus demonstrates that STREX-
STREX and STREX-ZERO a-subunit associations can occur.
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Figure 5.13
Heteromultimerisation of the BK channel:
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Figure 5.13: Representative co-immunoprecipitation of -HA tagged
BK channels with STREX-V5-H6. STREX-V5-H6 was co-transfected
with STREX-HA, ZERO-HA (Illustrated below the blots, See Figure
3.13) or peDNA3 and channels immunoprecipitated with mouse a-HA
antibody. Immunoprecipitations were separated by electrophoresis and
probed for epitope tagged channels by Western blot analysis using
rabbit a-HA or a-V5. STREX-V5-H6 co-immunoprecipitated with
STREX-HA and ZERO-HA channels, but did not pull-down in the
absence of the HA-tagged channels. a-V5 detected non-specific
proteins at -120 kDa in immunoprecipitations. Western blot analysis:
mouse a-V5 1/5000, rabbit a-HA 1/333, a-mouse-HRP 1/2000, a-
rabbit-HRP 1/5000, detection by ECL.
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Figure 5.14
Heteromultimerisation of the BK channel:
Association of STREX & ZERO-HA with STREX-V5-H
Immunoprecipitation by a-V5
Co-transfections:


























Figure 5.14: Representative co-immunoprecipitation of -HA tagged
BK channels with STREX-V5-H6. -V5-H6 and -HA epitope-tagged
BK channels (Illustrated below the blots, See Figure 3.13) were co-
transfected and channels immunoprecipitated with mouse a-V5
antibody. Immunoprecipitations were separated by electrophoresis and
probed for epitope-tagged channels by Western blot analysis. STREX-
HA and ZERO-HA co-immunoprecipitated with STREX-V5-H6
channels and did not pull-down in the absence of STREX-V5-H6. a-V5
detected non-specific proteins at -120 kDa in immunoprecipitations.
Western blot analysis: mouse a-V5 1/5000, rabbit a-HA 1/333, a-
mouse-HRP 1/2000, a-rabbit-HRP 1/5000, detection by ECL.
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5.3.1 PKAc interaction
Previous studies have described a direct association of the catalytic subunit of PKA,
PKAc, with the C-terminal domain of the Drosophila melanogaster BK channel [204].
The results described in this study, using the murine BK channel as a model, determine
that PKAc and the mammalian BK channel assemble in vivo, yet the characteristics of
this interaction are distinct from that of the insect channel homologue.
5.3.1.1 Splice variation has no influence upon PKAc-BK channel association
The ability of both the STREX and ZERO BK channel splice variants to co-
immunoprecipitate PKAc and reciprocally, the ability of PKAc to co-immunoprecipitate
the channels (Figures 5.1 & 5.2), suggests that the splice variation between these BK
channel a-subunit proteins does not influence the association of the kinase with the
channel. Indeed, in vitro, the bacterially-expressed fusion protein, GST-STREX did not
associate with PKAc (Figure 5.4) demonstrating that the 58 amino acid long insert
cannot, at least in isolation, function as a binding site for the kinase. Further evidence of
this determination was indicated by the inability of the AN-STREX-AC and AN-ZERO-
AC fusion proteins to associate with PKAc (Figure 5.6). The structural influence of the
fusion tags, the absence of conformational interactions and constraints induced in the in
extenso, in vivo channel protein, and chemical influences such as pH and ionic
environment may generate a conformation of the bacterial ly-expressed recombinant
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STREX insert that is distinct from that in the in extenso, in vivo channel protein.
Similarly, the conformation of associating proteins may be altered as to make binding
ineffective and thus, native associations may be inhibited whilst non-native binding
could be encouraged. However, binding conditions were equivalent to accepted
physiological conditions and were adequately favourable to enable the association of
other proteins with the fusion proteins (Figures 5.5 & 5.7). Thus, the STREX insert and
splice variation between the STREX and ZERO channels are suggested to not be
involved in the association of PKAc with the full-length channel protein implicating a
site or sites common to both splice variants as the region responsible for kinase-channel
association.
5.3.1.2 Phosphorylation has no influence upon PKAc-BJ£ channel association
The co-immunoprecipitation of PKAc with the S4A-S869A-HA channel paralleled the
pull-down observed with the STREX and ZERO variants (Figures 5.1 & 5.2)
demonstrating that the serine-869 and STREX serine-4 residues do not have to be intact
for the association of PKAc with the BK channel protein. Mutation of these residues to
non-phosphorylatable alanine prevented phosphorylation of the -HA-tagged BK channel
protein under in vitro phosphorylation assays (Figure 4.20). Thus, the ability of S4A-
S869A-HA to associate with PKAc suggests that phosphorylation of these residues is
not a prerequisite to kinase-channel association and. by inference, implicates a site or
sites distinct from these phosphorylation targets as the location of kinase binding.
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Further to this, the catalytic competence of the kinase is suggested not to be a factor in
the association of PKAc with the BK channel a-subunit. This is implied by the co-
immunoprecipitation of the catalytically inert PKAc-K72E with STREX-HA (Figure
5.3). Although HEK293 cells express endogenous PKAc that co-immunoprecipitates
with the -HA-tagged BK channels (Figure 5.1), the comparably weaker signal that
results without additional co-transfection suggests that, although a proportion of the
immunoprecipitated PKAc will originate from this source, the over-expressed PKAc-
K72E protein is contributing to this signal. Thus, this suggests that PKAc does not have
to catalytically active and hence, does not have to phosphorylate the channel protein to
associate with the BK channel a-subunit.
5.3.1.3 The LZ1 motif is responsible for the PKAc-BK channel association
The region identified as the domain responsible for the PKAc-BK channel association in
Drosophila [204] is equivalent although not identical to residues 806-978 of the murine
STREX sequence. This region is encompassed by the AN-AC fusion proteins, which
failed to associate with PKAc under the experimental conditions employed in this study
(Figure 5.6). Thus, the differences in the channel sequences must cause a difference in
the kinase association, implicating distinct channel-kinase interaction mechanisms
employed by the insect and mammalian systems. Therefore, in contrast to the
Drosophila channel, regions outwith the sequence of the murine AN-AC fusion proteins
are implicated in the BK channel-PKAc association. The inhibition of PKAc co-
immunoprecipitation with the STREX-HA channel in the presence of competing
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peptides against the LZ1 motif lead to the identification of the motif as a determinant of
this interaction (Figure 5.8).
As illustrated in Figure 5.15, the presence of the LZ1 peptide in the a-HA
immunoprecipitation of the STREX-HA channel is suggested to inhibit the channel
association with PKAc competitively by interacting with the LZ1 motif and/or PKAc or
the bridging protein via the dimerisation ability of leucine zipper motifs [214, 218], The
leucine to alanine substitutions of the mLZl mutant peptide renders it ineffectual as a
leucine zipper, prohibiting dimerisation and thus, preventing the competitive inhibition
of PKAc-BK channel association. The slight co-immunoprecipitation that is observed in
the presence of the LZ1 peptide may be due to incomplete inhibition. This could result
from the LZ1 peptide not encompassing a sufficient length of the leucine zipper 1 motif
sequence as to enable some background association, or insufficient peptide
concentration to induce complete block. Further studies could investigate this by the
application of protein denaturing detergents to inhibit protein-protein interactions, the
influence of different lengths of peptide sequence and peptide titration. However, for
the purpose of this investigation, the indication of the motif as the PKAc association site
was considered sufficient to warrant further study of the region by mutant channel and
fusion-protein generation and indeed, this provided corroborate evidence of this role.
The inability of the mLZ-HA channel to co-immunoprecipitate with PKAc (Figures 5.9
& 5.10) demonstrates that the L503 and L510 residues of the murine BK channel LZ1
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Figure 5.15
The action of inhibitory peptides upon PKAc association
with the BK channel LZ1 sequence
LZ1 Peptide mLZl Peptide
Figure 5.15: Model for the inhibition of PKAc association with the
LZ1 motif of the BK channel. PKAc (dark blue) is postulated to
associate with the BK channel a-subunit in vivo either directly or
indirectly via leucine zipper dimerisation involving the channel leucine
zipper 1 (LZ1) motif (cyan). The LZ1 peptide (blue circles) parallels
the motif sequence and thus, is assumed to inhibit the association by
binding the channel LZ1 motif and the PKAc / PKAc-associating
protein(s) as to competitively inhibit the interaction. The mutant
peptide, mLZl (red circles), is altered to make it ineffectual as a
leucine zipper (See Section 5.2.1.4.1). Thus, mLZl does not interact
with the channel LZ1 motif, nor the PKAc / PKAc associating
protein(s) and hence, PKAc can associate with the channel protein.
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motif are crucial to ability of the channel to associate with the kinase. Although the
leucine to alanine substitutions should confer minimal structural disruption to the
channel protein, it is possible that the mutations, and indeed the LZ1 peptide, could
disrupt the channel conformation as to inhibit the association of the kinase with other
regions of the protein. The ability of the mLZ-HA channel to be phosphorylated by
exogenous PKAc (Figure 5.1 1) demonstrates that the channel is still phosphorylatable,
and thus the phosphorylation state of the channel is not critical to kinase association and
is distinct from the role of the LZ1 motif. The motif could act as a facilitator to the
association and not be the target. However, the ability of the Thio-LZ fusion protein to
associate with rat brain PKAc indicates that the motif is indeed a critical and sufficient
mediator of kinase-channel association (Figure 5.12).
Again, the requirement of an intact LZ1 motif was observed with the leucine to alanine
substitutions of the mutant, Thio-mLZl, preventing kinase association with the
recombinant protein (Figure 5.12). Although structural influences of the mutations
could affect the association of PKAc with a distinct region(s) of the protein, the short
sequence length expressed in the fusion proteins (128 residues; See Table 3.1) implicates
the LZ1 motif, or residues proximal to it.
5.3.1.4 The LZ1 motif may enable PKAc-BK channel association through an
intermediary, bridging protein(s)
PKAc is highly conserved across species suggesting that the bovine and rat proteins are
sufficiently homologous to enable successful substitution (ncbi accession no's: bovine:
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P00517; rat: CAA37350). Thus, the affinity of Thio-LZl for the rat brain PKAc but not
the purified bovine PKAc (Figure 5.12) is not due to characteristic differences of the
PKAc proteins, but is indicative of an indirect interaction between the kinase and the
fusion protein, involving an intermediary protein or proteins that bridge between the
kinase and the leucine zipper (See Figure 6.1). This may facilitate the efficient
regulatory phosphorylation of the BK channel residues by PKA by ensuring proximal,
and thus effective, positioning of the enzyme. The leucine zipper 1 motif may associate
with an adapter protein via leucine zipper dimerisation. This protein may bind directly
to PKAc or there may be further intermediary, bridging proteins to facilitate and thus
maximise the effective and efficient positioning of the catalytically active kinase to the
phosphorylatable residues of the BK channel protein. Such a bridging protein, or
proteins, may also be associated with the membrane or cytoskeletal elements to maintain
its proximity to the BK channel, and may even be involved in bringing other regulatory
proteins into the immediacy of the channel. These may include other protein kinases,
protein phosphatases and calcium modulators, and even other ion channels such as
calcium channels, described previously as associating with SK channels to enhance the
efficiency of ion channel function [334],
The role of AKAPs in directing the anchoring of the regulatory subunit of PKA has been
described for several mammalian systems (See Section 1.5.1). However, these proteins
are not noted to associate directly with PKAc and their association with PKAr is through
hydrophobic and not leucine zipper-mediated interactions [335], Further studies will be
required to investigate whether an AKAP is involved in this association, and whether
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PKAr is co-immunoprecipitated by BK channel splice variants. The bridging protein(s)
responsible for associating with PKAc and aligning it to the BK channel may not be a
typical AKAP and thus, the determination of a novel protein, or group of proteins, that,
through the dimerisation of leucine zippers, parallels the action of a typical AKAP but
associates with PKAc instead of PKAr is possible. Such an adapter protein is probable,
as it would be detrimental to a cell to have uncontrolled, free PKAc capable of
phosphorylating proteins non-specifically, regulating cellular pathways inappropriately.
Insect cells may exhibit a different mode of PKAc control that results in the direct
association of PKAc with the Drosophila BK channel protein [204], Thus, the bridging
protein(s) may be specific to mammalian systems. Mass spectrometric analysis of the
co-immunoprecipitating bands could identify this protein(s) in future studies. This may
uncover an integral anchoring protein(s) that participates in the formation of the BK
channel complex to maintain a dynamic, effective and efficient ion channel complex
underlying the successful application of BK channels to their numerous physiological
roles. The protein(s) may be involved in proximating PKAc with other ion channel and
signalling complexes and may function as a linchpin to bring many integral signalling
proteins together. Equally, the LZ1 motif of the BK channel may be multi-functional
and enable the dynamic association of several, distinct accessory proteins. Future
studies of the dimerisation of leucine zipper motifs in non-DNA binding proteins may
uncover a more widespread and comprehensive method of protein-protein association
than was previously thought.
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5.3.2 Heteromultimerisation
The crucial component of the BK channel complex is the BK channel pore itself and the
results of Figures 5.13 & 5.14 indicate that channels can assemble as both homo- and
heteromultimers in vivo. STREX a-subunits can associate with other STREX a-
subunits as well as with the ZERO splice variant. However, such multimerisation may
result following the cellular lysis of the immunoprecipitation procedure, and functional
channels may not be formed between distinct splice variants in the co-transfected
HEK293 cells, nor indeed, in vivo. Future electrophysiological investigations of co-
transfected heterologous systems and native tissues will be required to fully assess this
issue. Affirmation of the specificity of such interactions could be confirmed in further
studies with BK channel proteins with mutated, ineffective RCK domains and indeed,
investigation of chimeras with RCK domains in Kv channels that do not expresses the
domain natively will be of interest. However, the conservation of the RCK
tetramerisation domain (Figures 1.3 & 1.4) between the STREX and ZERO splice
variants implies that the region may be non-specific to splice variation of the BK
channel a-subunit enabling such uinter-splice" associations. The conservation of the
domain in other BK channel splice variants suggests that many possible permutations of
the BK channel tetrameric pore may exist, as illustrated schematically in Figure 5.16.
With distinct splice variants displaying unique regulatory and functional characteristics,
the ramifications for possible regulatory variation of BK channels are enormous. For
example, channels composed of both STREX and ZERO subunits may confer unique
properties, or possess a character intermediate between the homomultimeric channels.
255
Chapter Five: The BK Channel Co
Figure 5.16
Heteromultimerisation of tetrameric channels
Large cylinders: different colours representing different
splice variants of BK channel a-subunits; pale nlue could
represent ZERO with red representing STREX splice
variants.
O Purple rectangles: accessory proteins such as p-subunits
Figure 5.16: Heteromultimerisation of tetrameric BK channels
may contribute to the wide regulatory & functional variation of the
channels. The immunoprecipitation evidence presented in this study
suggests that different splice variants of the BK channel a-subunit can
associate together. If this occurs in vivo, functional channels may
result from four identical subunit (a) or combinations of different
splice variants (b). As illustrated above, several combinations could
result where two variants are expressed. As several splice variants have
been described, channels could result from four individual splice
variants (c). The presence of accessory proteins such as the p-subunit
(d) may add to the complexity of regulation.
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The ratio of one splice variant to another in a functional tetramer is also likely to
impinge upon the precise functional properties of the channel. Cells and tissues that
express several unique splice variants may express channels ranging from
homomultimers to heteromultimers composed of four different a-subunit isoforms
contributing to wide variation in individual channel properties throughout the cell/tissue.
Especially in situations such as the cochlea where small differences in BK channel
properties are key to the fine-tuning of physiological requirement, splice variant
heteromultimerisation in combination with accessory subunit associations may be
fundamental. Thus, if different splice variants of the BK channel do form functional
channels in vivo, this may be a crucial mechanism for achieving the functional and
regulatory variation, dexterity and specialisation of these ubiquitous ion channels.
5.4 Chapter Summary
The catalytic subunit of PKAc was shown to associate with the BK channel a-subunit in
a manner that was not influenced by splice variation nor the phosphorylation state of the
channel protein or catalytic competence of the kinase. This association was dependent
upon a conserved leucine zipper 1 motif connecting the cytoplasmic C-terminal domain
with the tetramerising RCK domain. The motif is suggested to interact with PKAc via
an intermediary protein, or proteins, to facilitate the phosphorylation and subsequent
modulation of the BK channel by the kinase and thus contribute to the BK channel
complex. At the core of this complex is the BK channel itself, which is suggested to not
just to form homotetrameric channels, but also heteromeric channels composed of
different interacting a-subunit splice variants.
257
Chapter Six: General Discussion & Future Work
Chapter Six:
General Discussion & Future Work
258
Chapter Six: General Discussion & Future Work
Chapter Six:
General Discussion & Future Work
This study aimed to investigate the molecular nature of the regulation and interaction of
PKA with BK channel variants with particular emphasis upon the molecular basis of the
distinct regulatory responses of the ZERO and STREX BK channel splice variants.
Using recombinant fusion proteins of the BK channel a-subunit C-terminal domain in
conjunction with heterologously expressed epitope-tagged full-length channels, the
investigation of channel phosphorylation and complex assembly was performed in vitro
and in vivo.
In combination, site-directed mutagenesis, biochemical phosphorylation and the use of
phospho-specific antibodies revealed PKA phosphorylation of the conserved serine
residue, S869, in STREX and ZERO splice variants in vivo, a site that is also a potential
target for CaMKll but not PKC. Additionally, the STREX insert serine residue, STREX
S4, was identified as a PKA-mediated phosphorylation target, possibly functioning as a
PKC but not CaMKll phosphorylation target residue. Co-immunoprecipitation
strategies determined that the catalytic subunit of PKA co-immunoprecipitated with both
the STREX and ZERO BK channel splice variants in vivo. Such complex assembly was
dependent upon and mediated by a conserved -130 amino acid region encompassing the
a-subunit C-terminal domain leucine zipper motif, LZ1, with association requiring
intermediary adapter protein(s) whilst remaining independent upon the phosphorylation
state of the channel protein. Thus, these data suggest that the distinct responses of the
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STREX and ZERO channels to PKA is likely to result from the differential
phosphorylation of specific PKA consensus motifs within the splice variants and not as a
result of differential association of the kinase.
Physical interaction ofPKAc & BK channels
The determination of the PKAc - murine BK channel a-subunit association through
intermediary adapter protein(s) and the conserved BK channel LZ1 region contrasts to
the direct binding of PKAc described with the Drosophila BK channel [204], Although
in vivo phosphorylation of the S869 motif is conserved between insect and mammalian
BK channels, it appears that distinct mechanisms of kinase to channel association have
developed. The equivalent sequence of the Drosophila and, indeed, the C. elegans BK
channels to the mammalian LZ1 motif region express phenylalanine and lysine residues
at the third and fifth d positions of the heptad motif respectively (Appendix B). Thus,
Drosophila BK channels may not possess an intact, functional LZ1 that is able to
facilitate PKAc-channel interactions. Indeed, the direct association of the kinase with
the Drosophila BK channel suggests that such a mechanism may not be required in this
system. However, further investigations will have to be performed to uncover whether
the LZ1 motif is used ubiquitously to enable the PKAc-channel association, including in
Drosophila BK channels, or whether the mechanism is a specialisation of mammalian or
even murine systems.
Phosphorylation of the -HA-tagged channel with a mutated LZ1 motif, mLZ-HA, was
still possible with exogenous PKA indicating that association of the kinase with the
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channel is not necessary for phosphorylation. However, the effectiveness and efficiency
of the phosphorylation remains to be fully assessed and will provide the basis of future
electrophysiological studies. It is possible that, in vivo, without the excess of PKAc that
is applied in these experiments, PKA phosphorylation of murine BK channels with
mutated LZ1 motifs cannot be achieved effectively at a level sufficient to enable the
required physiological effect of the channels. Thus, the purpose of such an adapter
protein-dependent mechanism may be to proximate the kinase to the channel, perhaps
even bringing the kinase close to specific consensus motifs, to facilitate the dynamic and
effective regulation of the BK channels by PKA-phosphorylation. Such a model is
illustrated in Figure 6.1.
Increasingly, evidence of leucine zipper motifs functioning as mediators of protein-
protein interactions is mounting and going beyond their long-established role in DNA-
binding proteins, being described for other ion channels such as KCNQ1-KCNE1
potassium channels, inositol 1,4,5-triphosphate receptors and ryanodine receptors [318,
331, 332], Thus, the use of leucine zippers may be found to be a common mechanism of
regulating and mediating protein-protein associations with profound implications,
especially to the elucidation of the functioning and component identification of dynamic
signaling complexes. Mass spectrometric identification of the proteins co-
immunoprecipitating with BK channels may help to uncover the nature of proteins that
contribute to the BK channel signaling complex and, in time, the complex as a whole
may be revealed. Complex characteristics that could be investigated following-on from
the findings of this study include; dynamic regulation, positional targeting and
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Figure 6.1
Proposed interaction of PKAc with the BK channel
Plasma membrane
Bridging protein(s) with
Leucine zipper motif? AKAP
=
Cytoplasm
Figure 6.1: Model for the proposed interaction of PKAc with the
BK channel a-subunit. The leucine zipper 1 motif of the BK channel
a-subunit is integral to the association of the channel with PKAc but
does not bind the kinase directly. An associated protein may bind the
motif through leucine zipper dimerisation and directly or via other
proteins bind PKAc bridging between kinase and channel. This may
facilitate PKAc phosphorylation of channel residues namely serine-869
(S869) and STREX serine-4 (S4). The bridging protein(s) may be
involved in the associations of other regulatory proteins such as
calcium modulators and may even bind an AKAP perhaps facilitating
the dynamic PKA-mediated regulation of BK channels via AKAP
binding of PKA regulatory subunits (PKAr). For simplicity only the
cytoplasmic C-terminal domain of one of the a-subunits forming the
tetrameric channel is illustrated. This is represented in blue, is not to
scale and the putative a-helices and C-terminal labeled as Figure 1.4.
262
Chapter Six: General Discussion & Future Work
maintenance of signaling molecules/proteins, whether known proteins such as AKAPs or
even other ion channels such as calcium channels are included, and whether such
complexes are specific to a particular ion channel/protein kinase/protein phosphatase or
are promiscuous in nature.
Differentialphosphorylation underlies the distinct regulation ofBK channels by PKA
Consistently throughout this study, the S869 residue of ZERO fusion proteins and full-
length channels was phosphorylated by PKA in vitro and in vivo. Together with
previous electrophysiological investigation of S869 mutation [190, 202, 205, 229] and
by analogy to dual mutation of S869 and STREX S4 residues in STREX-expressing
channels, these results indicate that the S869 residue is the only residue that is
phosphorylated by PKA in the in extenso ZERO channel a-subunit protein in vivo.
Confirmation of these preliminary analyses could be performed by phosphorylation of
ZERO,S869A fusion proteins analogous to the proteins used in this investigation, and by
mass spectrometric analysis to determine the phosphorylation target residues in full-
length channels. However, the results presented here in combination with the
electrophysiological analyses indicate that such phosphorylation of S869 is critical to
PKA stimulation of the ZERO splice variant.
Inclusion of the STREX insert within the channel protein does not prevent S869 residue
phosphorylation. However, electrophysiological analysis in previous studies has
demonstrated that phosphorylation of the site is not critical to the inhibition of the splice
variant by PKA; alanine substitution of S869 did not prevent the inhibitory regulation of
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the kinase [229]. Further to this, use of the AN-AC fusion proteins in this investigation
indicated that S869 phosphorylation was not prerequisite to phosphorylation of the
distinct STREX S4 site. In vivo phosphorylation analyses using STREX,S869A
channels and, hopefully, antibodies with sufficient specificity to STREX S4
phosphorylation to enable determination of channel phosphorylation will have to be
performed in the future to confirm this assumption although, certainly, the current
evidence supports this view. Thus, inclusion of the STREX insert is proposed not to
inhibit, nor encourage, S869 phosphorylation, whilst the phosphorylation state of the
S869 residue is not influential to the regulation of STREX BK channels by PKA (See
Figure 6.1). Thus, S869 and STREX S4 residue co-phosphorylation in STREX channels
appears to be unimportant to PKA-mediated regulation of the channel. Therefore,
STREX S4 residue phosphorylation by PKA is suggested to be dominant to
phosphorylation of the S869 site. Why such seemingly inconsequential phosphorylation
should still occur remains to be elucidated. It may exert a subtle or a distinct influence
upon STREX channel activity that is currently undetermined. The possibility of
residual, non-functional phosphorylation appears wasteful and inefficient in such a
crucial and dynamic cellular system.
Although PKA-phosphorylation of STREX S4 has been determined in vitro through this
study, corroborating evidence of in vivo phosphorylation remains to be established.
Further studies may find an improved method of detection, either through enhanced
autoradiographic detection, or by improved, affinity purified antibodies against the
phosphorylated STREX S4 residue. Use of a different fusion tag or a distinct expression
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system may increase channel expression and subsequent protein levels following
isolation, and a method may be determined that removes the complicating non-specific
immunodetection that hampered analysis in this study by the a-phospho-STREX
antibody. Mass spectrometry, particularly techniques such as MALDI-TOF, may enable
the identification and conformation of phosphorylated BK channel residues in further
studies. However, the evidence amassed in this investigation through fusion protein
phosphorylation analyses suggests that the STREX S4 residue is indeed phosphorylated
by PKA in vivo, and that it is this unique feature of STREX channels that induces
differential regulation of the ZERO and STREX splice variants by the kinase.
Thus, differential phosphorylation is suggested as the molecular mechanism underlying
the distinct regulation of STREX and ZERO BK channel splice variants by PKA.
However, exactly how the phosphorylation of the splice variants influences channel
activity remains to be elucidated. The structural arrangement of the cytoplasmic C-
terminal domain of BK channels is currently undetermined, although with improvements
in crystallography, the relative topologies of STREX and ZERO variants, and
phosphorylated and non-phosphorylated forms may be comparable in the future.
Through conjecture, it is possible that the distinct PKA-phosphorylation of STREX and
ZERO splice variants could induce different conformational effects upon the a-subunit
protein, or upon the association of an accessory protein(s). As the topology of the
domain is undetermined, the proximity and relative conformation of the PKA-
phosphoryiation consensus motifs to other regions of the protein is unknown. PKA
phosphorylation of STREX and ZERO channels may exert influence differentially
265
Chapter Six: General Discussion & Future Work
through a common mechanism, just one inhibitory, one stimulatory, or the mechanisms
may be distinct. The gating of the channel may be differentially influenced through
phosphorylation-induced conformational constraint upon integral regions such as the P-
loop or voltage sensor (See Figure 1.4). This is certainly an area for future investigation.
Physiological implications
Whatever the ensuing mechanism of differential PKA-regulation of the splice variants
that results from the distinct phosphorylations, it appears that the STREX and ZERO BK
channel splice variants are regulated by PKA via LZ-mediated PKAc association. This
means that the signal transduction mechanism and associating accessory proteins, such
as the unidentified adapter proteins, are conserved. Thus, to induce a change in the BK
channel contribution to the electrical character of the cellular membrane only the BK
channel splice variant ratio has to alter. This could be useful in vivo especially in the
fine-tuning of cellular and tissue responses to particular physiological stimuli and
particularly, during negative feedback responses. Such alterations are not immediate
due to the requirement of protein transcription and translation and thus, may be of
particular influence in longer-term responses. This is likely to contribute to the
effective, dynamic responsiveness of BK channels to various physiological stimuli, and
may be found with other splice variants too.
Heteromultimerisation
Indeed, such physiological specialisation of BK channels resulting from alterations to
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the splice variant expression ratio may be further "fine-tuned" by heteromultimerisation
of different splice variant a-subunits into functional, tetrameric channels. The co-
immunoprecipitation assays performed in this study suggested that in addition to
homomultimers, heteromultimerisation between the STREX and ZERO a-subunit
variants could occur in vivo. Such interactions may contribute greatly to the regulatory
diversity of BK channels and may explain, at least in part, why BK channels are able to
be so ubiquitously expressed and integrated into diverse, critical physiological systems
requiring a smorgasbord of regulatory and functional diversity. As no alternative
splicing within the tetramerisation, RCK domain has been described currently, it is
possible that all BK channel splice variants, with all their distinct, displayed
characteristics may be able to associate functionally in vivo producing BK channels with
intermediary, or even unique, wide-ranging features. The benefits of this to BK channel
specialisation are immense and may go a way to explaining the evolutionary success of
these ubiquitous channels. Further studies upon other splice variants, and
electrophysiological analysis of heteromultimeric BK channels will be a fascinating area
of future research.
Influence ofotherprotein kinases
Additionally, the molecular influence of other protein kinases upon BK channel splice
variants should be addressed in future studies. This investigation has demonstrated that
protein kinases, in addition to PKA, can phosphorylate BK channel residues in vitro;
CaMKlI phosphorylated the S869 motif of S869 peptides and AN-AC fusion proteins,
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whilst PKC phosphorylated the STREX S4 residue of GST-STREX and AN-AC fusion
proteins. It will be interesting to see if such phosphorylations occur in vivo, and to
investigate other putative phosphorylation motifs of other protein kinases. Indeed, with
specific antibodies and multiple screenings, the co-immunoprecipitation of several
individual protein kinases and phosphatases could be assessed. Although such
signalling proteins are stimulated by distinct signal transduction pathways, it is
conceivable that they may exert their regulatory influence upon BK channels through
common mechanisms and even through phosphorylation of common consensus motifs
where applicable. Further analyses, inhibiting other endogenous protein kinases, will
have to be performed to confirm and assess their role further.
Final thoughts
How BK channels achieve the amazing regulatory variation that underlies their near-
ubiquitous expression, multi-functionality and requirement in diverse, critical
physiological processes is a complex and diverse issue of which this study is only
preliminary and elementary, a beginning to a more in-depth understanding of these
critical ion channels. With future studies, the complete molecular mechanism of the
reversible protein phosphorylation of BK channels may be uncovered and may provide
an insight into their regulation, diversity, ubiquity and how and why mutations and
expressional abnormalities of BK channels may underlie certain disease mechanisms,









Appendix A: Schematic of the mechanism of PKA activation.
(l)Unstimulated PKA exists as a a catalytically inactive holoenzyme
comprised of two catalytic subunits (PKAc; turquoise rectangles) and
two regulatory subunits (PKAr; green ovals). (2) With elevation of
intracellular cAMP (yellow circles) following adenylate cyclase
stimulation, (3) cAMP binds PKAr and induces the conformational
release of PKAc. (4) PKAc is now catalytically active and able to
associate with ATP (red square) and substrates (blue octagon) and (5)
catalyse substrate phosphorylation; the transfer of the terminal





Comparison of putative BK channel leucine zipper motifs
Appendix B a: The putative leucine zipper 1 (LZ1) and 2 (LZ2)
sequences from the murine BK channel. Schematic of channel (not
to scale) as Figure 1.4 with numbering as STREX splice variant (See
Figure 1.3) illustrating the LZ1 and LZ2 sequences and their positions
relative to the STREX S4 and S869 PKA-phosphorylation sites (red
asterisks). The standard one letter amino acid code is used.
Appendix B b: Alignment of the region equivalent to the mouse
LZ1 motif in the BK channels of other species. Numbering of
sequences as [341]. Heptad sequence, a-g, is
illustrated in the top row with the critical d residue highlighted.
Residues that may function successfully at this point, i.e., leucine (L),
isoleucine (I) and phenylalanine (F), valine (V) and asparagine (Q), are
also highlighted whereas residue that are unlikely to form a functional
leucine zipper d residue, including aspartate (D), glutamate (E),
arginine (R) and lysine (K) are not. For comparison, the LZ2
sequences is illustrated in grey below the alignment and shows that
murine LZ2 possesses one less leucine zipper heptad than murine LZ1.
This may be an influential factor in the differential abilities of LZ1 and
LZ2 to interact with PKAc (See Section 5.2.1.4.1). The leucine
residues of LZ1 and LZ2 that were mutated in this study are indicated
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Appendix C: Representative Western blots of ZERO-HA & ZERO-
mLZ-HA BK channel co-immunoprecipitation with PKAc. Cell
lysates from stable cell lines of ZERO-HA & ZERO-mLZ-HA BK
channels (illustrated below blots, See Figure 3.13) transfected with
excess free PKAc were immunoprecipitated (IP) by a-HA. IPs were
probed for free PKAc & -HA-tagged channels by Western blotting.
HA-tagged channels (-125 kDa) and PKAc (-45 kDa) were detected in
cell lysates (results not shown) and co-IP of PKAc and ZERO-HA was
observed following IP. PKAc did not co-IP with ZERO-mLZ-HA.
Western blot analysis: sheep a-PKAc 1/5000, rabbit a-HA 1/333, a-
sheep-HRP 1/2000, a-rabbit-HRP 1/2000, detection by ECL.
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Protein Kinase A Regulation of BK Channel Splice Variants
Coghill, L.S., Florance, H., Antoni, F.A. and Shipston, M.J.
Large conductance calcium- and voltage- activated potassium (BK) channels are
important determinants of endocrine, vascular and neuronal cell excitability. Despite
being the product of only one gene (KCNMA1), native BK channels display diverse
functional properties. Such diversity results from alternative splicing of the nuclear pre-
mRNA, and is exemplified by the different response of two major BK channel splice
variants to protein kinase A (PKA). Channels expressing a unique 59 residue, cysteine-
rich insert (STREX) located within the channel's intracellular C-terminal domain are
inhibited by PKA, whereas channels lacking this insert (ZERO) are activated. The aim
of this study was to investigate the interaction of PKA with STREX BK channels.
Hemagglutinin (HA)-tagged STREX BK channel splice variant was co-expressed with
PKA catalytic subunit (PKAc) in HEK293 cells, and immunoprecipitated (IP) with anti-
HA or anti-PKAc antibodies. Final IPs were analysed by SDS-PAGE, blotted, and
probed for HA or PKAc. IP with anti-HA resulted in co-IP of PKAc and, reciprocally,
IP with anti-PKAc resulted in co-IP of HA-tagged STREX channels suggesting that
PKAc and the STREX channel exist as a complex. To investigate whether the STREX
insert is a possible PKAc binding site, the 59 residue STREX insert was expressed as a
GST-fusion protein (GST-STREX) in E.coli and purified by glutathione sepharose
(GS4B) chromatography. PKAc did not directly interact with GST-STREX in an in
vitro pull-down assay. To investigate whether PKAc can interact with GST-STREX as
part of a larger complex pull-down assays were performed using rat brain lysate or
HEK293 cells as sources of endogenous PKAc. However, although PKAc was not
found to associate with the GST-STREX fusion protein, PKAc phosphorylated GST-
STREX in an in vitro phosphorylation assay. In vitro phosphorylation of GST-STREX
was completely abolished on mutation of a single serine residue (S4A) within a putative
PKA-consensus site within STREX.
These data suggest that PKAc associates with the STREX channel as observed by IP.
However, although the STREX insert is a target for phosphorylation by PKAc, affinity
pull-down assays indicate that the STREX insert is not required for interaction of PKAc
with the channel.
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